Проверка набора гипотез

SCOUT from stereochemistry and protein-aging chemistry, conditional: In a defined aging-human tissue, spontaneous post-synthesis aspartyl isomerization or racemization may produce a functionally consequential endogenous protein pool whose chemistry causes resistance to ordinary degradation. The frozen unexpected consequence remains: restoration of lysosomal membrane integrity or corpse uptake could leave disposal of this material incomplete. For an accessible and demonstrably repairable subset, protein-L-isoaspartate O-methyltransferase-dependent correction could enable subsequent destruction of the same protein backbone and reduce continuing accumulation. Modified-protein enrichment alone cannot establish this direction: prolonged residence may cause modification, modification may prolong residence, or both may occur. Correction preceding destruction is also insufficient without evidence that correction enables it. Persistence specifically attributed to chemical resistance after macrophage uptake requires the identified modified protein to enter macrophages and resist their processing machinery. Uptake can fail to affect an inaccessible or trafficking-limited pool through other routes. Direct correction of intact protein may independently improve function without accelerating destruction. The retained parent mechanism is correction-enabled degradation; superiority over the focal handles or measured metabolic-demand reduction and multisystem sufficiency remain separate conditional claims.

Механизм. The SCOUT role and proteochemical-stereoisomerization mechanism are retained. S_M_G1_DOM01_007 is the contextual PITT membrane-repair lead; Foundations C08–C10 remain provenance references rather than archived support. Integrity, acidity, delivery, enzymatic capacity and destruction are separate endpoints. Cytosolic proteins, extracellular matrix and corpse cargo have different routes and cannot be pooled as interchangeable substrates. Lower modification abundance can arise through intact-protein correction, destruction, altered synthesis, redistribution or changed cell composition. Modification may affect degradation through folding and aggregation; those mediated effects remain within this hypothesis. Direct functional repair is a compatible alternative, not a replacement of the parent mechanism. All shared source, SPV_1, accounting, measured-demand, function, safety, maintenance and human-feasibility conditions in IH_Q_L3_M_G1_1_01 apply. Short pulse–chase measurements do not establish long-lived human accumulation slopes. This mechanism remains distinct from dominant-negative coassembly, defective nascent sequences, catalytic damage propagation and lysosomal membrane repair alone.

Предсказание. Begin with sequence-matched modified, unmodified and pre-corrected proteins with analytically resolved modification sites, linkage and stereoisomers. Use standards and sample-handling controls to distinguish biological modification from changes introduced during preparation. In defined proteolytic conditions, compare direct effects with conformation, aggregation and accessibility held comparable; separately measure total effects when modification is allowed to change folding or aggregation, since these can mediate chemical resistance. Measure modification formation and backbone turnover independently to distinguish modification-driven retention from residence-driven modification. Identify a matching endogenous pool at functionally consequential abundance in older-human donor cells, initially proposed dermal fibroblasts, recording age, sex, disease and treatment. Define consequential abundance through a measurable effect on specified tissue-relevant function at endogenous exposure rather than merely enrichment in old material. Specify whether the pool is cytosolic, lysosomal, extracellular-matrix-associated or corpse-associated. Cross verified lysosomal integrity, leakage, acidity, delivery and ordinary proteolytic capacity with active versus catalytically inactive repair enzyme at comparable delivery, localization, substrate access and cofactor exposure. Avoid artificial overload and independent toxicity; measure metabolic flux, synthesis and stress responses. The focal result is selective persistence of the modified pool despite restored ordinary processing, followed by verified chemical correction that causally increases destruction of the same labeled backbone. Establish the correction-mediated step using analytically characterized pre-corrected substrate: remove the repair enzyme and reaction components before a matched degradation challenge, with sham-treated modified controls, so a direct effect of the enzyme or carryover on proteases cannot alone explain rescue. Confirm the relevant result in endogenous material; cell-free rescue does not establish cellular delivery. Measure correction yield, remaining modified forms and the accessible repairable fraction. Track intact modified and corrected backbones, degradation products, export, cell loss, redistribution, new synthesis and label recycling across original cells, macrophages and medium. Loss of an isomer signal, catalytic dependence or temporal order alone is insufficient. For the uptake prediction, directly trace the same identified modified backbone from corpse cargo into macrophages, verify restored ordinary macrophage processing, and test persistent material and correction-enabled destruction within that compartment. Fibroblast retention and cell-free resistance do not establish macrophage resistance. If the pool never reaches macrophages, investigate access and trafficking. Observe chemical conversion over hours and turnover over days or longer within demonstrated viability. Comparable degradation after ordinary processing restoration weakens the proposed chemical limitation for that substrate. Correction that improves function without increasing backbone destruction supports a compatible direct-repair interpretation rather than the parent degradation chain. Only after establishing the causal sequence should repeated exposure compare post-transient accumulation, functional injury and harms with membrane repair, uptake restoration and measured metabolic-demand reduction.

CROSS-DOMAIN TRANSFER, conditional: In a defined aging-human tissue, direct macrophage obstruction or contest over targets may cause consequential interruptions of completed corpse clearance and thereby sustain secondary injury. The frozen unexpected consequence remains a conditional ranking reversal: at sufficiently high physiological macrophage density, an achievable reduction in interference could outperform a specified TIM-4 attachment enhancement, whereas attachment enhancement would be more effective at sufficiently low density. Density alone does not establish this ordering. Under the assumed response F=aN/(1+ahN+cM), compare attachment enhancement a→qa, q>1, with interference relief c→rc, 0≤r<1, at the same positive N and M and unchanged h. For c>0 and qr<1, interference relief produces greater throughput when cM>(q−1)/(1−qr), attachment enhancement wins below that threshold, and they tie at equality. Whether physiological densities and achievable exposures span both regimes is an unverified assumption. The equation predicts increasing total clearance with recruitment at fixed N and increasing, saturating per-cell clearance at fixed N/M. A clearance advantage could improve SPV_1 only through separately demonstrated reduction of continuing injury and preservation of tissue function.

Механизм. The CROSS-DOMAIN TRANSFER role and consumer-interference mechanism are retained. The corrected fixed-N and fixed-N/M predictions remain in force; the historical fixed-N/M decline is not a current defect or prediction. The original high-versus-low-density intervention ranking remains prospective and conditional. Baseline a, h, c, target identity, density ranges and achievable q and r must be specified before evaluating that ranking. The mathematical crossover needs no empirical citation to be derived, while its named provenance, biological applicability, achievable exposures and downstream benefit remain unverified. Recognition, handling and interference can coexist. Lysosomal repair may improve limiting handling or affect other processes; its role must be measured. The contextual TIM-4 node is an unverified recognition lead. All shared source, SPV_1, transport, measured-demand, function, harm, maintenance and human-feasibility conditions in IH_Q_L3_M_G1_1_01 apply. This mechanism remains distinct from corpse-derived nutrient recycling, consumer replacement, finite energy inventories and physical barrier restoration.

Предсказание. Use older-human donor macrophages in a defined three-dimensional dermal system with verified irreversibly dead targets of specified identity and size. Record donor age, sex, diseases, medications and macrophage state. First measure relevant human-tissue density ranges and spatial distributions. Independently vary N and M, separating fixed-N and fixed-N/M paths. Directly image contacts that interrupt encounter, capture, internalization or subsequent processing; quantify their duration, recurrence and attributable lost clearance time. Mere contact at high density is insufficient. Measure accessible volume, target depletion and accessibility, motility, encounter frequency, capture probability, oxygen, nutrients, viability, activation, metabolic flux, intracellular processing and readiness for another target. Cross calibrated attachment enhancement with selective relief of the observed interruption. At the same N and M, interference relief should recover consequential lost clearance time and increase completed destruction beyond changes explained by ordinary access, resources, capture or intrinsic handling. Relief of the obstruction itself may improve access; distinguish that causal change from unrelated changes in baseline accessibility rather than requiring access to remain invariant by definition. Use reversible or orthogonal perturbations where feasible and verify their specificity. Define a completed-removal event for the chosen target using observed uptake and processing of specified material; separately report any residual refractory fraction. Calibrate q and r independently and prospectively compare the two interventions below and above the crossover when c>0 and qr<1. Compare per-cell and total clearance within each density. Continued benefit from attachment enhancement, a positive fitted c or a throughput crossover alone does not prove direct interference. If qr≥1, the stated pure-parameter interventions have no crossover. If interventions also alter h, geometry, access or cell state, use measured changes to test the full response rather than applying the simple threshold. Validate predictions on held-out density combinations and during serial processing; allow rejection of constant parameters or the quasi-steady approximation. Observe contacts over hours and processing over days within demonstrated culture viability. Measure corpse production, extracellular residence, uptake, intracellular stock, export and destruction products separately. Faster uptake may increase storage, and faster destruction may leave an injury process unchanged. After a selective clearance rescue, test secondary injury, tissue function and post-transient damage slopes directly against attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls. Failure of selective rescue at relevant densities challenges direct interference in that regime; failure of the crossover constrains the comparative prediction without excluding interference generally. Failure to reduce injury despite increased destruction limits the downstream aging claim.

HERETICAL, provisional and conditional: In a prospectively defined subset of aging human dermal fibroblast lineages, repeated partial reprogramming could produce durable recovery chiefly by expelling chemically persistent lysosomal residual bodies through lysosomal exocytosis. The strong hypothesis remains that removal of the nominated material is necessary and sufficient for the prespecified durable functional component under fixed extracellular-disposal conditions, and that sustained nuclear rejuvenation is dispensable for that component. These are separate unverified causal claims. Sustained nuclear rejuvenation is operationalized as persistent movement of prospectively nominated age-associated nuclear features or programs toward an independently characterized younger-adult fibroblast reference, beyond predefined measurement uncertainty, throughout a fixed post-withdrawal repeated-repair interval. The specification must include relevant narrow regulatory programs as well as broad profiles; it cannot exclude a program merely because it proves necessary for recovery. Ordinary nuclear regulation means the transcriptional and regulatory activity needed to maintain viable specialized fibroblasts, without necessarily reversing an independently established age-associated nuclear state. Persistent regulatory changes are classified by the prospective reference criteria, not by whether they favor the hypothesis. Functional benefit persisting while broad profiles return toward baseline establishes divergent trajectories, not causal or statistical independence. Dispensability requires a separate selective perturbation comparison preserving verified cargo removal and ordinary cell function. Recovery must occur in original contributors and persist after confirmed factor withdrawal through repeated repair. Safe downstream disposal, adequate replacement, reserve and growth control remain conditions to test. Reduced annual fibrotic-area progression, SPV_10, remains a separate conditional extension.

Механизм. The frozen mechanism and strong unexpected consequence are preserved as hypotheses. The operational nuclear definition bounds an interpretable test; it does not replace the broader claim with independence from a few age markers. Unmeasured nuclear changes remain an explicit limitation. Persistent regulation that meets the preregistered rejuvenation criteria cannot be relabeled ordinary regulation after results are known. Selection, transient state changes and genuine restoration may coexist. RA_M_G4_04 requires clearance compatible with replacement, but a dermal fibroblast construct cannot establish epithelial replenishment. RA_M_G4_07 requires spatial and delayed assessment. S_M_G4_DOM01_016, S_M_G4_DOM01_017 and S_M_G4_DOM06_006 supply unverified transplantation-selection, blood ancestry/state and muscle-compensation analogies, respectively. They do not demonstrate those processes in reprogrammed dermis. The mechanism remains export of persistent material, distinct from generic transport improvement, positional assembly memory, dominant-negative coassembly and catalytic damage propagation. The reader and reconstruction must use the corrected Russian definitions below rather than their historical claims of independence.

Предсказание. Before confirmatory testing, use independent calibration samples to fix cargo chemistry, baseline dysfunction, eligibility, the load-bearing matrix endpoint, required improvement, equivalence margins, measurement uncertainty, repair challenges, disposal criteria and observation interval. Eligibility must not depend on treatment response. Establish chemically and ultrastructurally that pre-existing cargo exits surviving original cells, accounting for intracellular, extracellular and recipient compartments, chemical transformation, degradation, division, death and selection within labeled lineages. Then compare sham, matched delivery, repeated reprogramming, selective export blockade, specific export rescue and export alone. Two independent interventions support cargo mediation only if their shared and distinct effects on membrane repair, secretion, lysosomal metabolism, signaling, survival and replacement are characterized. Where technically possible, independently vary cargo removal while matching non-cargo effects, and reproduce those non-cargo effects while cargo remains retained. Failure to achieve this separation leaves full mediation unresolved. Selective blockade should abolish the specified durable benefit, rescue should restore it, and export alone should reproduce it within the locked equivalence margin. Full recovery with retained cargo challenges necessity; verified safe export without recovery challenges sufficiency within the locked population, including when a newly discovered parallel defect explains failure. Do not retrospectively exclude such failures. Separately nominate a nuclear-state vector N, comprising specified broad features and narrow programs, with independently measured older and younger reference distributions under matched identity, cell-cycle, culture and loading conditions. Fix the age-associated direction, required magnitude, persistence rule and post-withdrawal interval before outcomes. After export is complete, selectively prevent or reverse the nominated persistent younger-directed nuclear changes while maintaining low cargo burden, downstream disposal, ordinary nuclear regulation, viability and replacement. Compare with cargo-cleared cells retaining those changes and matched perturbation controls; restore the nuclear changes in a rescue arm if feasible. An additional arm preventing their establishment tests whether they are needed to establish, rather than maintain, recovery. Preserved function within a prespecified equivalence margin supports dispensability only for the tested nuclear changes and interval. Loss of function under a validated selective perturbation, reversed by nuclear-state rescue at unchanged cargo burden, challenges that dispensability claim. A nonsignificant difference, an incomplete panel, or a perturbation that damages ordinary regulation is inconclusive. Follow recipient injury, inflammation, local reserve, absolute competent replacement, matrix architecture and growth control. Measure fibrotic area longitudinally and separately from stiffness, collagen production and load-bearing performance.

SCOUT from corrosion chemistry and radical-chain kinetics, unverified: In a subset of aging humans with postinfectious exertional intolerance, an ordinary contraction could release a localized, catalytically available heme-associated iron pool that initiates lipid radical propagation despite genuine early reconditioning. Continued formation of oxidative damage after the initiating contraction could then cause delayed functional loss and incomplete recovery. The heme-derived species, accessibility and compartment are part of the hypothesis: total iron, ferritin stores or labile nonheme iron cannot substitute for that pool. The radical state remains an active catalyst with susceptible material and continuing propagation, not merely persistent end products or generic oxidative stress. It could be an autonomous post-initiation process or a downstream amplifier of mechanical, inflammatory or infectious injury; those versions require separation. A safe activity-preserving interruption could improve SPV_4 and SPV_5 only if the chemical injury materially drives them; neither effect nor their ordering is established.

Механизм. ROLE: SCOUT_1. Retains catalyst-dependent initiation and radical propagation from corrosion chemistry as the non-obvious source field, explicitly as an unsupported transfer. Living muscle differs in oxygen supply, buffering, antioxidant defenses and repair, so the analogy supplies no empirical validation. S_M_G2_DOM04_018 and S_M_G2_DOM08_015, audited unknown in G2_5_20–24, do not supply iron speciation. Novelty and grounding remain unknown. Iron-dependent force loss alone does not establish ferroptosis. Neither chronic inactivity nor indiscriminate antioxidant use follows; shared conditions and limitations govern human aging inference. Frozen originating central mechanism, retained verbatim as a conditional conjecture and identity anchor, not as an observation or an operative comparator: SCOUT from corrosion chemistry and radical-chain kinetics: In aging humans with postinfectious exertional intolerance, a contraction-triggered release of catalytically available heme iron could initiate lipid radical propagation in otherwise successfully reconditioned muscle. The important stored state is a chemically active catalyst together with oxidizable local material; it is not an energy shortage or an error in manufacturing new contractile proteins. Force can rise through adaptation while each subsequent bout renews chemical injury that outlasts the initiating contraction. A small initiator can therefore produce delayed local pathology and larger SPV_5 losses without a new infection or mechanically correlated regional failure. Interrupting catalytic propagation, if causally supported and safely achievable, could stabilize SPV_4 and subsequently SPV_5 while preserving useful activity. Frozen originating unexpected consequence, retained verbatim as the conjectured surprise: A small initiator can therefore produce delayed local pathology and larger SPV_5 losses without a new infection or mechanically correlated regional failure. Scope of these frozen originating statements: the present process_hypothesis, discriminating_prediction and limitations specify the operative causal comparison. Assertions of sufficiency, abolition, exclusivity, required ordering or guaranteed benefit in the originating wording remain stronger conditional extensions, unverified and subject to the original source limitations; no empirical status is upgraded. The central new-product/path/catalyst/rebuilding-gate object is unchanged.

Предсказание. Under shared_conditions and the time-indexed effect definition in competition_interpretation, identify an endogenous physiological species and compartment: distinguish heme retained in protein, released heme-associated catalyst and any subsequent conversion to dissociated nonheme iron. No one readout substitutes for another; source, accessibility, concentration, conversion kinetics and contraction threshold remain unknown. Conditional on their identification and artifact-controlled preservation, the implicated catalytic rise must precede newly forming lipid oxidation and injury. Quantify formation separately from clearance and follow new oxidative flux after contraction and before delayed force loss. Measure or bound fresh initiation from inflammation, mitochondrial dysfunction, ischemia/reperfusion, mechanical disruption and peroxide breakdown, together with propagation and termination in the relevant compartment. Operationally, the stronger autonomous version predicts continuing consequential new damage over a specified post-initiation window after the initiating contraction ends and continuing external initiation is absent or bounded too small to explain the flux under an explicit kinetic model. Internal catalyst/substrate/peroxide cycling must be specified within that model rather than silently counted as zero initiation. No duration or quantitative bound is supplied. If ongoing initiation cannot be bounded or independently varied, autonomy is unidentified; an input-dependent chemical amplifier remains possible. The ordinary alternative predicts continued insults or slowly cleared products without the proposed preceding catalytic transition. For a future delayed interruption define t0 after the documented initiating history and before intervention. Compare pre-t0 actual work and imposed demand, viable mass, force, injury, catalyst state and productive pathogen burden, then estimate the total subsequent protection from target-engaged interruption against its control under a comparable independently imposed demand schedule where feasible. Measure compartment-level target engagement and new oxidation before subsequent injury and force change. Direct tool actions on metabolism, contraction, host defense or pathogen growth that bypass the intended catalytic change are alternative intervention pathways requiring specific controls if feasible; if unresolved, rescue alone cannot attribute protection to the proposed catalyst. Changes after t0 in viability, injury, force, achieved work, inflammation or pathogen burden caused by chemical protection or feedback belong to the total effect and must not be matched away. Do not require subsequent viability or injury equality to test preservation. A changed imposed load or direct contractile impairment is reported separately as an exposure tradeoff. A contrast holding specified later infection or injury trajectories fixed concerns a narrower controlled direct effect and is attempted only when independently feasible with overlap; it is not a prerequisite for the total amplifier effect. Convergent sequestration and independently acting chain termination support attribution only after target engagement and direct off-target routes are examined, not simply because both rescue. Conditional restoration must reproduce the identified physiological species, localization, concentration and timing; bulk toxic iron addition is not a validating reversal. Relate the amount and duration of new oxidation to subsequent force loss and the fraction of recovery delay/residual loss, with useful adaptation and defense assessed. Lower products without less injury or functional loss are insufficient. Iron dependence can identify a downstream amplifier without autonomy or exclusion of mechanical/infectious causes. Adequate sensitive negative tests constrain the specified compartment/window only and do not establish a rival.

CROSS-DOMAIN TRANSFER, conditional: In a prospectively characterized subgroup of older humans, maintained training could strengthen a cardiovascular corrective response faster than compensating relaxation and feedback-delay adjustments occur. If the complete acquired parameter trajectory reduces damping, and regional regulation transmits the excursions to vulnerable tissue, alternating ordinary activity, posture changes and heat could produce recurrent renal or splanchnic perfusion undershoots despite acceptable mean perfusion. Muscle adaptation could improve mobility while sufficiently deep, prolonged and recurrent undershoots cause incomplete recovery and persistent receiving-organ dysfunction. Increased sympathetic-to-pressure responsiveness b with initially approximately unchanged delay tau remains one concrete test assumption. Neither increased b nor a larger workload response alone guarantees reduced damping. Correcting the acquired mismatch or avoiding its independently predicted vulnerable timing could protect organs while preserving mobility, conditional on all transmission and injury links. The mechanism remains a mismatch among corrective gain, relaxation and delay; it does not invoke learned neural memory.

Механизм. The cross-domain creative role is retained while empirical status remains assumption. S_M_G3_DOM05_011 on orthostatic recovery and S_M_G3_DOM05_002 on thermal circulatory strategies are contextual leads, not archived support. Stable forced resonance, reduced stable damping and instability are distinct. SPV_12 is a conditional model-dependent coupling coefficient and delay, not an established aging biomarker or universally desirable target. Electrolyte feedback, temporal competence windows and learned-controller explanations remain distinct proposals.

Предсказание. At fixed measured thermal state, perform repeated baseline and serial acquisition-period identification during maintained training and an appropriate control, using safe independently varied nonperiodic workload and posture inputs. Estimate trajectories and relative adaptation rates for the full parameter set, with uncertainty; a before-and-after difference cannot establish the proposed mismatch. The candidate b increase and delayed compensating changes must precede a verified reduction in damping, regional consequences and any persistent deficit. Record respiration, heart rate, pressure, cardiac output estimates and validated regional flow, with muscle sympathetic recordings in a specialist subset. Test structural and practical identifiability, parameter recovery and plausible omitted respiratory, cardiac, vascular and baroreflex states. Independently estimated parameters must predict held-out pressure settling and regional-flow responses across new sequences and acquisition stages. Predictive superiority must be evaluated against stable forced-response models and models allowing training-related changes in vascular reserve, thermal accumulation and ordinary recovery kinetics. A training-by-timing interaction is necessary for the proposed timing implementation but is not specific to it. Do not require an unestablished linear proportionality between benefit and a fitted parameter: prospectively predict the direction, sequence dependence and uncertainty from the identified model. Even superior prediction does not establish a coefficient's biological identity; that requires independent physiological validation or a selective perturbation with collateral effects assessed. Validate the regional arterial-to-venous pressure-gradient and resistance bridge, then determine whether regional excursions produce epithelial microperfusion or oxygen deficits. Protected tissue despite systemic oscillation contradicts that transmission link in the tested regime. Establish organ-specific magnitude-duration and recovery relationships separately in appropriate preparations or safe observations; a root shift cannot supply an injury threshold. Follow sustained renal and intestinal function alongside mobility. Failure of identification leaves attribution unresolved, failure of held-out regional prediction weakens the specified model, and adequately precise absence of the acquired trajectory or tissue consequences contradicts the corresponding biological link.

SCOUT 1, from cellular stress-response kinetics, conditional: In a prospectively characterized subgroup of older humans, an initially noninjurious ordinary warm-activity exposure could induce epithelial protection that subsequently becomes insufficient before heat-shock transcriptional inducibility recovers. This ordering would create an intermediate susceptibility interval in a specified renal tubular or intestinal epithelial population. Refractoriness concerns the capacity to initiate a new transcriptional response; existing functional protection follows a separately measured trajectory. Reduced inducibility can instead accompany sufficient retained protection, so neither low transcription nor decline in one selected chaperone measure establishes the proposed gap. If the gap exists, a second ordinary exposure could cause disproportionate protein-refolding failure and epithelial dysfunction despite comparable perfusion, cellular oxygenation and transport work. Early repetition could remain buffered by existing protection and late repetition by restored inducibility. Muscle adaptation and mobility could continue improving while receiving tissue repeatedly encounters this interval. A persistent organ cost additionally requires cellular deficits to exceed compensation and repair and cause sustained organ dysfunction. Restoring timely second-pulse output could prevent injury; a response appearing after injury may instead aid repair and must be interpreted separately.

Механизм. The stress-response premise, temporal ordering, rescue and cellular-to-organ transition have status assumption, evidence_status unverified and source_ids []. C08-C09 and delayed-recovery descriptions do not establish heat-shock refractoriness. The original scout role is retained, distinct from defective or self-templating protein assembly, catalytic damage propagation, bistable states and depletion of an energy inventory. The formal cross-domain import remains in IH_Q_L3_M_G3_2_02. Novelty and previously untried status are uncertified.

Предсказание. First establish separate tissue-region temperature-time profiles and repeat intervals from safe older-human observations or a validated exposure model with explicit uncertainty. Ambient and core temperatures alone do not establish epithelial exposure. Experiments outside a defensible ordinary-exposure envelope test cellular possibility only. In separately characterized older-donor renal and intestinal preparations, compare sham, single-pulse and prespecified early, intermediate and late repeat conditions at matched oxygenation, flow, nutrients, transport demand and thermal history. Preserve naturally cycling and noncycling distinctions. As a concrete unverified implementation, measure inducible HSP70-family activity, relevant co-chaperone activity, HSPA1A/HSPA1B and DNAJB1 nascent transcription, and HSF1-associated promoter activation. Pair these candidate-specific measures with broader functional refolding, aggregation-suppression, proteostasis and tissue-function assessments; one HSP70-associated assay cannot represent all protective capacity. Define inducibility as the incremental nascent transcription elicited by an identical second pulse relative to matched sham-first-pulse preparations, accounting for viable cell identity and baseline state. Use matched sister preparations when protection assays could precondition the cells. The focal prediction is independently insufficient existing protection and depressed inducibility before excess intermediate-pulse injury, with better early and late tolerance. Serially quantify residual aggregates, refolding, repair capacity, metabolism, viability and cell composition after the first pulse and report detection limits. Bound the largest residual impairment compatible with negative assays; if that uncertainty could explain the second-pulse excess, attribution remains unresolved. A nonmonotonic interval curve alone is insufficient. A proposed temporally gated restoration must leave pre-pulse protection comparable, restore functional protein activity before the injury it is claimed to prevent, and preserve relevant metabolism, survival, repair and composition. Compare immediate injury onset and burden separately from later recovery. Equal initial injury followed by faster recovery supports a repair effect, not the proposed preventive rescue. Inactive controls and an independent response perturbation are required where feasible; broad activation or protective preloading is ambiguous. Finally, repeated cellular deficits must predict control-adjusted sustained organ impairment beyond acute exposure and compensatory tissue responses, with mobility benefit in the same maintained-training comparison. Adequately resolved absence of the gap contradicts the specified tissue-exposure implementation, not every possible tissue or interval.

CROSS-DOMAIN TRANSFER, conditional: In aging human dermal fibroblast lineages whose dysfunction is partly caused by a defined endogenous transcription-obstructing DNA lesion, partial reprogramming could enable accurate excision and replacement using an intact complementary strand, restoring a durable component of specialization after withdrawal. For the nominated complementary-strand-dependent reaction, demonstrably unavailable required information removes that reaction's contribution when direct reversal, sequential restoration and alternative templates cannot supply it. This preserves the original template-dependent consequence. Damage on both strands is only a possible configuration producing information loss; it does not establish that condition. A usable template is necessary for this reaction but insufficient without recognition, chromatin access, competent machinery and completed accurate synthesis. The biological hypothesis additionally requires that this reaction explain incremental durable reprogramming benefit beyond ordinary repair. Other mechanisms may restore function. A separate SPV_8 benefit requires the nominated lesions otherwise to generate substitutions and accurate repair to reduce their fixation within retained lineages. Function may improve without a detectable substitution-rate change. Correctly paired substitutions already fixed in an intact duplex remain outside the proposed reversal mechanism.

Механизм. The cross-domain role, chemical DNA-repair substrate and restored template-dependent unexpected consequence are retained. The previous drift toward treating a template as merely a possible constraint is not repeated. Loss of a reaction's required information removes that reaction's contribution under the stated conditions; loss of all functional recovery is not implied. Function/substitution dissociation remains secondary. Potential distinctiveness concerns a particular endogenous lesion and reaction explaining incremental durable benefit, not the coding analogy alone. The mechanism remains distinct from information-control or sensing resets and genome complementation through fusion. RA_M_G4_01 requires function and growth control alongside clone competition; RA_M_G4_07 requires spatial and delayed assessment. Cargo disposal, DNA repair, centrosome abnormalities and adhesion changes can coexist.

Предсказание. Prospectively nominate one chemically characterized endogenous lesion L, complementary-strand-dependent reaction R, affected loci and matrix-function endpoint. L and R are specifications to establish, not findings. First show that L obstructs relevant transcription and that treatment increases sequence-accurate endogenous correction before substantial composition change, measuring lesion production as well as removal. Cross reprogramming versus sham with intact R, selective blockade and specific rescue, and usable versus demonstrably unavailable required-template information. Under viable conditions with bypass access assessed, information loss should remove accurate R-mediated correction and its additional functional contribution; restoring information should restore those components if other requirements are adequate. This conditional reaction requirement alone does not establish mediation of aging or treatment benefit. Require a treatment-by-repair effect linked to endogenous sequence accuracy, transcription and durable repeated-repair output in original contributors. Evaluate lesion configuration, toxicity, loci, chromatin, replication, cell-cycle state, exposure, survival and replacement. Equal lesion counts do not establish equal injury. Disproportionate blockade toxicity can produce an apparent interaction. Reporter-only dependence, increased synthesis or reduced average lesions is insufficient. Preserved incremental benefit under verified selective blockade challenges mediation by R. Apparent accurate R-mediated repair despite truly unavailable required information and excluded bypasses challenges the reaction specification or information assay. Recovery through another route does not refute R's template requirement. Independently test lesion mutagenicity and measure new substitutions per diploid genome per year with division histories, absolute contributor accounting and error-controlled sequencing; report per-division information separately rather than substituting it for the annual metric. Fewer divisions or changed composition must not be interpreted as increased repair fidelity.

SCOUT 1, from centrosome biology and chromosome segregation, conditional: Repeated partial-reprogramming pulses could uncouple centriole duplication from successful division in cycling aging human dermal fibroblasts. A centriole is a cylindrical microtubule structure; a centrosome contains centrioles and surrounding pericentriolar material that organizes microtubules. Counts depend on cell-cycle phase and ploidy. Inappropriate centriole reduplication is the specifically nominated acquisition route, distinct from failed cytokinesis, polyploidization, baseline abnormalities, normal duplication and preferential survival. If newly acquired excess functional centrosomes persist after factor withdrawal in initially recovered contributors, their inheritance could cause later segregation errors or, through a separately tested link, abnormal daughter placement during repair. Initial specialization and favorable molecular profiles could therefore coexist with subsequent loss of repair competence and growth control. Arrest, death, asymmetric inheritance, elimination of excess structures, adequate replacement and neutral expansion may prevent tissue injury. Selective correction could prevent this route while preserving necessary division and replacement; neither such correction nor a favorable SPV_9 direction is established.

Механизм. Ganem, Godinho and Pellman, 'A mechanism linking extra centrosomes to chromosomal instability,' Nature, 2009, remains a supplied bibliographic lead without archived text or source ID. It cannot verify induction or delayed mediation after partial reprogramming of older-human fibroblasts. Standard organelle definitions add no evidence for the causal chain. The scout preserves the original broad duplication/division-uncoupling mechanism and delayed hazard; inappropriate reduplication remains a specific subprediction. The mechanism is distinct from generic selection and developmental fusion timing. RA_M_G4_01 concerns consequential competition, RA_M_G4_04 adequate replacement, and RA_M_G4_07 spatial and delayed defects. SPV_9 is relative clone growth, not an organelle, function or malignancy measure. Copy number and composition complicate conversion of variant allele fractions into cell fractions.

Предсказание. Continuously observe original contributors from baseline through exposure, withdrawal and subsequent repairs. Count centrioles separately from centrosomal organizing material and verify functional centrosomes relative to phase and ploidy, distinguishing pericentriolar changes from new organelle excess. Record cytokinesis, reduplication, baseline abnormalities and every cell fate. Establish new acquisition, persistence and initial specialized matrix contribution before linking individual later divisions to segregation errors, daughter copy-number changes and repeated-repair output. An alternative acquisition history fails the specific reduplication subprediction without necessarily eliminating the broader inherited-organelle mechanism. At comparable actual exposure and adequate mitotic opportunity, independently validated prevention or correction should reduce errors per mitosis and preserve absolute competent replacement and matrix function. Analyze the full pretreatment population as well as the per-mitosis endpoint: retain deaths, arrests, detached cells and unresolved tracking losses, rather than conditioning conclusions on surviving dividing cells. Report cumulative divisions, errors and functional output together; do not force equality of division counts by discarding affected contributors. Apparent benefit obtained solely through arrest or elimination is not correction in original cells. Measure DNA injury, replication stress and checkpoint state; upstream genomic injury may coexist with downstream centrosome mediation. Independent induction of comparable excess without reprogramming tests the specified cellular hazard, not inevitable cancer. Measure daughter placement directly under characterized matrix, adhesion and cytoskeletal conditions. Verified selective correction that leaves excess failure unchanged challenges mediation in affected lineages. Failures in normal-centrosome lineages identify parallel hazards. Follow descendant replacement, reserve and growth behavior before inferring tissue injury.

HERETICAL, provisional: In a subset of aging humans with endogenous recognition of defined antigens shared by removed and subsequently arising damaged cells, synchronized apoptotic removal could induce persistent antigen-specific functional tolerance. Tolerogenic presentation of the removed cells would reduce later immune recognition of the same damage-associated antigen repertoire. Anatomical repair could therefore succeed while subsequent damaged-cell accumulation accelerates. Every biological link in this aging-human extension remains an unverified assumption. Functional tolerance here means cell-intrinsic anergy in retained viable effectors or functionally demonstrated antigen-specific regulatory suppression. Exhaustion, deletion, affinity-dependent clonotype selection, altered antigen-presenting-cell competence and changed effector abundance are alternatives or concurrent processes, not states already distinguished by the proposed assays. Synchrony changes antigen-delivery peaks and corpse-clearance demand together; measuring both does not identify their separate causal contributions. Repair before removal could worsen tolerance if it removes immunogenic contextual signals, but could instead improve immune access or reduce persistent exposure. Its direction depends on the actual repair intervention and presentation history. Reduced immune elimination accelerates endogenous accumulation only if it remains quantitatively limiting after accounting for target production, antigen escape, redistribution, proliferation and compensating clearance. Repeated external depletion could compensate for the defect, worsen it or leave it unchanged. Maintenance dependence and its appearance after safe cessation remain conditional predictions.

Механизм. The proposed stored state remains antigen-specific immune responsiveness, distinct from a learned neural controller or assumed somatic-clone replacement. Compare lineage-resolved and broad marker-based removal where justified, measuring protective niche function, barrier recovery and antigen-specific surveillance separately. Protective lung niches and harmful muscle populations remain unverified contextual possibilities, not a basis for universal removal. Necessary disease treatment remains in place; omit repair or depletion where no relevant deficit or safe manipulation exists and maintain sufficient barrier function before further loss. Functionally active persistent engineered clearance cells count as continuing treatment; detection alone does not establish activity. Sustained maintenance benefit, treatment-free persistence and harmful rebound require separate observations without deliberately hazardous withdrawal. Immune, signaling, mineral and nuclear mechanisms can coexist. Local confirmation does not establish radical slowing of human aging or exclude infection, cancer, repair or other-organ costs.

Предсказание. Begin with autologous older-human bronchial epithelial, antigen-presenting-cell and lymphocyte cultures. This is a conditional anatomical setting, not evidence that the prerequisites exist. Identify an endogenous damaged-cell population using a reproducible damage phenotype independent of its recognition antigen, then establish antigen identity, baseline recognition, immune contribution to elimination and antigen retention on later damaged cells. Generic senescence-marker positivity is insufficient; engineered recognition tests only an explicitly artificial model. Compare synchronized and staggered apoptosis using the same calibrated method and matched cumulative killed-cell number, antigen amount and initial tissue deficit. Record antigen delivery, presentation, costimulation, corpse uptake, inflammatory exposure and immune access over time. Initially interpret this as the total effect of synchrony. To separate antigen peaks from clearance demand, conditionally use split cultures receiving antigen-bearing and antigen-negative matched apoptotic material with independently varied delivery schedules while holding total corpse arrival constant, and complementary comparisons varying corpse demand while preserving measured antigen-presentation trajectories. Such preparations and manipulations require validation for damage phenotype, uptake, presentation and inflammatory effects; absent independent variation, the mediators remain unresolved. Add repair-order comparisons only when a defined repair action and removal can be manipulated independently. After verified washout and a prospectively bounded acute-recovery interval, challenge with matched and unrelated targets standardized for viability, antigen density, access and killing susceptibility. Use reciprocal tissue, antigen-presenting-cell and lymphocyte transfers to distinguish tissue access, presentation competence and effector defects. Test retained clonotypes separately and in reconstructed mixtures matched for clonotype abundance and measured antigen responsiveness; equal total effector numbers alone are insufficient. Test candidate suppressors by removal and restoration, with matched-antigen triggering crossed against matched and unrelated responder targets in both mixed and separated settings. Suppression triggered by one antigen but affecting nearby unrelated responses must be reported as bystander suppression rather than evidence of selectively impaired recognition alone. For first-episode presentation causation, a concrete conditional contrast is to split equally antigen-loaded autologous antigen-presenting cells and transiently alter their costimulatory state only during first contact with effectors, then remove that manipulation and use common untreated presentation cells and targets for later tests. No selective reagent is supplied or claimed validated. This contrast supports presentation-mediated induction only if antigen-presentation duration, recruitment, viability, initial removal and repair are comparable and carryover and direct effects are excluded; otherwise it identifies only the total effect of the presentation intervention. Finally track endogenous entries into the damaged state, proliferation, elimination, repair-related exits and movement independently. Persistent functional tolerance must precede a sustained clearance-attributable accumulation increase. Artificial target challenges or a transferred immune defect alone cannot establish this rate extension. Preserved surveillance, recovery after acute suppression, sufficient explanation by repertoire selection, exhaustion or presentation defects, or compensation by other clearance pathways rejects or limits the corresponding link in the tested domain.

CROSS-DOMAIN TRANSFER, conditional: During aging human alveolar repair, a still-responsive progenitor could select between initiation-associated and differentiation-associated responses by comparing simultaneous effective pathway scores. The central mechanism remains selection of the strongest effective signal above a minimum threshold rather than progression determined only by one absolute input threshold. Continuing repair-initiation stimulation after closure could therefore keep newly generated cells transitional, while selectively reducing that signal could permit functional maturation despite unchanged cell number. The molecular comparator, identifiable inputs and sensitivities, sufficiently exclusive responses and bounded precommitment interval remain unverified assumptions. The response must predict a consequential same-lineage difference in later maturation or function; opposing reporters alone do not establish such a choice. If the relevant programs merely overlap or form obligatory sequential stages, the proposed two-response selection rule does not apply in that domain. Reversibility concerns the specified precommitment response or commitment propensity, not reversal of mature identity. Repair order matters only through changes in relevant inputs during that interval. Following finite, independently defined proximal pathway reset and equilibration, the rule predicts no additional history dependence within a fixed eligibility domain. This is a restrictive prediction despite potentially persistent receptor, chromatin and downstream states; their persistence cannot be excluded by resetting two proximal activities. Mature identity and other tissue injuries can persist independently. Comparator-directed maturation changes human aging rates only if sustained effects on injury or clearance are separately demonstrated under relevant recurrent exposures.

Механизм. S_M_G1_DOM05_011 is an unverified contextual account of initiation-associated alveolar signaling and stalled completion under persistent exposure. Neither it nor the allocation analogy verifies this comparator. The mechanism remains distinct from independently closing fusion-competence windows and an autonomous bistable stored state. The bounded no-memory prediction concerns only the stated input-response relation. Immune memory, mineral deposits, genomic injury and mature identity can persist. Functional barrier continuity, limiting reserves, growth termination, clonal selection, overgrowth and necessary disease treatment remain separate constraints. Neither a signal-rescue result, fitted switching boundary nor high accuracy on a small selected subset proves the comparator, novelty or SPV_1 improvement.

Предсказание. Use older-human alveolar repair cultures with one defined injury and matched depletion, density, matrix, closure and repair stage. First identify two accessible inputs and a reversible same-cell precommitment response, then demonstrate that this response predicts later functional maturation rather than only reporter opposition. IL-1β-associated signaling is a candidate initiation input from an unverified contextual summary; a differentiation-promoting input remains unidentified. Use the explicit measurement model in operational_definitions. Independently determine background, reporter response functions and reference activities on separate calibration material, fixing the reference convention before estimating sensitivities. A sensitivity may receive biological meaning only if a separately measurable comparator-proximal coupling quantity supports it; otherwise retain only identifiable effective products as phenomenological parameters and report the molecular comparator as unverified. Normalize the common score scale by a declared convention; do not mistake this convention for an empirical sensitivity measurement. Freeze calibration, threshold, uncertainty, response lag, eligibility and donor domain before held-out tests. Test new input magnitudes, durations and histories, including common scaling in measured score space above threshold and crossings of score ordering. Proportional ligand changes need not produce proportional score changes. The focal rule predicts preserved selection when ordering is preserved and a changed response within the declared lag after crossing. Report predictive coverage over all eligible cells and separately across donors and exposure strata; predeclare an independently justified minimum informative coverage. If most observations are indeterminate or score combinations cannot be manipulated with adequate overlap, the test is inconclusive rather than successful. After a molecular comparator is identified, a targeted perturbation must shift the boundary in an independently predicted direction and magnitude without arbitrary refitting. Compare with prespecified absolute-dose, saturation, cumulative-exposure and history-dependent models. Ordinary biochemical antagonism implementing exactly the same rule is compatible. Track cells through immediate response, commitment and mature function. Compare different histories after the fixed proximal reset and equilibration interval; residual response differences falsify this bounded no-history rule, even if later associated with receptor abundance or chromatin. Such a result does not uniquely identify another memory mechanism. Finally test sustained injury and clearance under independently justified ordinary-exposure patterns; improved maturation alone does not establish an aging-rate effect.

SCOUT 2, from confined-cell migration and nuclear mechanobiology, conditional: In a specified aging human epithelium, recently mobilized replacement cells could restore closure and permeability while remaining unusually susceptible to nuclear-envelope rupture under ordinary tissue-relevant deformation. Early exposure to the same ordinary load could cause rupture-mediated genomic injury despite apparently adequate barrier function; escalation is not required. The post-closure vulnerability interval, physiological transmission route, age dependence and injury mediation remain unverified assumptions. Repair before removal may be insufficient if later replacement creates a new susceptible population, and overlap matters only when migration and relevant loading coincide. Maturation could change both force transmission and intrinsic rupture susceptibility, so the total effect of the same physiological load and the effect at matched nuclear deformation are separate predictions. If the same surviving cells acquire adequate nuclear mechanical competence and retain it after protective treatment ends, this particular excess rupture hazard could disappear without continued treatment while previously fixed substitutions persist in surviving descendant lineages. This is an unobserved conditional consequence over a declared interval, not mutation reversal or permanent protection. Geometry changes, selection, death, replacement and residual treatment action are alternative explanations for apparent recovery. Resistance to rupture and faster resealing affect different aspects of rupture exposure. Lesions, substitutions, structural variants and lineage loss remain separate outcomes; SPV_8 requires temporal substitution-accumulation evidence with representative recurrence and lineage accounting.

Механизм. Denais et al., 'Nuclear envelope rupture and repair during cancer cell migration', Science, 2016, https://doi.org/10.1126/science.aad7297, remains an unarchived bibliographic lead. The supplied record does not verify its findings or their transfer to older-human repaired epithelium under ordinary loading. Muscle-conditioning and tendon-turnover summaries do not establish epithelial nuclear readiness, and muscle recovery does not establish tendon or bone readiness. This scout retains injury originating through replacement-cell nuclei, distinct from force-transmission topology as a different central mechanism, positional assembly memory, defective nascent contractile proteins and fixed fusion windows. Measuring transmission within this hypothesis tests how the ordinary load reaches the nucleus; it does not replace rupture-mediated injury with another mechanism. Immune, signaling and mineral processes may coexist or interact. Treatment-free resolution of excess rupture can coexist with a persistent mutation offset and equivalent later slopes under IH_Q_L3_M_G1_2_03. No result supplied demonstrates radical whole-human aging deceleration.

Предсказание. Use repaired older-human bronchial organotypic cultures only after mapping ordinary breathing-related load histories to epithelial and nuclear deformation. Exercise-related respiratory loading is relevant only after its local transmission is validated. Include multiple independent older donors, younger references, paired early and later repair states and unloaded controls; a single older-donor culture cannot establish age specificity. Independently calibrate physiological amplitude, frequency, cycle count, deformation rate, geometry, confinement and prior force history. First compare the same external physiological waveform early and late without conditioning away maturation-dependent transmission. This estimates the total loading-associated difference and includes changes in local nuclear exposure. Separately, where experimentally feasible, impose or compare matched nuclear deformation trajectories, including rate, direction, geometry and loading history, to assess susceptibility at comparable exposure. This second contrast cannot estimate the total maturation effect; matching only scalar strain can leave important exposure differences. Preserve the competence difference under test while accounting for barrier function, depletion, matrix, composition, cell cycle, proliferation, inflammation and oxidation. Track the same cells, distinguishing leakage from death, and measure rupture frequency, duration and cumulative exposure followed by lesions, newly fixed substitutions, structural variants and lineage survival. Rupture preceding injury is necessary but insufficient for mediation. A concrete conditional protection contrast is a temporally restricted envelope-protection manipulation active only around the loading episode versus sham, crossed with loaded and unloaded cultures; a complementary delayed manipulation after the rupture interval tests some direct effects on repair. No selective molecular tool is supplied. Independently validate effects on force transmission, nuclear deformation, chromatin, migration, proliferation, survival, selection and DNA repair. To attribute injury reduction to rupture, require selective variation in rupture exposure or a justified causal model with explicit assumptions about direct effects, unmeasured common causes and treatment-induced confounding. Measurements and two interventions alone do not satisfy those assumptions. A change in unloaded injury or benefit from a delayed manipulation identifies possible direct effects; negative controls cannot prove their complete absence. If separable variation is unavailable, report the total protective-intervention effect and leave rupture mediation unresolved. After competence is independently demonstrated, withdraw protection only in a justified safe model. Establish loss of active exposure and residual target action using separately calibrated kinetics and activity assays, then repeat the same ordinary load and the deformation-matched challenge over a prespecified interval in the same surviving lineages. Analyze all tracked lineages, including losses, rather than conditioning only on survivors. Continued competence with retained earlier substitutions supports the treatment-free consequence within the interval; recurrence supports treatment dependence, and replacement or selective loss supports a population explanation. If residual action cannot be excluded, classify persistence as indeterminate. Restrict findings to nonphysiological conditions if rupture occurs only there. Annual mutation-rate claims require representative recurrence, temporal sequencing evidence and explicit lineage selection analysis.

CROSS-DOMAIN TRANSFER, conditional: In older humans with limited renal reserve, potassium-acid interactions could cause harmful renal-muscle feedback after an ordinary meal or a separately evaluated tolerable activity challenge. Increased extracellular potassium is hypothesized to suppress renal ammonium excretion sufficiently to reduce total net acid disposal. The resulting retained acid burden must generate a sufficiently large and timely exposure at skeletal muscle to reduce potassium uptake; the secondary extracellular potassium rise then further impairs renal acid disposal. Urinary ammonium, whole-body retained acid and muscle extracellular exposure are distinct quantities. Every directed effect, its magnitude and its timing remain unverified. Renal elimination and temporary muscle sequestration provide nominally redundant one-out-of-two protection only if either independently accommodates the same load within the same horizon and physiological limits under matched shared hormonal conditions. Under that condition, reciprocal chemistry could make otherwise sufficient protective functions jointly unavailable. If the functions are sequentially necessary, the redundancy interpretation fails while the chemical-loop question remains open. The target is harmful amplification with useful coordination preserved. Preventing repeated reserve loss and slowing human aging remain additional hypotheses, including the possibility that temporary sequestration merely postpones the burden.

Механизм. The CROSS-DOMAIN TRANSFER role and reversible potassium-ammonium-acid-muscle mechanism are preserved. S_M_G3_DOM05_003 motivates separating total filtration from reserve but supplies no archived evidence for this loop; healthy aging is not assumed to cause universal single-nephron hyperfiltration. Hyperkalemia means potassium above the applicable extracellular reference range. Metabolic acidosis is an acid-base disorder with a primary bicarbonate reduction and does not identify an acid species or cause. Type IV renal tubular acidosis is a comparison diagnosis involving impaired renal acid and potassium handling commonly associated with deficient aldosterone effect; it is not a diagnosis of participants or proof of feedback. Potential novelty concerns a consequential acid-mediated muscle return arm under ordinary loads, not the probability identity. The candidate remains distinct from spatial connectivity and cell-clearance competition. source_ids remains empty.

Предсказание. Measure dietary potassium entry separately from activity-related redistribution, regional muscle potassium uptake and release, urinary potassium, urinary ammonium, titratable acid, bicarbonate excretion, acid production, nonrenal acid-base gains and losses, relevant extracellular volumes and buffering. Urinary net acid excretion is ammonium plus titratable acid minus bicarbonate, expressed as equivalent amounts over the same interval. Titratable acid is operationally the acid equivalents in urinary non-ammonium buffers determined by titration to a specified reference pH, with assay conventions reported. Whole-body acid retention requires an independent balance; buffering redistributes or binds retained acid equivalents rather than automatically eliminating them. Serial blood chemistry does not by itself establish the acid exposure at muscle. Identify the relevant acid-base species, pH and concentration-time trajectory reaching muscle using direct measurements where feasible or an independently validated transport-and-buffering model with uncertainty bounds. If the interval permits negligible or insufficient muscle exposure, the acute mechanism remains unsupported even with reduced ammonium excretion. Replay the participant-range muscle exposure at matched potassium, glucose, insulin, aldosterone and other relevant inputs, and measure regional uptake, release, dose-response and delay. Separately replay the resulting secondary potassium trajectory in renal preparations at matched acid exposure and other inputs; quantify total net acid disposal. Both independently estimated response functions and potassium and acid balances must predict the secondary coupled response on held-out ordinary challenges. A candidate muscle-specific intervention qualifies only if it selectively removes the acid-associated uptake defect while its independent effects on baseline transport, hormones and renal exposure are quantified. Test it in a crossed set of participant-relevant acid, potassium, hormonal and tissue states, including baseline-acid and open-path controls. Validate that direct-effect estimates transfer to the corresponding coupled states; do not subtract a single baseline effect from a nonlinear coupled response without demonstrating that transfer. Under the loop, interruption removes the predicted acid-mediated secondary potassium rise and renewed renal suppression beyond state-matched direct effects. Under primary renal or shared hormonal dysfunction, acid transmission is absent, too weak or too late, although nonspecific uptake enhancement or systemic alkali can still improve concentrations. If no selective interruption or defensible state-specific direct-effect bound is available, report the identified local responses and leave complete-loop rescue unresolved. Separately demonstrate that each protective function alone accommodates the same load over the same horizon and limits, with shared determinants and the other compartment's support specified, before interpreting joint indicator failure as failed redundancy. Follow later potassium release and eventual elimination. Acid exposure developing only after the relevant muscle response rejects the acute timing claim in the tested setting; a slower interaction remains a separate unestablished possibility. Null results require verified target engagement, adequate sensitivity, relevant exposures and represented pathways.

SCOUT 2, from steroid biotransformation and endogenous pharmacokinetics, conditional: In a subset of aging humans, inflammatory suppression of a specific hepatic cortisol-inactivation pathway could prolong biologically active free-cortisol exposure after the initiating external stress ends and adrenal secretion begins to normalize. Sustained exposure could activate an enteric-glial and immune inflammatory relay whose liver-reaching output further suppresses hepatic inactivation. The frozen retained state is reciprocal gut-liver control of endogenous steroid exposure. Systemic clearance alone cannot localize the defect to liver. The enzyme pathway, inflammatory suppression, older-human glial response and physiologically sufficient liver-active mediator remain unknown. The contextual chronic-glucocorticoid mouse mechanism supplies no numerical human dose or duration equivalence. Strong persistence requires sufficient coupling under physiological hormone production, transport and hypothalamic-pituitary-adrenal feedback; tissue reciprocity might instead be stable and merely alter recovery time. Continuing psychosocial stress, administered steroids and learned neural memory are not necessary components, but they, residual infection, injury and retained inflammatory memory remain alternatives or coexisting causes. Restoring the clearance arm could reduce harmful SPV_12 coupling and permit sleep and ordinary-activity recovery while preserving the necessary initial stress response. This consequence remains conditional on preserved useful glucocorticoid actions, host defense and stress competence, and on compensatory secretion not canceling the exposure change.

Механизм. The SCOUT 2 role and endogenous exposure mechanism are preserved, distinct from an unmeasured administered-drug explanation, microbial reservoir, receptor agonism and antigen tolerance. Enteric glia are non-neuronal glial cells of the intestinal nervous system. CSF1 means colony-stimulating factor 1, and TNF means tumor necrosis factor; these names do not establish their involvement in the human phenotype or identify M_G. Tissue cortisol regeneration means conversion of an inactive precursor back to active cortisol and is distinct from adrenal secretion and irreversible disposal. Clearance is removal relative to a specified concentration convention; binding and distribution can change concentrations without equivalent irreversible disposal changes. The hypothalamic-pituitary-adrenal axis regulates adrenal secretion through feedback. E_H and M_G remain unresolved operational placeholders rather than molecular discoveries. Separately described neuronal motility effects are not established components of the frozen loop. Clinical recovery or discharge does not establish pathogen clearance. source_ids remains empty.

Предсказание. First separate adrenal secretion, reversible tissue regeneration, binding, distribution, extrahepatic metabolism and irreversible disposal using specialist isotope kinetics, serial free and total cortisol, binding measurements and steroid metabolomics over repeated circadian cycles. Establish identifiability; report bounds when these determinants cannot be separated. Specify whether clearance is referenced to free or total concentration. Establish a hepatic contribution independently through regional or enzyme-pathway measurements. E_H denotes an unidentified candidate hepatic disposal pathway, not an identified enzyme. Before claiming an enzyme-specific defect, identify the enzyme or defined reaction sequence, labeled products, irreversible fate, hepatic contribution and response to participant-range inflammatory exposure. Measure substrate-to-product conversion and candidate enzyme abundance or activity under matched substrate conditions; a changed expression marker alone is insufficient. A validated pathway-specific loss-and-restoration experiment would need to change irreversible disposal as predicted while alternative pathways and tissue viability are characterized. Until these steps identify E_H, the parent remains a conditional pathway-class hypothesis. Next replay participant-measured free-cortisol concentrations, durations and recovery periods in human enteric preparations containing glia and necessary immune cells, distinguishing glial responses from direct immune glucocorticoid suppression. M_G denotes an unidentified liver-active gut output. Determine its cellular source, production rate, molecular identity or explicitly characterized active fraction, transport, binding, degradation and removal, and the resulting hepatic concentration-time profile. Local gut abundance or culture-supernatant concentration cannot substitute for hepatic exposure. If direct hepatic exposure measurements are unavailable, use a prospectively specified transport model with independently constrained parameters and uncertainty bounds. Test whether the supported exposure range overlaps the measured hepatic inhibitory range. Suppression only at higher concentrations demonstrates pharmacological sufficiency, not operation of the human return arm. At fixed free cortisol and non-gut inflammatory inputs, selective gut interruption should increase pathway-resolved hepatic inactivation after direct hepatocyte exposure to the intervention and active products is excluded. Add-back using the supported hepatic exposure profile should restore suppression. This establishes a return arm only if specificity and physiological delivery are adequate. In a separate unclamped condition, the initial clearance improvement should lower free cortisol, reduce gut output and yield additional clearance recovery. Cortisol replacement should remove the exposure-mediated secondary component; the initial direct consequence of gut interruption can remain. Hepatic restoration followed by replacement alone fits a one-way downstream model. Estimate both tissue response functions, mediator transport, cortisol production and disposal, and adrenal feedback with delays. Test whether their independently measured ranges predict a persistent post-stress state and its interruption, versus stable delayed recovery, on new observations. Include compensatory secretion after increased clearance rather than treating it as zero. A persistent state may coexist with negative feedback without requiring that one local positive gain exceed every opposing process; the complete physiological dynamics must determine the outcome. If compensation restores exposure, predict reduced or absent exposure-mediated functional benefit rather than inferring benefit from clearance alone. Fixed apparatus cortisol tests exposure-response behavior only. Null results constrain adequately represented, specifically perturbed pathways within the tested physiological range. Sleep, activity, host defense and the response to a subsequent safe stress require separate assessment.

CROSS-DOMAIN TRANSFER, conditional and empirically unverified: A common regenerative input could select a harmful lineage in aging human epithelium by increasing simultaneous failures of two growth restraints that each independently veto the same inappropriate cell-cycle entry. Both pathways could remain present while their joint permissiveness increases at comparable individual failure dynamics. The additional escapes must causally generate retained harmful output; post-repair division or high occupancy alone does not make an entry inappropriate. A susceptible lineage could consequently expand despite apparently preserved individual restraints. The frozen withdrawal consequence remains a conditional special case: positive selection can end when independent operation returns if the other relevant probabilities, opportunity processes, descendant outcomes and background fitness also equalize, while accumulated lineage abundance persists. Independence alone supplies none of those equalities. Reducing joint failure could preserve appropriate renewal while limiting harmful output, but it could also suppress necessary repair or release another harmful competitor.

Механизм. The original identity, correlated-redundant-restraint mechanism and cross-domain role are retained. Mathematical identities are distinguished from biological assumptions. No archived text establishes a qualifying pair, regeneration-induced joint failure, selective overlap manipulation or relevance to human aging. Functional independence means separately sufficient vetoes for the same event, not merely molecular separation. Post-closure proliferation may be healthy turnover. A new mutation, permanent abnormal state or residual exposure is unnecessary for the mechanism, although each must be evaluated if present. Pulse phase or oncogene dosage can act upstream of real joint failures; immune history can affect survival. Estimate total upstream effects before testing mediation, preserving phase-caused signaling in the total timing effect. Ending an induced component can leave unequal basal fitness, accumulated abundance and tissue harm. Assess alternate competitors and polyclonal renewal. Separate within-lineage damage from composition and variant allele fractions from cellular fractions. Whole-human inference requires sustained multisystem damage, reserve, deficit and clinical-vulnerability trajectories under ordinary life loads relative to comparable untreated aging, with compensating harms assessed. All empirical links remain unverified, source_ids []; abstract-only evidence remains abstract_only.

Предсказание. Prospectively define the cell-cycle decision, observation horizon and functional criterion independently of restraint reporters. Closure of a repair deficit and restored occupancy identify a candidate context only. Validate inappropriate entry by an intervention showing that allowing the nominated entry, compared with selectively vetoing it in comparable starting conditions, causes persistent excess retained occupancy or impaired mature function while ordinary replacement demand is accounted for. In the same lineage and comparable decision-state strata, factorial interventions must show that either functioning restraint blocks that same event when the other is permissive and that joint permissiveness permits it. Serial components or correlated reporters do not satisfy the architecture. Failure limits this implementation, not every possible restraint pair. Next attempt a programmable relative-timing intervention preserving prespecified marginal distributions of failure probability, episode duration and within-restraint temporal dependence, with comparable relevant phase strata, delivered exposure and pre-intervention histories. It must change cross-restraint overlap; identical realized joint histories cannot be preserved. Check attainable probability bounds and measure opportunity frequency, checkpoint recovery and direct effects on death, differentiation and extrusion. A selective change in functional joint escape should change completed harmful divisions and retained output consistently with observed fates. Reporter covariance alone is insufficient. Use complete pedigree and tissue outcomes as primary endpoints even if the instantaneous rate approximation fails. After withdrawal, compare with matched unstimulated trajectories and measure total net rates rather than infer zero selection from independence. Assess every tracked competitor, spatial occupancy, mature output, barrier function and renewal through a subsequent calibrated repair challenge.

SCOUT 1 from cancer genome amplification biology, conditional and empirically unverified: In an aging human epithelial mosaic already containing a rare lineage with replication-competent extrachromosomal oncogene DNA, regenerative cycles could preferentially enrich pre-existing higher-copy descendants. Natural substrate presence, replication, transmission, expression and a causal growth contribution are separate prerequisites. If retained copies continue to express sufficient oncogene activity under the prevailing niche and checkpoint conditions, they could supply heritable excessive signaling after withdrawal. This is independence from the removed regenerative input, not from basal support, immunity or cooperating defects. The frozen unexpected consequence remains possible: selectively reducing extrachromosomal dosage could restore restraint while ordinary chromosomal growth regulation and neighboring renewal remain intact. Reduced proliferation or lineage death alone would not establish this consequence. The mechanism applies only to substrate-positive tissue, with dysplasia or cancer retained in its scope. Natural prevalence in ordinary nonmalignant aged epithelium and relevance to whole-human aging remain unknown.

Механизм. The cancer-genome import is an unverified assumption with source_ids []. Turner et al., 'Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity,' Nature, 2017, remains an unverified bibliographic lead; its absent text supplies no result. Oncogene denotes the nominated gene whose activity is hypothesized to cause excess growth; identity and causal activity must be established. Extrachromosomal denotes a physically separate DNA species verified by complementary structure and localization, not copy gain alone. Replication competence requires new-copy production and continued lineage transmission. An inherited epigenetic state is a persistent regulatory state transmitted through division without requiring a corresponding sequence change; it remains an alternative. The substrate is replicating oncogene dosage, not fusion, topology, centrosome dysfunction or chromosome missegregation substituted for the parent mechanism. Within-founder comparisons retain possible linked genetic and regulatory differences. Selection, copy generation, segregation and additional division opportunities can coexist. Immune escape, joint restraint failure and pulse phase may mediate or modify dosage effects. Persistent copies, expression, abundance, relative selection, absolute expansion and independence from the withdrawn input are distinct. SPV_9, lineage/reference rates and absolute growth require separate evaluation; variant allele fraction is not automatically cellular fraction. Decompose damage averages into within-lineage and compositional changes. Organoid growth, animal tumors and human cancer incidence have different evidential scopes. One disease risk does not establish whole-human aging acceleration. Such inference requires sustained multisystem damage, reserves, deficits and clinical vulnerability under ordinary life loads relative to comparable untreated aging, with compensating harm assessed. Sources are absent and abstract-only material remains abstract_only.

Предсказание. Before stimulation, establish the naturally occurring extrachromosomal oncogene species using complementary localization, structural and junction evidence, distinguishing chromosomal amplification and integration. Separately demonstrate new-copy production and transmission through divisions. Before claiming selection of pre-existing high-copy descendants, validate a way to link each starting copy state to its subsequent pedigree. A proposed route is minimally perturbing live copy-state measurement calibrated against terminal structural and copy assays in tracked cells and matched sacrificial subsets; its accuracy, temporal resolution and neutrality remain prerequisites. Do not equate an expression reporter with DNA copies or infer one sister's copy state from the other without validated segregation information. Compare unstimulated, repeated-regeneration and withdrawn arms, tracking copy-conditioned division, survival, retention, per-division copy transitions, new amplification, bottlenecks and linked genetic or regulatory states. The focal prediction is preferential retained output from identifiable pre-existing higher-copy descendants relative to the unstimulated trajectory. Additional divisions with unchanged per-opportunity fitness support increased opportunities for basal selection; new-copy production alone does not establish selection of pre-existing high-copy descendants. If only destructive cross-sectional measurements are available, population redistribution may be estimated, but direct individual inheritance and selection remain unresolved unless an independently validated model identifies them. After verified withdrawal, separately measure retained copies, expression, signaling and continuing excess absolute and relative growth. Structurally specific copy reduction, if achievable without consequential damage or integrated-copy effects, should reduce its growth contribution. Orthogonal oncogene-output suppression and matched expression rescue test oncogene mediation. The conclusion is limited to the specificity achieved: expression rescue alone does not prove a special role for extrachromosomal inheritance. Persistent growth after sufficient validated output reduction supports other drivers or coexistence. Functional rescue requires restored restraint in surviving cells, mature differentiation, barrier integrity and later repair, with neighboring replacement capacity assessed separately from lineage elimination.

SCOUT 2 from cell-cycle chronobiology, conditional and empirically unverified: Repeated regenerative pulses could select a harmful lineage in aging human epithelium when its daughters repeatedly encounter pulses in a responsive cell-cycle phase and consequently produce more completed, retained descendants. This can occur despite no advantage under continuous exposure. Phase-dependent receptor availability, downstream integration and checkpoint behavior can implement the mechanism. Elapsed-time recovery that operates without repeated phase alignment is a distinct, potentially coexisting route. The frozen unexpected consequence remains conditional: changing pulse spacing at comparable integrated delivered exposure could reverse lineage ranking where independently measured, context-appropriate response patterns predict a crossing. Jitter weakens the alignment contribution only if it disrupts relevant repeated alignment; altered recovery can independently change growth. After withdrawal, the alignment-dependent contribution should diminish as residual input, committed divisions and relevant synchronization memory resolve, but no decay time or zero-total-selection guarantee is established. Accumulated abundance, other induced states and harm may persist. Favored lineages may be harmless or beneficial, so aging harm and preserved basal and challenged renewal require separate evidence.

Механизм. Chronobiology is the creative origin and an unverified biological assumption, source_ids []. Matsuo et al., 'Control mechanism of the circadian clock for timing of cell division in vivo,' Science, 2003, remains an unverified bibliographic lead. The contextual mouse-liver description provides no archived finding and no evidence of aged-human selection. The temporal causal order is: baseline lineage properties and prior exposures influence pre-pulse phase, recovery and tissue context; delivered input encounters that state; phase may change receptor availability and responsiveness; these jointly affect downstream signals, restraints, division, death, differentiation and retention; prior pulses also alter later phase, receptor state, composition and density. Receptor state therefore has no universal role as a confounder or mediator. Estimate the total effect of the assigned policy before asking which part is attributable to alignment and then testing signaling or checkpoint mediation. Randomizing a schedule does not automatically randomize cellular phase or identify its mediated effect. Lack of independent phase–recovery variation leaves attribution unresolved. Oncogene dosage can modify phase responses, and immune history affects survival; schedules may also alter antigen presentation. These mechanisms may cooperate. The parent concerns actual differential reproductive success, not sampling artifacts or precursor-fusion windows. Operational timing memory is a measured persistence of pulse-associated phase organization or correlated daughter timing relative to appropriate withdrawn controls; its causal relevance to output still requires testing. Persistent abundance, ongoing selection, absolute growth and independence from removed input are distinct. Variant allele fraction is not automatically cellular fraction. Separate within-lineage damage from composition. Whole-human relevance requires sustained multisystem damage, reserve, deficit and clinical-vulnerability trajectories under ordinary loads relative to comparable untreated aging, with compensating harms assessed. All tests are proposed; abstract-only evidence remains abstract_only.

Предсказание. Use an independently perfused culture chamber containing a defined organoid or epithelial mosaic as the exposure-assignment unit; a shared pulse is not independently randomized to every cell. For initial response mapping, prospectively randomize replicate chambers to phase-triggered delivery rules, with a prespecified focal lineage or cell-selection rule and fixed follow-up measured from delivery. Record all cells' pre-pulse phases and complete fates. Assignment identifies the effect of the delivery policy; interpreting it as a phase-specific effect additionally requires separating waiting time, prior exposure and other state differences. Complement these maps with chamber-level randomized pulse times that encounter naturally varying phases, recognizing that phase-conditioned associations alone can remain confounded. Where feasible, obtain overlapping combinations of pre-pulse phase and elapsed time since prior exposure across comparable chambers. If meaningful overlap or a valid independent intervention is absent, phase and recovery contributions remain nonidentifiable even if schedules causally change output. Preserve phase-caused receptor, downstream and checkpoint changes in the total alignment effect. Use independently estimated phase and recovery responses to predict held-out repeated schedules, then test them in shared competing mosaics while measuring density, composition, repair demand, daughter-cycle distributions, death, differentiation, extrusion and retained output. A causal alignment change producing predicted retained output supports the mechanism, including effects through signaling mediators. A short synchronized burst, jitter effect or rank reversal alone does not. Rank reversal is predicted only within supported tissue states and intervals where response curves cross. Recovery-only accounts are favored where schedule effects persist without repeated alignment and a phase-independent recovery model predicts the causal output changes within the experiment's resolution. After verified withdrawal, independently track signal clearance, phase-distribution and pedigree evidence of memory, committed divisions, absolute and relative growth, mature barrier function and a subsequent calibrated repair challenge. Persistent fraction alone establishes neither memory nor continuing selection.

SCOUT 2, from glycobiology and the physical chemistry of adhesion, conditional: Partial reprogramming could replace or reorganize the glycocalyx of aging human dermal fibroblasts so that persistent geometry at cell-matrix contacts limits receptor access to matrix ligands or destabilizes adhesion under repair-associated load. The glycocalyx is the carbohydrate-rich surface layer. Integrins are transmembrane receptors linking extracellular ligands to intracellular force transmission and signaling; abundance, activation, clustering and trafficking are distinct properties. Surface recovery could lag behind measured nuclear-identity recovery, leaving otherwise competent original contributors vulnerable to detachment or failed integration, potentially before another division. If reattachment, replacement and neighboring compensation fail to preserve specialized output or reserve, contributor loss becomes real tissue injury even when survivors show molecular rejuvenation. Functionally validated geometric correction could preserve contribution without requiring a different nuclear reset, while allowing downstream adhesion signaling to change. The relevant glycans, direction, persistence and magnitude remain unknown. Neither thickness nor the aged pretreatment coat is intrinsically classified as harmful or optimal. SPV_9 remains a conditional composition measure.

Механизм. Paszek et al., 'The cancer glycocalyx mechanically primes integrin-mediated growth and survival,' Nature, 2014, remains a supplied bibliographic lead without archived text or source ID. It cannot establish the existence, sign or magnitude of the proposed effect in reprogrammed aged stroma. Integrin regulation, cytoskeletal force, secreted matrix, membrane mechanics, incomplete regulatory recovery and stress susceptibility remain alternative initiators or co-mediators. The scout preserves a physical surface lesion, distinct from information-control, tissue-link topology and positional assembly memory. RA_M_G4_01 and RA_M_G4_07 concern consequential selection and hidden local failure; RA_M_G4_04 requires adequate replacement. Detachment, reduced diversity and changed fractions remain separate from injury. Molecular improvement and harmful contributor loss may coexist, but neither is demonstrated here.

Предсказание. In donor-matched constructs with pretreatment competence recorded, compare loaded and unloaded conditions after confirmed cessation of factor activity. Prospectively specify the contact-local geometric variable, independently calibrated functional reference, matrix, loading, contact endpoint and later tissue endpoint. Measure geometry at receptor-ligand contact regions, receptor access, adhesion force and subsequent failure in the same original contributors; bulk glycan abundance or whole-cell thickness alone is insufficient. Independently follow nuclear identity and programs regulating adhesion, secretion and cytoskeletal force. Measure integrin abundance, activation, clustering and trafficking, ligand chemistry, membrane mechanics, force coupling and secreted matrix throughout loading. A predivision event or earlier geometric change establishes timing, not causation. Use independently validated geometric correction and reciprocal alteration in untreated aged cells with matched matrix and loading, characterizing direct biochemical and mechanical side effects and shared effects across interventions. Geometry-induced downstream signaling remains an allowed mediator. Reciprocal changes in contact-local access and force, followed by retention and durable functional effects, support geometric initiation only where these alternatives are distinguishable. Verified geometric correction without contact rescue challenges the specified initiating mechanism under the defined conditions; receptor or cytoskeletal rescue with persistent geometry supports alternatives or co-mediation. Track all detached cells, reattachment, death, absolute competent replacement, local reserve and matrix output for months. Contact rescue without durable tissue benefit supports at most the cellular link. Preserved output and reserve through effective compensation challenge the injury extension. Normal averages alone neither establish nor exclude local deficits. Full restoration of the same endpoint despite a verified limiting contact defect under the same load challenges its necessity; partial rescue through DNA repair or export does not.

PHENOMENON-DOESN'T-EXIST, conditional: In a specified older-human population, barrier restoration, selective damaged-cell removal and reserve loading could improve separate deficits while leaving specified subsequent age-related damage accumulation rates materially equivalent to contemporaneous care without the added combination. A favorable starting level could persist while subsequent deterioration proceeds at the rate expected without the combination. The original 'previous slope' is interpreted through this contemporaneous counterfactual, not assumed continuation of an individual's pretreatment slope. Real repair, burden reduction, conditioning and transient regulatory responses remain candidate explanations requiring their own observations. Equivalent net rates neither prove unchanged formation and removal nor establish those explanations. Offsetting fluxes, delayed effects, nonlinearity and episode-related losses remain possible. Maintenance could preserve clinically valuable functional levels without changing the specified chronic rates. Shared readiness constraints and maintenance mechanisms can still exist. Transition-limited immune, signaling, mineral or nuclear injury can coexist with equivalent later slopes and materially affect the complete trajectory. Missing evidence, an insensitive damage channel or lack of statistical significance does not establish this hypothesis.

Механизм. The phenomenon-absence role concerns the specified sustained aging-rate effect, while allowing real and valuable repair and training benefits. CALERIE, mobility and tendon descriptions remain contextual summaries, not archived evidence for equivalence. SPV_1 is a vector of tissue-specific rates: use ratios only when comparator deterioration is stably positive, otherwise absolute differences. Report damage, signed reserve trajectories, deficit accumulation and infection, cancer, disability, other disease events and mortality separately, preserving competing risks and opposing organ effects. Full-period benefit or harm and post-transition equivalence answer different questions. A finite accessible-tissue panel cannot establish whole-organism equivalence, absence of hidden injury or radical whole-human slowing.

Предсказание. Keep the full three-component hypothesis explicitly conditional until its population, independently justified components and safe depletion method are identified. A separate reduced-combination comparison can concern older adults with documented epidermal barrier impairment and reduced mobility reserve, receiving independently justified topical barrier care plus individualized walking, strength and balance support versus contemporaneous usual care. This supplies no evidence for selective depletion or the full combination. Before confirmatory interpretation, freeze population and deficit definitions, component formulations and actual intensities, sequencing, maintenance, ordinary exposures, each damage channel, transition rule, intervals, equivalence margins and required precision. Where these specifications cannot be justified from independent information, the corresponding equivalence claim remains untested. Select damage channels for their plausible connection to component action, not solely because they are accessible or yield null results. Conditional candidates include accumulation of persistent structural injury or scar/remodeling burden following naturally occurring barrier lesions and persistent muscle structural injury associated with ordinary loading and recovery; each requires a validated definition, longitudinal sensitivity and evidence connecting it to the component's action. They are proposed candidates, not established aging surrogates. Retain epidermal fixed-substitution accumulation as an auxiliary channel whose relevance to topical care and mobility may be weak. Distinguish new mutations from selection, migration, clone expansion and sampling changes through lineage reconstruction with quantified uncertainty; destructive biopsies do not repeatedly observe the same cells and can themselves injure tissue. If lineage accounting fails, report population-average burden without relabeling it as mutation formation. Analyze the complete trajectory from intervention initiation: burden at specified times, total accumulation, time-integrated burden where biologically interpretable, episode incidence and residual losses, alongside transition and post-transition rates. A prospectively fixed transition boundary must not discard early benefit or harm; if adaptation overlaps continuing deterioration, use the predefined time-varying comparison and report that a distinct chronic phase was not established. For channel j and the declared interval, sufficiently precise uncertainty bounds for Δb_j entirely inside [-ε_j,+ε_j], accompanied by demonstrated level benefits, support bounded equivalence. A reproducible exposure-linked divergence beyond the independently justified margin rejects equivalence for that channel and interval; neither conclusion settles other organs. Measure formation and removal separately where possible, and verify proposed repair or conditioning mechanisms independently. Safe maintenance changes require confirmed exposure change, carryover and a predefined response lag. Continuing relevant behavior or active engineered cells precludes complete-cessation claims. Hazardous withdrawal remains unperformed without invalidating the maintenance comparison.

SCOUT 1, from biomineralization chemistry, conditional: In an aging human tissue with demonstrated local mineral permissiveness, selective apoptotic damaged-cell removal could generate accessible bodies whose surfaces nucleate calcium-phosphate deposits and materially increase total deposition. The central mechanism remains inorganic mineral nucleation on corpse-derived surfaces. Successful epithelial coverage could fail to remove these newly created mineral nucleation sites if their anatomical connection, access to permissive chemistry and persistence after closure are demonstrated. The surfaces promote initiation; reducing their nucleating activity is predicted to reduce deposition when their contribution is material. Sequence dependence could arise from temporal overlap between active body surfaces and locally permissive chemistry, including the chemical history that creates early seeds. Endpoint chemistry alone cannot establish that overlap. Timing may also change uptake, inflammation and surviving-cell mineralization. Deposits may stabilize, grow or dissolve and produce a lasting functional offset, continuing deterioration or little functional effect. Existing mineral may persist after removal ends, and preventing new deposition need not reverse it. Continued post-cessation deposition requires source-specific attribution rather than inference from persistence. Age, mineral localization on bodies or vascular-culture deposition alone establishes neither their limiting contribution nor an epithelial-readiness criterion.

Механизм. Proudfoot et al., 'Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies', Circulation Research, 2000, https://doi.org/10.1161/01.RES.87.11.1055, remains an unarchived bibliographic lead. Its title names the central connection but supplies no auditable methods, doses or findings. Novelty of intervention-generated bodies and repair-order effects remains unverified. This scout concerns inorganic precipitation, distinct from corpse-derived nutrient consumption and catalytic radical-chain injury. Mineral may interact with immunity, signaling and nuclear mechanics. Stable mineral burden and a lasting functional offset can coexist with IH_Q_L3_M_G1_2_03. No human nucleation assay, disappearance threshold, sequence, loading criterion or maintenance regimen follows from an in-vitro result.

Предсказание. First apply the intended removal method in older-human vascular smooth-muscle-cell cultures under measured tissue-relevant conditions. Establish whether it produces accessible nucleation-active bodies at plausible abundance and residence time. Use source tracing, matched other vesicles, body-depleted preparations, permissive and nonpermissive chemistry, and controls for initial mineral seeds. Confirm new mineral phase and time-resolved origin with complementary methods; staining and colocalization alone are insufficient. Quantify total mineral as well as body-associated mineral. Separate the causal investigation into stages. In a cell-free assay, compare matched body preparations with untreated versus candidate surface-passivated preparations and sham processing under the same local ion activities, pH and temperature. A passivation method is a conditional tool to be developed, not a supplied validated intervention; verify that any difference reflects altered surface nucleation rather than changed free-ion activity, aggregation or pre-existing seeds. This test addresses physicochemical activity only. In living cultures, test a validated body-specific intervention and a mechanistically different mineral-directed intervention, with reconstitution, to distinguish body contribution to total deposition from mineral contribution to dysfunction. Both require selectivity checks for uptake, corpse residence, inflammatory ligands, nutrients, viability and repair; two interventions with shared off-target effects do not identify mediation. A conditional functional contrast is to suppress deposition while maintaining comparable non-mineral debris exposure, then restore characterized mineral of matched phase, location, amount and formation history where feasible. Added mineral may not reproduce in situ deposits, so failed matching leaves mediation unresolved. For timing, independently cross body-availability schedules with permissive-chemistry schedules at matched cumulative body exposure and chemical exposure where feasible. Record complete local ion-activity histories, body accessibility and seeds formed before the comparison; equal endpoints or equal exposure integrals do not ensure equal nucleation history. A specific overlap effect should follow the joint presence of accessible active bodies and permissive chemistry and diminish after validated body-surface inactivation, beyond effects attributable to surviving cells or inflammation. Before any epithelial-order claim, separately establish in an anatomically appropriate older-human model, such as the conditional skin-over-stroma example, that removal-derived bodies or their mineral seeds actually reach the relevant compartment and remain after closure. Follow transport, retention and clearance directly. After removal stops, measure deposition, dissolution, live-cell mineralization and function separately. Unchanged total deposition despite reduced body-associated mineral limits body specificity; persistent dysfunction despite effective mineral prevention limits mineral-mediated injury. A sustained aging-rate extension requires continuing attributable deterioration, not merely a stable deposit.

HERETICAL, provisional and conditional: In a subset of aging humans, excessive muscle-to-liver lactate-to-glucose recycling could become a primary generator of post-stress metabolic demand. Muscle glycolysis supplies lactate; hepatic gluconeogenesis returns glucose while consuming more ATP equivalents than the preceding muscle glycolysis generated. This energetic accounting is a background assumption unverified by the supplied archive, and its quantitative contribution in the proposed subgroup is unknown. Increased hepatic energetic demand is hypothesized to sustain cardiovascular and endocrine mobilization, which renews muscle glycolytic production and supplies further lactate. The frozen mechanism requires energetic demand to cause the return signal. A collateral hepatic output that changes independently of demand could establish a different liver-to-muscle mechanism but would leave this mechanism unresolved. Muscle glycolytic production, lactate formation, uptake, oxidation, accumulation and net release are distinct quantities. The strong claim remains that reciprocal coupling maintains an unnecessarily costly state after ordinary activity ends despite recovery of the constituent organs under otherwise matched uncoupled conditions. Excess recycling, demand-dependent transmission, causal primacy and autonomous persistence are unverified assumptions. Stable delayed recovery or transient amplification would establish a narrower result. Reducing excessive recycling while preserving glucose availability and necessary compensation could improve sustained muscle recovery without increasing intrinsic muscle respiratory capacity. Functional benefit, whole-person energetic benefit and radical slowing of human aging remain separate unestablished outcomes.

Механизм. All proposed human-aging causal links remain unverified; source_ids remains empty. An operational relay is a measurable transmission with an identified origin and muscle target, and calling it demand-dependent does not establish that dependence. The retained state is continuous costly interorgan flux, distinct from finite-fuel depletion, nascent-protein defects, catalytic damage propagation and microbial persistence. Other candidates may coexist and change recycling indirectly. If cortisol is R, a cortisol clamp is a separate blockade experiment; intact transmission requires it to respond. SPV_12 is a conditional model-dependent directed response measure with a delay, not a validated aging biomarker. SPV_4 is the time to sustained return of a specified function to an individually justified prechallenge range accounting for error, ordinary variability and clinical significance. A possible mobilization-to-sleep-to-muscle-renewal extension is explicitly unverified: test older-human sleep, muscle renewal and the physiological cost of a subsequent matched activity episode separately, with safe reversible sleep-related changes and relevant upstream inputs characterized. The contextual young-adult sleep-deprivation synthesis result does not establish this older-human loop. No alternative mechanism is substituted for the parent; collateral signaling remains a competing explanation.

Предсказание. First establish whether a quantitatively important excess-recycling phenotype exists after matched mild activity. Combine complementary glucose and lactate tracers, regional muscle balance and an identifiable non-steady-state carbon model. Account for circulating glucose, glycogen, alternative lactate fates, other glucose sources and compartment exchange. For a defined muscle compartment, lactate-pool change equals local formation plus uptake minus oxidation, other disposal and export; net vascular release equals export minus uptake. Arteriovenous balance alone cannot identify production. Report uncertainty bounds where formation, uptake or disposal cannot be separated. Bound hepatic energetic expenditure using regional or independently validated mechanistic measurements; whole-body calorimetry, hepatic oxygen consumption alone and an ATP concentration alone cannot identify recycling-specific ATP demand. Define Q_H as hepatic ATP-equivalent turnover attributable to the relevant processing over a specified interval, R as a candidate demand-transmitting cardiovascular or endocrine relay, and Z as specified competing substrate, redox or secretory changes with a possible demand-independent action. These are experimental variables requiring identification, not observed pathways. Identify R's origin, muscle target, exposure-response relation, gain and delay. Validate a liver-restricted recycling perturbation and exclude direct muscle exposure to it or its active products. Match glucose concentration and delivery, insulin, oxygen, electrolytes, arterial lactate and independently imposed upstream inputs; independently replay altered substrate trajectories. Then add a demand-versus-collateral-output discrimination. In one experimental series, independently vary Q_H within the relevant hepatic compartment while matching the specified Z trajectories and allowing R to respond. The frozen mechanism predicts a change in R followed by a corresponding change in independently resolved muscle glycolytic production. In a complementary series, vary candidate Z trajectories while Q_H and upstream inputs are matched. A muscle response fully attributable to Z without an independently demonstrated Q_H-to-R effect supports collateral hepatic signaling rather than establishing the frozen mechanism. If Z is itself proposed to be R, first test whether changing Q_H causes its production; subsequent Z add-back at fixed Q_H tests downstream sufficiency only. Never clamp the actual mediator in a test intended to establish intact transmission. A validated restoration of the relevant hepatic demand during continued recycling reduction, at matched competing outputs, should restore R and muscle production if demand is the operative cause. Generic ATP consumption in another compartment, hypoxia, injury or altered ATP concentration does not qualify as equivalent demand restoration. Independent perturbations or a quantitatively identified dissociation must separate the effects; correlated measurements and statistical adjustment alone are insufficient. No qualifying manipulation is supplied. If separation is infeasible, even successful relay blockade and physiological add-back justify only liver-to-muscle signaling, leaving demand dependence unresolved. In separate mediation experiments, relay blockade should remove the transmitted muscle response and physiological R replacement should restore it despite reduced recycling. Independent glucose replacement should fail to restore the loop only if a non-glucose demand-dependent relay closes it; include the replacement's physiological production, delivery, endocrine and other-organ costs in whole-person accounting. A fall in net lactate release with unchanged formation does not confirm the mechanism. Compare complete coupled and uncoupled systems with matched substrates, hormones, oxygen, waste removal, tissue support and local history. Before testing persistence, specify individualized recovery ranges, required duration within those ranges, an observation horizon based on independently measured recovery distributions, and measurements of residual tissue injury and retained states. Estimate directed responses independently and predict held-out challenges. The strong claim additionally predicts a post-input state incompatible with measured stable-decay and local-memory alternatives, and termination of that state after specific return-path interruption. Longer recovery or a positive root of a local fitted model alone is insufficient; finite observation cannot prove indefinite persistence. Under common forcing, hepatic processing may fall while muscle production follows residual injury or upstream activation. Null results constrain only the tested subgroup and window when target engagement, specificity, sensitivity and pathway representation are adequate.

HERETICAL candidate, provisional and conditional: Repeated regeneration in aging human epithelium could establish persistent harmful clonal selection through antigen-presentation-mediated deletion of effector T cells that previously restrained an otherwise nonautonomous epithelial lineage. The required starting conditions are an endogenous lineage antigen, functionally validated autologous recognition, demonstrable baseline immune restriction of lineage survival, and a nominated antigen-presenting-cell population. Presentation during repair could cause cognate-cell death whose consequences, accounting for concurrent proliferation, redistribution and replenishment, leave insufficient functional surveillance after regenerative signaling and ongoing suppression resolve. Inadequate recognition alone is insufficient to predict excess epithelial survival: the target must remain accessible, recognizable and susceptible to killing, and removal of the previously demonstrated immune pressure must actually change its survival. The frozen unexpected consequence remains possible: the lineage could retain a survival advantage despite normal intrinsic growth-control responses and a falling tissue-average molecular damage burden. These are jointly testable conditions, with normality bounded by the particular growth-control functions examined. Restoring the missing surveillance could remove its contribution while preserving unrelated repair only if essential antigen-sharing cells, mature tissue output and later renewal remain adequate. Intrinsic fitness, reversible immune dysfunction and antigen escape may coexist. A contribution to accelerated human aging requires sustained functional deterioration and subsequent vulnerability beyond clone expansion.

Механизм. The sources array is empty. All biological links have status assumption, evidence_status unverified and source_ids []; contextual pillars, readiness labels, reviews and bibliographic leads are not archived observations. Any abstract-only material remains abstract_only. A T-cell clonotype is operationally a population sharing a specified paired receptor sequence; viability and antigen specificity require separate validation. Functional antigen-specific coverage means the combined recognition and killing capacity of available cognate cells under explicitly specified target abundance, presentation, access and susceptibility. Its loss must be distinguished from loss of particular clonotypes. The presenting-cell identity and molecular death pathway remain unknown; no specific pathway is fabricated. Presentation-induced activation followed by deletion can implement the parent mechanism, whereas direct toxicity or reversible suppression alone cannot substitute for it. SPV_9 is d ln(f_g)/dt for cellular clone fraction. Absolute counts, births, deaths, retention and lineage/reference ratios separately establish growth and selection; variant allele fraction is not automatically cellular fraction. Persistent abundance, relative selection, absolute expansion and independence from withdrawn input differ. Intrinsic growth-control normality is limited to the tested functions and observation window. Decompose bulk damage into within-lineage and compositional changes. Whole-human inference requires sustained multisystem damage, reserve, deficit and clinical-vulnerability trajectories under ordinary physical, infectious, psychosocial and environmental loads, compared with expected untreated aging under comparable conditions and with compensating harm assessed. No safe human protocol, maintenance schedule or stopping rule follows.

Предсказание. First validate the endogenous antigen–lineage pair, baseline cognate restriction and presenting-cell population. Cross regenerative exposure with intact, selectively interrupted and restored presentation by that population, preserving epithelial target presentation and measuring support, injury, presenting-cell viability and delivered exposure. Restoration uses matched parallel induction cultures or a new matched induction cycle; it does not resurrect deleted cells. Follow identified starting cognate cells and their descendants through activation, division, directly observed death and movement between sampled compartments. Reconcile absolute counts with births, deaths, arrivals and departures. Include unstimulated presentation controls, unrelated specificities and stimulus-exposed T cells lacking the nominated presentation route. The focal prediction is a regeneration-associated, presentation-dependent death contribution that reduces subsequent functional coverage after accounting for expansion and replenishment, rather than merely fewer activated or expanded cells. Activation caused by presentation may mediate deletion and must not automatically be matched away; direct toxicity and presentation-independent attrition require separate controls. After verified signal clearance, place arms in a common permissive surveillance environment and independently exchange T cells, presenting cells and epithelium. Exchanges localize persistence but do not establish its induction mechanism. Test recovery of original survivors, alternative cognate clonotypes and defined autologous replenishment over an independently justified immune-recovery interval. Where baseline immune pressure, target access and killing susceptibility remain demonstrable, persistent inadequate coverage predicts a survival component reversible by physiological cognate add-back and reproducible by cognate depletion. Match avidity distribution, activation, differentiation, banking history and effector-to-target ratio; use irrelevant add-back controls. Recovery by original cells supports reversible dysfunction. Deletion with restored coverage defeats the persistent-deficit link in that setting. A count difference explained solely by failed proliferation does not establish deletion. Death unaffected by a validated presentation intervention challenges the nominated induction route. Residual immune-free growth permits an intrinsic contribution. Rescue requires immediate mature output and barrier integrity plus preserved renewal during a subsequent calibrated repair challenge.

SCOUT from microbial life-history ecology, unverified: In a subset of aging humans with postinfectious exertional intolerance, a viable tissue reservoir with little or no productive output could become productively permissive through an exertion-associated rebuilding signal. Repeated transitions could generate new pathogen output before local injury and later residual loss while parallel adaptation genuinely improves early strength or endurance. The distinctive conditional claim is the rebuilding-dependent reservoir-to-productive-population gate, not persistent fragments or infection in general. A postinfectious syndrome does not imply such a reservoir, and stress signaling, impaired immune containment, continuous infection or reinfection could instead explain an observed rise. Infection could also worsen fidelity, alter mechanics or initiate chemical propagation. Preventing demonstrated new productive output could reduce its contribution to SPV_5 only if it materially drives recurrent injury; it need not reverse old damage, restore every reserve or establish whole-human aging preservation.

Механизм. ROLE: SCOUT_2, preserving microbial life-history ecology and distinct from SCOUT_1’s nonliving chemical propagation. The possible novelty is a reproducible rebuilding gate in the named phenotype, not microbial persistence itself; grounding and novelty remain unknown. G2_5_31 leaves ongoing/recurrent infection unresolved and supplies no productive-reservoir observation. Pathogen population growth is ongoing infection, not clonal host-cell composition as stored aging state. A serial path through fidelity, mechanics or chemistry can show multiple rescues. Four causal objects are retained without adding duplicate variants; ordinary clinical alternatives remain in the shared conditions and limitations. Frozen originating central mechanism, retained verbatim as a conditional conjecture and identity anchor, not as an observation or an operative comparator: SCOUT from microbial life-history ecology: In a subset of aging humans with postinfectious exertional intolerance, exertion-associated tissue rebuilding could temporarily make previously nonproductive infected tissue permissive for renewed pathogen production. Repeated bouts would repeatedly seed active infection from a persistent reservoir, while parallel adaptation genuinely improves early strength or endurance. The increasing infectious burden, rather than deconditioning, shared mechanical failure, nascent-protein sequence errors or an autonomous chemical chain, would renew tissue injury and prolong recovery. The state is an actually replicating biological population coupled to host rebuilding; residual pathogen fragments are insufficient. Breaking the reservoir-to-productive-infection transition, if verified and treatable for the identified pathogen, should stabilize SPV_5 and allow rehabilitation to contribute to reserve preservation. Frozen originating unexpected consequence, retained verbatim as the conjectured surprise: Repeated bouts would repeatedly seed active infection from a persistent reservoir, while parallel adaptation genuinely improves early strength or endurance. Scope of these frozen originating statements: the present process_hypothesis, discriminating_prediction and limitations specify the operative causal comparison. Assertions of sufficiency, abolition, exclusivity, required ordering or guaranteed benefit in the originating wording remain stronger conditional extensions, unverified and subject to the original source limitations; no empirical status is upgraded. The central new-product/path/catalyst/rebuilding-gate object is unchanged.

Предсказание. Under shared_conditions and the time-indexed effect definition in competition_interpretation, first identify an organism and an anatomically constrained viable reservoir, with an organism/assay-specific upper bound on low or nonproductive baseline output and a predeclared site/window. No organism, site or threshold is supplied. Demonstrate linkage of genuinely new productive output to that same reservoir rather than another site or new exposure. A specified rebuilding-associated host change must precede the rise, followed by local injury and delayed loss despite genuine early adaptation. Repeat this ordering across natural tolerated episodes and quantify output burden, recurrence, injury and functional magnitude. Organism-appropriate orthogonal assays must distinguish productive output from persistent nucleic acid, static antigen, abortive expression, noninfectious particles, redistribution and fragments released after damage. The ordinary alternative at the same initial states, tolerated demands and times permits sterile immune injury and fragments, already active or independently fluctuating infection, reinfection, or stress/immune-containment changes without rebuilding as a gate. Separate two causal questions. For the total effect of suppressing demonstrated new productive output, define t0 before suppression; compare pre-t0 reservoir/output history, host rebuilding, synthesis/fidelity, inflammation, metabolism, mechanics, catalytic state, viable mass, force and work history, with comparable independently imposed demand where feasible. Only after an observed transition, a state-preserving contained preparation and a sufficiently selective pathogen-specific perturbation exist does reduced output followed by reduced new injury support infection-dependent protection. Direct drug effects on inflammation, metabolism, rebuilding, fidelity, mechanics, chemistry, viability or contraction that bypass output reduction must be assessed and separated where possible; otherwise a rescue is only a total intervention effect. In contrast, downstream changes caused by lower infection in those same host variables, including subsequent achieved work, viable mass and force, are intended mediators or outcomes and are included in the total infection effect. Reduced downstream inflammation or catalysis is compatible with infection causality, not a specificity failure. Do not require post-suppression host fidelity, mechanics, chemistry or force to remain equal. Controlled direct-effect contrasts fixing specified host mediators are additional questions only if independently feasible with overlap. Record any changed imposed activity exposure separately. For the distinctive rebuilding gate, output suppression alone is insufficient. A preparation must retain the same viable reservoir-host transition. Identify the proposed rebuilding change and, only if possible, selectively vary it before productive output while comparing pre-gate stress, injury, immune containment, nutrient availability and baseline host/organism capacity. Determine whether gate-associated changes act through an explicitly specified permissiveness pathway or are independently caused alternatives; measure their trajectories without automatically matching away any proposed gate mediator. A manipulation merely reducing general replication capacity or host survival does not identify a rebuilding gate. If rebuilding cannot be separated from its covarying alternatives, keep the gate unverified even if infection-dependent injury is supported. Conditional restoration must reproduce the same host-state transition and organism; fragments or an unrelated imposed infection cannot validate it. Existing damage need not reverse immediately. A verified reduction in output without less new injury over an adequately sensitive causal window constrains ongoing dependence locally, not all historical infection effects. Negative samples constrain the named organism, site, sensitivity and window, not every reservoir and not a rival. Susceptibility, safe duration, relapse after withdrawal, host defense and activity-preserving net benefit remain unknown.

CROSS-DOMAIN TRANSFER, conditional: In a defined aging-human epithelial–stromal repair unit, endogenous IL-11-dependent communication may couple distinct receptor-positive populations toward compatible repair-completion states. A population's repair state could alter an IL-11 signal that appropriately changes its partner's progression. Blockade could disrupt this relationship while preserving isolated repair competence under comparable support, causing premature termination or inappropriate continuation of collective repair. Persistent functional incompatibility could prolong barrier deficits and secondary injury despite lower mean inflammatory signaling. The specific claim concerns the causal value of correct alignment between actual partner state and delivered signal, physically implemented through ligand exposure and receptor response. Ordinary state-dependent paracrine signaling may implement this relationship. Restoring alignment could shorten function-specific SPV_4 recovery while retaining reduced harmful inflammatory injury, but this separation must be demonstrated through injury and function, not inferred from lower mean signaling.

Механизм. The required cross-domain role and collective-completion mechanism are preserved. Information is physically implemented by biochemical signaling; independence from its complete mediator history is not claimed. S_M_G1_DOM05_011 is the contextual IL-1β alveolar initiation/completion account, and S_M_G1_DOM03_006__M_G1__DOM_M_G3_03 is the contextual muscle-repair sequence. Their reports are absent, they concern other pathways or tissues, and neither verifies IL-11 communication. They require archived reports or phase-specific perturbation tests linking entry, termination and mature function before serving as empirical precedents. Directly testing the IL-11 sender–receiver chain does not depend on accepting those accounts. The hypothesis remains distinct from a developmental cell-fusion competence window. gp130 allocation may implement or modify a communication edge, and other injury mechanisms may coexist. No replacement mechanism, completed experiment, clinical timing rule or verified novelty is introduced.

Предсказание. First identify a native responsive older-human lung epithelial–stromal sender–receiver pair. Independently perturb sender repair state across independently varied receiver starting states while controlling initial injury, matrix, nutrients and nonspecific support. Measure whether endogenous IL-11 output changes with sender state and whether selective sender IL-11 loss and receiver IL11RA loss interrupt the attributable response, with appropriate perturbation-alone and restoration controls. Monitor other secretions, nutrient changes, matrix changes and material transport. Then randomize correct alignment versus mismatch between actual partner state and delivered IL-11-dependent signal. Compare contingent signals with yoked signals from independently assigned, appropriately matched partners, shuffled signals and state-independent schedules. Balance waveform amplitude, duration, integrated exposure, pulse statistics and relevant delay distributions where feasible, while retaining state–signal alignment as the changed variable. Measure realized receptor activation and adaptation without forcing complete mediator histories to equality. The focal prediction is that mismatch impairs complementary mature differentiation and barrier recovery and correct alignment reverses this penalty while isolated competence and lower mean inflammatory signaling remain separately verified. A favorable separation additionally requires maintained reduction in actual inflammatory injury during rescue, with cell-specific exposure, peaks and duration assessed; a lower average can conceal damaging local pulses. Equivalent recovery with an appropriately chosen state-independent schedule after receiver readiness, shared injury history and support are addressed favors the alternative that actual partner state adds no necessary guidance. Unmatched replay superiority, equal integrated ligand and pulse-versus-tonic superiority are insufficient. Demonstrated endogenous feedback supports the biological coupling claim but does not establish novelty beyond reciprocal paracrine support or validate the consensus equation. For the model, calibrate coordinates and parameters independently and predict held-out changes in sender state, communication edges, delays and mature functional recovery; compare these predictions with receiver-only exposure/support models.

CROSS-DOMAIN TRANSFER, unverified: In a subset of aging humans with postinfectious exertional intolerance, rehabilitation could restore reproducible regional force contributions while leaving a damaged connective-tissue path that mechanically couples those regions vulnerable. A localized path event during later ordinary activity could propagate failure among otherwise capable linked regions, causing residual loss despite genuine early aggregate gain. The proposed state is demonstrable shared load-bearing architecture, not correlation caused only by a common high-demand bout, global perfusion or recruitment. Reducing that path-specific cofailure could improve SPV_5 if it materially reduces recurrent loss while useful force is retained. The conservative benefit scenario of no greater marginal loading, reduced independence or compensating harm elsewhere is retained; it is not a demand to equalize post-event local loads. Whether a change permitting some greater local loading has a favorable net functional and injury tradeoff remains unknown. Regional strength, redundancy, retention probability and long-term aging preservation are distinct quantities.

Механизм. ROLE: CROSS-DOMAIN TRANSFER, preserving the reliability-engineering field and the specific shared mechanical pathway. Adjacent anchors S_M_G2_DOM06_009__M_G2__DOM_M_G2_06 (molecular fatigue beneath apparent recovery) and S_M_G2_DOM08_011 (load-history-dependent matrix mechanics) are contextual narratives, not authenticated support. Empirical grounding and prior use are unknown. The candidate remains architecture-dependent cofailure, not a finite inventory or neural-controller model; ordinary shared overload remains its strongest rival. Shared conditions and limitations govern later SPV_6 and whole-human inferences. Frozen originating central mechanism, retained verbatim as a conditional conjecture and identity anchor, not as an observation or an operative comparator: CROSS-DOMAIN TRANSFER: In aging humans with postinfectious exertional intolerance, rehabilitation can restore the force capacity of individual muscle regions while a shared mechanically damaged connective-tissue load path leaves their failures positively dependent. The person gains real aggregate strength but not independent redundancy: an ordinary later strain event disables several restored regions together. Correlated mechanical failure, rather than insufficient total tissue or an intrinsically defective new proteome, converts apparently restored reserve into larger episode-associated loss. The maladaptive substrate is the common load-bearing architecture linking regions. Reducing that common mechanical vulnerability, if achievable while retaining activity, should stabilize SPV_5; increasing strength along the same shared path alone need not do so. Frozen originating unexpected consequence, retained verbatim as the conjectured surprise: The person gains real aggregate strength but not independent redundancy: an ordinary later strain event disables several restored regions together. Scope of these frozen originating statements: the present process_hypothesis, discriminating_prediction and limitations specify the operative causal comparison. Assertions of sufficiency, abolition, exclusivity, required ordering or guaranteed benefit in the originating wording remain stronger conditional extensions, unverified and subject to the original source limitations; no empirical status is upgraded. The central new-product/path/catalyst/rebuilding-gate object is unchanged.

Предсказание. Under shared_conditions and the time-indexed effect definition in competition_interpretation, map repeatable regional force contributions, capacities and a named vulnerable physical load-bearing path before a focal event. Define t0 immediately before that event, separately from any earlier coupling intervention. Record pre-event strain histories and rates, fatigue cycles, recovery intervals, stress concentrations, perfusion, recruitment and achieved work, and contemporaneous externally imposed common demand that is not generated by the event. Compare linked and unlinked regions with overlap in those pre-event states and common inputs. The focal prediction is a localized path event followed by demonstrable mechanically transmitted change and persistent injury/force loss in otherwise capable linked regions. Temporal/spatial resolution must separate path transmission from an independently traveling perfusion or recruitment disturbance. An ordered lesion map alone does not establish that separation. The ordinary alternative permits correlated loss through common overload, incomplete recovery, marginal weakness or shared perfusion/activation without a path-transmitted event. Equal total work and peak strain alone do not control that alternative. The primary target is the total effect of the demonstrated path event or, separately, of a feasible coupling modification on later joint injury and task retention. Event-generated redistribution of strain, stress concentration, perfusion or recruitment, and resulting changes in marginal failure probabilities, are possible transmission mediators; they are measured after t0, not conditioned away. No excess beyond all post-event local histories or post-event marginals is required for this total effect. Identification still requires adequate control of pre-event common causes and independent evidence of the named transmitted process; unexplained correlation is insufficient. A future noninjurious modification must first be validated in an architecture-preserving preparation, with sham handling and comparable pre-intervention state and independently imposed demand where feasible. Measure its direct effects on capacity, force transmission and viability, its effect on the path event/transmission, subsequent local doses, achieved task force and displaced injury. Protection caused by lower imposed demand, or redistribution with no demonstrated path-event sequence, is a meaningful total intervention result but does not alone identify this damaged-path mechanism. Changes in local dose generated by a demonstrated path effect remain part of that effect even without post-event exposure overlap. A controlled direct architecture effect at fixed local histories is a distinct, optional contrast requiring feasible independent control and overlap; absence of either leaves that narrower contrast unidentified rather than disproving total path-mediated injury. Useful force retention, independence and absence of displaced harm are separately required for an activity-preserving benefit. Distinguish persistent structural/functional injury from transient inhibition. Lack of reproducible regions or the required vulnerable path weakens this particular import; a good aggregate fit, unexplained cofailure or a rival rescue alone cannot identify or exclude it. Biochemical and infectious processes may lie upstream or downstream. For the conservative benefit scenario in process_hypothesis, assess later regional loading, task force, independence, viability and injury elsewhere as outcomes at the declared ordinary tasks across repeated episodes. A loading increase alone does not negate a demonstrated total path effect; any broader activity-preserving benefit requires a prospectively specified clinically meaningful net comparison of retained function and injury, with the individual outcomes reported separately. No acceptable numerical tradeoff or safe manipulation is supplied.

SCOUT from molecular assembly thermodynamics, conditional: In a subset of aging-human cells, IL-11 receptor complexes may occupy a consequential fraction of a functionally limiting shared surface gp130 pool. An IL-11 blocker that actually reduces this occupancy could release gp130 for a specified coexpressed competing cytokine receptor system, such as a directly verified human oncostatin-M system, increasing its signal while IL-11 activity falls. The complexes must access the same exchangeable pool within the relevant cells and membrane compartments. If the alternative signal maintains injury or disrupts differentiation in those cells, redistribution could prevent improvement in a corresponding SPV_1 component. Physiological occupancy, localization, access and assembly kinetics are prerequisites. Receptor coexpression, shared-subunit naming and successful signaling inhibition alone establish none of them. Circulating cytokine changes and multicellular communication are unnecessary for the proposed cell-intrinsic allocation step.

Механизм. The molecular-assembly scout is retained alongside the required distributed-consensus transfer. It concerns rapid, potentially reversible allocation among receptor complexes, distinct from direct lipid-receptor activation and progressive resource exhaustion. Fixed ligands and rapid onset do not exclude intracellular feedback. Allocation and trafficking may coexist, and constant surface totals do not establish absent turnover. Competing-receptor rescue demonstrates pathway contribution rather than shared-component competition by itself. Redistribution may initiate fidelity, communication or antigen-presentation changes; serial mediator tests can establish a common chain while preserving every candidate identity. Mouse receptor biology does not establish the relevant human architecture. No application-specific novelty, clinical benefit or human protocol is established.

Предсказание. In a characterized older-human epithelial population under fixed defined ligands, an occupancy-releasing blocker should produce a quantitatively compatible loss of gp130 from IL-11 complexes and gain in specified competing complexes within the same accessible pool. Resolve individual cells and relevant membrane compartments with sufficient temporal resolution to establish exchange compatibility before the competing signal and functional cost. Reciprocal population or whole-cell averages from different subpopulations or disconnected compartments are insufficient. Use convergent minimally perturbing complex and localization measurements and, where validated, tracking of component movement or a pool-selective perturbation to test access and exchange. Account for free, other-bound, incoming, internalized and recycled components rather than assume direct one-for-one transfer. Compare blocker modalities at comparable IL-11 inhibition; occupancy-retaining inhibition need not redistribute gp130. Independently demonstrate a limiting range where additional accessible surface gp130 increases competing-complex assembly and a nonlimiting range where further increases do not materially increase assembly, with adequate precision and unsaturated detection. Independently verify that downstream and functional readouts retain responsive range. Quantify receptor abundances, ratios, localization, baseline complexes and trafficking across the manipulation. Only the conjunction of same-pool allocation, validated limitation and its relief, responsive readouts and functional mediation supports competition. Controlled occupancy restoration should reverse allocation, subject to controls for its effects on signaling and trafficking. Competing-receptor interruption should remove the attributable cost while IL-11 suppression persists, with interruption-alone controls. Rescue or attenuation at high gp130 alone does not distinguish allocation from feedback, saturation or trafficking. Follow the acute step into sustained harmful differentiation or function and post-transient deterioration; neutral, beneficial or transient allocation does not confirm the harmful extension.

SCOUT from transplant immunology and immunopeptidomics, conditional: In a prospectively specified susceptible population of aging-human epithelia, IL-11 blockade may change proteasomal processing and thereby change the identity of displayed self-peptides at comparable cell composition and total antigen-presentation abundance. Previously quiescent, pre-existing cognate autoreactive memory T cells could recognize those altered identities and impose repeated epithelial injury despite intact intrinsic repair capacity, adequate pathogen killing and reduced soluble inflammatory markers. If injury exceeds epithelial replacement and immune restraint and produces persistent functional damage, it could worsen particular SPV_3 clinical transitions and offset an independently demonstrated beneficial effect. Peptide identity is the frozen switch; increased quantity of already displayed peptides is an alternative. Processing, identity change, physiological recognition, killing, persistence and clinical consequence remain separately testable links. Finite baseline sampling may leave the identity distinction unresolved without disproving a broader antigen-specific injury mechanism.

Механизм. The antigen-identity scout and its complete repair/pathogen/inflammatory-marker contrast are preserved. Abundance-only recognition and identity changes caused by source-protein expression, transport, loading, HLA composition or cell state remain alternatives rather than substitute confirmations. No alternative mechanism is adopted as a new hypothesis. The mechanism remains distinct from macrophage ingestion of reversibly stressed cells. gp130 redistribution may initiate processing and presentation changes; demonstrating that chain would connect both scouts without deleting either identity or requiring downstream injury to persist after its upstream cause is removed. The reader and recall terminology should consistently read: «Лейкоцитарные антигены человека (HLA; human leukocyte antigen) образуют человеческую систему главного комплекса гистосовместимости. Молекулы этой системы представляют пептиды для распознавания Т-клеточными рецепторами. Какие именно молекулы и аллели участвуют в предполагаемом механизме, предстоит установить». The conventional expansion is resolved; molecule identity, allele dependence and causal involvement remain scientific uncertainties. No archived evidence, completed rescue, established novelty or human treatment recommendation is supplied.

Предсказание. First establish epithelial IL-11 responsiveness and a reproducible change in endogenous displayed self-peptide species under orthogonal epithelial IL-11 perturbations. Identify peptide sequence, relevant modifications and presenting HLA molecule. Compare baseline and treated samples with quantitative recovery controls, targeted baseline measurements and explicit detection limits. Baseline non-detection cannot establish absolute absence. Constrain baseline abundance and compare it with independently characterized recognition over physiological display ranges, testing whether increased abundance of an unchanged species can explain recognition. If that account remains plausible, report identity change as unresolved; do not count new detection as confirmation or reject broader antigen-specific harm. At comparable cell composition and total presentation, the full chain predicts altered proteasomal processing before the repertoire change, recognition by a baseline memory population with independently demonstrated cognate specificity, and then selective killing. Measure source proteins, direct cleavage products, transport/loading, HLA composition, turnover and cell state. Selective processing intervention should prevent the identity change and attributable injury while preserving epithelial fitness; physiological downstream reconstitution should restore the specified peptide–HLA complex and recognition. Broad proteasome inhibition is insufficient. Separately remove and restore the implicated peptide–HLA–T-cell-receptor interaction at endogenous-range display, preserving source-protein function and IL-11 blockade. Include epithelial-only, T-cell-only, coculture, perturbation-alone and pretreatment/washout controls with residual drug and pathway-state measurements. Demonstrate baseline memory phenotype, specificity, tissue access and response under prospectively defined physiological activation support; strong artificial stimulation cannot establish the in-tissue conjunction. Measure preserved intrinsic repair, adequate laboratory pathogen killing and reduced soluble inflammatory markers separately. Follow repeated killing, replacement, immune restraint and barrier function before claiming persistent injury. Identity change without processing mediation leaves the proteasomal link open; antigen-specific killing without an identified switch supports only a partial or alternative route. Injury independent of the specified recognition pair favors stress, bystander activation or generalized susceptibility.

SCOUT 2, from replication-fork biology, conditional: In a prospectively characterized subgroup of older humans, ordinary activity during maintained training could cause an activity-attributable increase or redistribution of proliferative intestinal epithelial replacement beyond ongoing physiological turnover. If subsequent meal or activity-associated signals induce consequential transcription in those same naturally replicating stem or progenitor cells and loci, excessive transcription-replication conflicts, including persistent conflict-associated RNA-DNA hybrids, could stall forks and generate new heritable epithelial genome alterations. Cycling crypt cells, tissue-average transcription and initial barrier restoration do not establish these initiating links. Durable injury requires newly generated alterations to survive in lineages, pass to cellular descendants and impair renewal at the observed burden. Common-environment descendant dysfunction alone cannot assign the impairment to DNA because epigenetic or organelle-mediated states may also persist. Mobility could improve while intestinal recovery progressively deteriorates despite initially restored perfusion and barrier function. Selective prevention of the conflicts could preserve intestinal SPV_4 and normal renewal if the complete sequence exists. New genome injury remains the central mechanism; lineage selection and other inherited cellular states may coexist but cannot substitute for it.

Механизм. All activity-to-replacement, signal-to-transcription, conflict, inheritance, genomic-causation and organ-loss links have status assumption, evidence_status unverified and source_ids []. S_M_G3_DOM08_025 and C23 concern possible restitution and do not establish additional proliferation or genome injury. The original scout role is retained. New genome damage is distinct from mechanical nuclear injury, centrosome inheritance, clonal composition as the primary mechanism and primary-sequence-defective contractile rebuilding. Selection, inflammation, perfusion disturbance, heat-response failure and inherited nongenomic states may coexist. None supplies the missing genomic causal link by definition.

Предсказание. Use unsynchronized older-donor crypt-villus preparations distinguishing stem/progenitor cells from mature absorptive epithelium. First compare a human-constrained activity exposure with sham or matched no-activity conditions at equivalent baseline turnover. Require an activity-attributable change in identified replacement-cell recruitment, division, fate or timing before the later demand; baseline cycling alone is insufficient. Distinguish proliferative replacement from closure by surviving nondividing cells. In a discovery phase, identify a plausible activity- or meal-associated signal, its responding crypt population, receptor or signaling route where ascertainable, induced transcriptional program, loci and exposure interval. Freeze that implementation before independent confirmation. A signal-induced program in the same S-phase cells is a conditional implementation, not an observed pathway; if the bridge cannot be identified under ordinary exposures, it remains unresolved. Compare activity-only, subsequent-demand-only, combined-sequence and appropriate sham conditions at matched thermal history, oxygenation, flow, nutrients and initial injury. Require excess locus-associated transcription-replication interference beyond physiological coexistence, with conflict-associated hybrids and fork slowing preceding new lesions. Hybrid abundance alone cannot determine causality. Combine cell-cycle and nascent-transcription measurements, orthogonal nuclease-controlled hybrid assays, locus-associated fork assessment and lesion mapping. Characterize baseline sister lineages, detection limits, absolute survival and representation; follow descendants through multiple measured turnovers to distinguish new retained alterations from transient lesions and expansion of rare pre-existing clones. Test descendant function in common environments and composition-controlled reconstituted tissue, while also measuring inherited epigenetic and organelle states. These comparisons remain insufficient to identify DNA causation by themselves. Conditional on identifying a candidate alteration or alteration set, independently correct it in affected descendants and recreate it in matched baseline descendants, with editing and clone-selection controls, then test renewal and barrier recovery at the observed burden. If such separation is infeasible, retain genomic causation as unresolved rather than replacing it with inherited state. Proposed locally targeted active RNase H1 must show locus-level target engagement, reduced conflict before fork and lesion rescue, and prevention of retained alterations and later dysfunction while preserving lineage-specific cycling, transcription, differentiation, survival and absorption. Include catalytically inactive, targeting-only and delivery controls, and an independent intervention such as altered timing relative to natural S phase, with nutrient-handling and repair effects assessed. Protection through reduced cycling, changed survival or lower initial injury is nondiagnostic. Absence of activity-attributable replacement or consequential natural overlap contradicts the corresponding initiating implementation. Inheritance without genomic attribution or functional effect leaves downstream links unresolved.

SCOUT 2 from decomposition biogeochemistry and isotope-resolved trophic ecology, conditional: In aging human epithelium, killing a resident while retaining locally accessible corpse material may create an incremental nutrient pulse that a pre-existing invasive lineage uses through assimilation or catabolic/energetic maintenance to support extra survival or proliferative output during repair. This is material feeding only if access to and metabolic use of that pulse causally support the extra output at a quantitatively plausible scale. Extraction that carries biomass away, prompt apoptotic clearance and lysis with retained debris are different perturbations; physical removal does not inevitably supply nutrients. Viable or growth-suppressed residents can already secrete metabolites, so the claim concerns an incremental death-derived flux, not zero baseline transfer. A functionally irrelevant killed lineage could supply the same effect only if the chemical composition, accessible amount, death mode, clearance and local uptake are equivalent. Nutrient-driven growth can coexist with instructive death signals, loss of daughter displacement, fusion-mediated arrest or matrix changes, and need not produce anatomical invasion. Adequate functional replacement might improve tissue quality after removal while an acute feeding contribution occurs. No macrophage Arg1/ODC pathway is assigned to epithelial invaders; the trophic transfer remains unverified. Any effect on dangerous clone fractions must be measured separately from material assimilation and absolute output.

Механизм. All causal claims are hypotheses about older human epithelial renewal, not demonstrated human-aging effects. The complete archived source corpus is empty; CHECKED FOUNDATIONS rates all supplied premises unknown. Candidate S-node IDs below identify motivating assertions, not primary evidence. No published novelty, effect size, safe clone size, clinical regimen, or whole-human aging benefit is claimed. Role: SCOUT 2, from decomposition biogeochemistry/trophic transfer, distinct from the microbial genotoxicity scout. Candidate grounding is the supplied macrophage corpse-nutrient recycling assertion S_M_G2_DOM_G4_03_006__M_G4__DOM_M_G4_03, not evidence that epithelial invaders use this route; the transfer is explicitly unverified. S_M_G2_DOM_G4_03_007__M_G4__DOM_M_G4_03 instead motivates a signaling alternative that must be separated experimentally, not silently included here. This is an acute measured biomass-transfer mechanism, not a generic finite inventory exhausted with age. Novelty in this focal setting is unknown. Conditional practical implication: a future selective-removal strategy would have to separate removal from invader access to released biomass while preserving adequate repair. No dietary manipulation or salvage inhibitor regimen is inferred. The set stops here because adding another death-derived metabolite, another competition genotype or another microbial toxin would repeat a mechanism; a direct structural matrix hypothesis is excluded by the mutation directive, not judged biologically absent. Across all four rivals, local success must be followed by intact specialization, growth control and repeated-repair function and eventually separate SPV_3 and multisystem SPV_1 outcomes before any contribution to radical slowing of human aging can be claimed. All predictions are proposed tests, not observations. Within each contrast use one prespecified older-human donor-derived epithelial site, recorded resident/invader genotypes and baseline lineages, comparable initial coverage, local contacts, nutrients, non-toxin injury, basement membrane and matrix. Site, donor age range and sex, perturbation intensity, repair timing and effect sizes remain unspecified. Measure absolute viable renewing and differentiated lineage counts, mutation acquisition, anatomically verified invasion and functional barrier recovery separately. SPV_9 is change in log cell fraction per year with a defined denominator and ancestry rule, not absolute growth or malignancy. Preserving mature output, progenitor reserve and growth control through repeated repair is an independent requirement. Experiments that change an intended control remain informative about a coupled mechanism but cannot isolate the proposed route. All four mechanisms can coexist with matrix effects; a selective effect identifies a contribution, and a null result bounds only the tested tissue, exposure and detectable effect. No whole-human antiaging efficacy follows. Operative repair qualifications (all proposed and unverified): Macromolecular incorporation demonstrates material use but not causal growth. If corpse substrate mainly supports catabolism, energy or maintenance, survival can improve with little label retained in newly synthesized biomass. Retained biomass label is therefore not necessary for every feeding survival branch. Identify the candidate limiting chemical species and its stoichiometric, energetic or catalytic requirement at measured local concentrations. A limiting cofactor need not supply bulk biomass; high incorporation of abundant carbon need not be growth limiting. No limiting species, requirement or yield has been established. Assume conditionally that the same NOTCH1 lesion changes daughter fates differently in normal esophageal progenitors and tumor cells; the supplied metadata do not establish any species, age, genotype combination or follow-up. Intrinsic tumor impairment is distinct from resident–neoplasm competition. Assume conditionally that competent mutant residents can exclude early neoplasms without immune removal being the operative cause. The mouse-style premise is unverified and transfers neither thresholds nor long-term human safety. Assume conditionally that chronic-colitis injury gives some IL-17-response mutant lineages, including NFKBIZ, relative resistance. Enrichment, resistance, barrier competence and prospective cancer prevention are different claims, all unverified here; the inflammatory-bowel-disease restriction remains. Assume conditionally that specified LOX-associated collagen crosslinking alters integrin/focal-adhesion signaling and cooperates with an oncogenic epithelial state to affect invasion. LOX crosslinking, LOXL2 inhibition, bulk stiffness and glycation chemistry are not interchangeable; no direct archived invasion or mutation-number result exists. Death-derived feeding requires an incremental accessible pulse above living-resident secretion under the actual removal/death procedure, plus a limiting material contribution in a baseline-supported tissue. Extraction, rapid apoptotic clearance and retained lysis can have different accessible fluxes; no procedure inevitably feeds an invader. No selective invader uptake/conversion target is supplied. Redundant routes may preserve flux after one block; an apparently effective block may instead impair signaling, sensing or repair-stress survival. Causal nutritional identification requires separation of these effects, not merely baseline fitness matching. Physiological nutrient delivery, perfusion and clearance remain unspecified. Local microdomains may retain or concentrate substrate despite ordinary bulk supply, while rapid clearance may dissipate it; starvation culture and one highly perfused condition are each insufficient for generalization.

Предсказание. Proposed common-condition test: in a defined older-donor epithelial mosaic with a barcoded pre-existing invasive lineage, initially exclude microbes and immune cells. Compare resident retention, viability-preserving suppression, killing with retained debris and physical extraction, recording local coverage, successful replacement hazard, mature function, death mode, nutrient delivery, matrix and non-target injury. Prelabel resident biomass, wash and chase, then measure the amount, chemical species and kinetics released, cleared and reaching invaders. Trace label through extracellular species into purified newly synthesized invader macromolecules and, for survival/maintenance, quantify catabolic products and energetic use; exclude residual medium/free label, adherent corpses, undegraded engulfed material and acellular carryover. Add macrophages only in separate arms to distinguish direct from indirect recycling. Quantify absolute births, deaths, net newly produced biomass and invasive events. Use carbon/nitrogen or substrate-relevant mass balance, with medium inputs, recovered corpse material and metabolic losses, to ask whether accessible assimilated material and its measured yield plausibly account for extra output; a limiting trace substrate need not supply most biomass, but its necessity and quantitative capacity must be shown. Test measured resident-equivalent concentration/time courses under baseline-supporting, physiologically defensible nutrient/perfusion and clearance conditions; dependence manufactured by starvation does not establish an ordinary-human route. After identifying a candidate limiting substrate, use orthogonal invader-specific uptake/conversion perturbations with target engagement and demonstrated loss of relevant flux, rescue the pathway, and compare equally injured invaders supplied with non-corpse nutrients. Baseline fitness alone cannot exclude a general repair-stress or signaling effect, and one redundant transporter block is not a complete salvage interruption. Under the hypothesis, selective loss of material flux reduces the extra production/survival component and its restoration rescues it. Fraction sufficiency at measured kinetics is supplementary: separately interrupt signaling versus metabolic conversion where feasible and test alternative nutrient rescue to distinguish instructions from feeding. If signaling drives extra growth despite adequately verified loss of material flux, the feeding contribution is bounded; if selective separation is impossible, label plus growth does not establish nutrition. High-flux or fusion-competent resident add-back can consume the pulse or suppress fed invaders, so restored restraint does not disprove feeding. Measure actual uptake and birth/loss terms in such factorial arms; matrix may separately determine crossing. Null invasion alone does not exclude nutrition, and null single-step perturbation alone does not exclude redundant salvage. Additional required discriminators and bounded interpretations: For the survival branch extend substrate-relevant mass balance to extracellular metabolites, intracellular flux, catabolic products and energetic/maintenance use, while separating contamination and indirect macrophage recycling. Couple measured flux to absolute survival/death and selective loss/rescue; absence of retained biomass label alone cannot exclude catabolic feeding, and catabolic label alone cannot establish its causal benefit. Bound accessible amount, uptake rate and plausible output supported using the measured requirement/yield and uncertainty; test graded physiologically defensible availability with alternative nutrient rescue and pathway-selective loss/rescue when feasible. Do not equate bulk isotope enrichment with causal contribution or claim a numerical capacity absent measurements. Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. Quantify release, delivery, uptake and use versus viable/suppressed-resident secretion, and test whether a limiting material input causes extra survival or production after controlling independent instructive signaling while allowing downstream nutrient-state signaling to vary. Equivalent dead mass from another lineage predicts equivalence only when species, composition, death mode, clearance and local availability are matched. Demonstrate loss of the relevant material flux, intact matched-injury responses and alternative-nutrition growth, and orthogonal pathway-specific rescue. If redundancy or inseparable signaling prevents these controls, report transfer plus association and bounds, not proven nutritional causation; a single null transporter perturbation does not reject the mechanism. Measure local release, availability, uptake and output over an explicitly justified delivery/clearance range anchored to the chosen tissue once such data exist. Report the range as unvalidated until measured. An immune-free arm isolates direct transfer; separately add phagocyte clearance/recycling and record net effects before making any in-vivo inference. Current finding-specific qualification: Material feeding can cause downstream nutrient-state signaling. Preserving independent instructive signaling in the nutrition contrast must not mean clamping signaling caused by restored limiting material or energy. The rival is instruction independent of that limiting material function, not every signaling response to nutrition. Where selective separation is feasible, compare material-use loss and orthogonal pathway or suitable nutrient restoration while preserving independent instructive exposure and matched-injury/alternative-nutrition competence, allowing downstream nutrient-state responses to vary. Attribute assimilative and catabolic/maintenance flux to viable invaders with the existing sterile, acellular and separate-phagocyte controls. If material and instructive roles cannot be separated, report transfer, association and substrate-specific quantitative bounds rather than proven nutritional causation.

CROSS-DOMAIN TRANSFER: If ordinary renewal in aging human muscle transiently disables critical force-transmitting links, equal removed mass can cause different residual losses according to the spatial arrangement and capacity of surviving routes. A bridging-path loss could interrupt transmission before replacement, whereas redundant removal could preserve it. The distinctive conditional candidate is renewal-induced, spatially patterned disconnection that predicts which recovery sequences leave persistent loss and which small route-specific replacements prevent it; a bridge's mechanical importance alone is not a novel mechanism. Connectivity loss may redistribute load, overload some paths or unload disconnected regions depending on force-, displacement- or work-controlled boundaries and active regulation. Persistent injury must follow independently; transient lower transmitted force is insufficient. Route-specific prebuilding or spatially staggered removal might reduce the accumulating SPV_5 analogue without universally reversing clearance order, if retained damage does not offset the gain. A registered template can help by building later connections and is compatible with this account. Organelle turnover enters the graph only if shown to disable a functional link; lysosome counts are not nodes. Human occurrence, age dependence and dominance over ordinary heterogeneous mechanics remain unverified.

Механизм. Evidence status: the archived source corpus is empty. The supplied S-nodes and CHECKED FOUNDATIONS are candidate assertions; all audited verdicts are unknown. Source dates, readiness labels and apparent specificity do not verify them. No published experiment, historical novelty or older-human causal benefit is certified here. These are competing hypotheses for a dominant bottleneck under matched conditions, not mutually exclusive biological laws. The candidate grounding is RA_M_G2_04's spatially staggered renewal architecture (audit G2_1_032) and S_M_G2_DOM05_010's separation of formation from functional integration. These are unverified prompts, not proof of a percolation threshold in human muscle. No universal occupancy target or infinite-network critical fraction is assumed. The mechanism concerns mechanical connectivity within tissue, not vascular transport, a barrier defect, systemic environment or simple depletion of a finite resource. Preserve path occupancy and template registration independently when comparing with IH_01. Practical implication is a conditional research direction, not a drug, nutrition or exercise prescription. A reduction in tissue-level cumulative force loss would motivate human recovery studies, but would not establish radical slowing of whole-human aging. That further claim requires persistent multisystem damage and vulnerability trajectories without offsetting harm. Continued maintenance and benefit after withdrawal must be evaluated separately. If SPV_6 is subsequently used, preservation of a declining reserve means its signed annual slope increases toward zero, not decreases. All scientific support is unknown because the supplied sources archive is empty; S-node IDs, foundation IDs, RL labels, dates and embedded URLs are candidate metadata, not source evidence. No experiment or result described here has been performed in this task. These are conditional explanations of possible residual recovery loss in aging human muscle, with no certified historical novelty or living-human causal benefit. mTOR inhibition, autophagic initiation, completed cargo degradation, lysosome reformation, contractile-protein turnover, precursor fusion and whole-cell senolysis require separate causal accounts and readouts. Nutrient supply, absorption, utilization, synthesis, net accretion and mature integration are distinct. The post-disuse candidate concerns impaired rather than necessarily absent nutritional response; its related population is overweight, prediabetic older adults, and transfer to ordinary infection convalescence is unverified. Clearance can also remove toxicity, preserve precursor competence or supply repair substrates; direct repair can reduce replacement demand. No universal clearance-first or replenishment-first rule follows. The four mechanisms may coexist, oppose or enable each other within one tissue and across cycles. A failed selective manipulation is inconclusive; weakening one candidate does not establish another. Local force preservation tests a muscle recovery mechanism and cannot establish radical slowing of whole-human aging. Use SPV_5 only as a function-specific residual-loss measure: 100×(expected function−observed function)/expected function after the acute phase, where greater function is better and the expected denominator is meaningful. The counterfactual is uncertain, values may be negative, and episode changes are percentage points. The construct analogue needs an explicit reference trajectory. Avoid a progressively deeper residual deficit; stabilizing an already large deficit does not restore reserve. SPV_6, if later used, is a signed annual reserve slope; preservation raises a negative slope toward zero. Whole-human transfer requires persistent multisystem damage and vulnerability trajectories relative to expected untreated aging from the person's actual starting chronological age and state under comparable ordinary physical, infectious, psychosocial and environmental demands, without comparable harm or accelerated decline elsewhere. Maintenance during exposure and persistence after withdrawal are separate claims. Neither a radical effect magnitude nor a drug, nutrition or exercise protocol, dose, frequency, duration, adaptation or stopping rule is established. Latest repair preserves the frozen mechanism and unexpected consequence, all original fields and every current limitation. Criticisms retained in limitations are historical problem statements; the current tests below supersede the specific defective inference, not the candidate identity. Unknown evidence alone is not rejection. No alternative mechanism replaces a parent, so no branch is needed. The archive remains empty and no reported abstract is upgraded beyond abstract_only; here no abstract or source text is supplied.

Предсказание. Under the common conditions, validate functional links by local transmission/strain tests and predeclare the graph, candidate bridges, capacities and redundant/lateral routes before perturbation outcomes. Derive a heterogeneous continuum-mechanics comparator from the same measured geometry, material properties, active capacity and loading boundaries. Prospectively compare held-out predictions across architectures and force- versus displacement-controlled regimes. At matched removed material, initial lesion and direct procedural injury, target engagement, nutrient use, registration and integration timing, with downstream local loading and injury observed rather than equalized, IH_02 predicts that a specified renewal event disables a preidentified critical route before redistribution and later residual loss; route-specific reconnection or staggered removal prevents that loss more effectively than equal off-path material in the susceptible architecture. Do not require overload where boundaries predict unloading. Measure immediate transmission, local strain/injury and final unassisted recovery separately; remove any temporary bypass and map new links at removal, rebuilding and final testing. A bridge cut and attached bypass improving current force are also predicted by ordinary mechanics and do not establish the new aging account. Equal predictive success of the continuum account supports mechanics but no uniquely additional percolation explanation. A selective null in a preidentified vulnerable layout weakens the proposed dominant path bottleneck there; a null in a highly redundant layout does not generally refute it. Delayed template rescue with rebuilt connections is compatible with both mechanisms. Controlled ablation tests mechanical sufficiency only; physiological clearance at a relevant scale must independently be linked to the path loss. Identify an actual endogenous substrate-removal event and its spatial scale, measure functional transmission before/during it, and record its incidence in eligible older-donor tissue. Test whether compensating or new lateral routes preserve transmission; then test event→route loss→boundary-dependent redistribution→new injury→later residual loss across cycles. An imposed bridge ablation establishes mechanical sufficiency only. Failure to observe a link-loss event in an eligible, sensitive chosen setting limits that setting; no frequency or general age dependence is supplied. Parameterize both models from the same measured geometry, capacities, constitutive properties, active regulation, lateral routes and boundaries, with comparable complexity and measurement uncertainty. Before outcomes, specify a feasible condition where their predictions differ beyond uncertainty. If none exists, call them representations of the same mechanical pathway and report prediction/parsimony only; bridge-specific rescue cannot distinguish them. Differences caused by omitted continuum structure or unequal flexibility are non-diagnostic. Do not fabricate a separating perturbation merely to claim novelty. Under each separately prespecified force- or displacement-controlled regime, observe rather than equalize redistribution, effective local load, new strain-dependent injury and later residual force. Follow injury after removal as the predicted mediator. Boundary-dependent unloading remains possible and no automatic overload is claimed. All six comparisons inherit this rule. Validate on-route versus off-route attachment effects on chemistry, maturation and initial procedural injury, plus whether the same total biological material is removed. Prospectively predicted natural renewal vulnerability must precede an intervention-induced change in the route-loss sequence. Follow the complete repaired map, including newly built lateral routes, during removal, rebuilding and final unassisted testing. Remove temporary support before final force measurement while retaining its full earlier strain/protection history. A benefit through ordinary mechanical protection supports that pathway, not an extra percolation law.

HERETICAL, conditional: In a prospectively specified population of cycling epithelial progenitors from aging humans, endogenous IL-11 signaling may preserve DNA-break repair fidelity. Blocking IL-11 could shift repair toward polymerase-theta-mediated end joining, increasing newly generated deletions and rearrangements in surviving descendants despite reduced inflammatory injury, adequate early wound closure and mature epithelial function, and initially preserved pathogen clearance. Each concurrent outcome requires separate demonstration. The proposed fidelity defect concerns repair of comparable damage substrates within tracked lineages; more errors caused solely by changed lesion production, location or complexity would not establish it. Persistent genomic damage could later increase malignant or organ-failure transitions within SPV_3 and offset an independently demonstrated beneficial effect. Persistence, clinical consequence and sufficient magnitude for cancellation remain additional conditional links.

Механизм. All IL-11-to-repair links remain unverified assumptions with prospective tests. No supplied review, causal map, reader reconstruction or revision history is independent experimental evidence. The contextual mouse account concerns late-life treatment and carries RL-1 status; its numerical effect, dose, sex-specific results and detailed follow-up are unavailable. The reported ERK–AMPK–mTORC1 association is a signaling lead, not a demonstrated human causal chain. ERK means extracellular signal-regulated kinase, AMPK means AMP-activated protein kinase, and mTORC1 means mechanistic target of rapamycin complex 1. Definitions establish terminology rather than mediation. Test human pathway perturbation, inflammatory injury and sustained damage/function separately. The MUTYH and repair-associated epigenetic accounts require their archived reports or direct tests before serving as empirical anchors. The different-target IL-1β vascular/infection account cannot establish IL-11 harm. This hypothesis concerns newly generated repair errors within lineages, retaining its distinction from cell fusion, genome complementation and clonal composition as a stored state. A substrate-mediated error increase is an explicit alternative, not a replacement mechanism or confirmation of this parent. No treatment recommendation follows.

Предсказание. Before observing repair outcomes, specify the donor population and baseline cellular eligibility, including epithelial lineage, cycling capacity and a reproducible endogenous IL-11 response measured in independent baseline aliquots. Do not define susceptibility by subsequently observing excess errors. Under randomized donor-paired control, ligand-neutralization and inducible IL11RA-loss conditions, compare characterized nonlethal lesion classes at matched genomic sites. Characterize initial break-end structure and chemistry, clustered or associated damage, complexity, local chromatin and replication context, lesion induction timing and burden. Equal break counts alone are insufficient. Combine a defined-break reporter with direct measurements at endogenous loci, including matched-site induced lesions and separately characterized ordinary endogenous damage where feasible. Follow lesion processing over time: treatment-induced end processing may itself mediate repair choice and must not automatically be matched away. Estimate the total treatment effect separately from repair accuracy under experimentally comparable initial substrates. Retain unchallenged cultures and the complete randomized starting population. The focal prediction is excess de novo structural repair errors for comparable initial lesion classes before differential expansion explains the result, with orthogonal IL-11 perturbations and a validated physiological, perturbation-compatible rescue reversing that excess. Orthogonal polymerase-theta perturbation should identify its contribution while accurate repair, other erroneous repair, persistent breaks, arrest, death and lineage loss remain accounted for per initial lesion and starting cell; descendant-level estimates are additional denominators. A reduced microhomology signature accompanied by worse unresolved damage or lineage survival does not demonstrate improved fidelity. The substrate/selection alternative predicts that differences follow lesion characteristics, lesion production, division history or lineage recovery, with equivalent accuracy for comparable substrates. If initial substrates cannot be adequately characterized or controlled, fidelity versus substrate mediation remains unresolved. Separately demonstrate reduced inflammatory injury, adequate early epithelial replacement and mature function, and preserved laboratory pathogen clearance at the same exposure. A fidelity defect alone supports only part of the frozen conjunction. Sensitive bounded equivalence constrains the prospectively defined population and tested lesion classes; it does not justify retrospectively excluding nonresponders. Receptor competition, communication defects and immune injury may coexist or lie upstream.

HERETICAL, provisional and conditional: In a prospectively characterized subgroup of older humans, maintained training could improve mobility while producing an acquired increase in renal filtration during the same ordinary activity. If this increase raises actual regional sodium reabsorption and its oxygen cost beyond local oxygen availability, the apparently improved filtration response itself could produce recurrent tubular oxygen deficits during ordinary warm activity. Normal resting filtration and preserved total renal arterial inflow could coexist with this regional mismatch. Filtration alone does not establish additional oxygen-consuming transport: sodium excretion, transport distribution, transport efficiency, oxygen extraction and delivery may accommodate the response. Persistent renal functional loss additionally requires consequential injury and incomplete repair across repeated episodes. Thus mobility could improve while renal function deteriorates, but every link in that joint phenotype remains unverified. Selectively limiting the acquired filtration-imposed transport burden could preserve renal recovery and mobility if the complete sequence exists. A protective effect of reducing transport demand alone would establish neither training acquisition nor the initiating cause.

Механизм. All biological links have status assumption, evidence_status unverified and source_ids []. The original heretical role and acquired-filtration mechanism are retained. This proposal remains distinct from muscle-to-liver lactate recycling, potassium-acid feedback and depletion of a stored resource. Preserved total arterial inflow does not establish regional oxygen sufficiency. Transport and delivery limitations may coexist. Persistent functional cost, structural injury, irreversibility, accelerated renal aging and altered whole-human aging are separate claims.

Предсказание. Apply the shared population, exposure and outcome conditions in notes. Before outcomes, define baseline strata using measured renal functional response, resting function, disease and medication exposure; these are candidate effect modifiers, not validated susceptibility criteria. Estimate the training effect across the prespecified population and strata rather than defining susceptibility retrospectively from injury. If subgroup discovery is necessary, freeze its baseline-only rule before independent confirmation. Obtain repeated pretraining baselines and serial acquisition-period measurements during maintained training and a concurrent appropriate control. The focal sequence is a training-associated increase in challenge filtration at matched absolute exposure, followed by increased regional transport-associated oxygen consumption, oxygen imbalance, incomplete recovery and sustained renal dysfunction in the same participants whose mobility improves. Account separately for baseline reserve, hydration, medications and cumulative daily activity. Cortical proximal tubular S1/S2 segments remain one conditional first localization; their involvement is unknown. Align filtration-marker kinetics, plasma sodium and urinary collections, accounting for transit and nonsteady intrarenal storage. Whole-kidney balance screens for the phenotype but cannot establish regional transport or oxygen consumption. In a complementary preparation, independently characterize segmental sodium transport, transport-associated oxygen consumption, oxygen delivery, extraction, tissue oxygenation and function. Cross baseline and human-phenotype-matched elevated filtered loads with baseline-adequate and augmented regional oxygen supply. Establish baseline adequacy before escalation; it is not a claim that the same supply remains sufficient after demand rises. Load-dependent injury, prevention when load is reduced and recurrence when restored support a downstream transport contribution only with verified separation of pressure, osmotic, oncotic, signaling, transport-distribution and direct intervention effects. Augmented oxygen preventing high-load injury would further support supply-demand mediation. Such results remain compatible with conventional transport energetics; independent human acquisition evidence is required for the distinctive training-origin claim. Demand reduction can also protect primary delivery-limited tissue. Persistent harm requires control-adjusted recovered-state filtration and functional-response trajectories, corroborating tubular dysfunction where measurable, and concurrent mobility benefit. A sustained filtration shift alone remains compatible with adaptive regulation. Adequately precise absence of acquisition, regional excess cost, oxygen imbalance or sustained dysfunction contradicts the corresponding link within the tested population, segment and exposure range.

SCOUT 1 from microbial chemical toxicology, conditional: In an aging human mucosal mosaic with a verified active genotoxic producer, loss of a resident's functional barrier contribution during removal-to-repair may increase the toxin dose delivered to surviving renewing cells. A subset might survive with newly acquired heritable lesions that causally confer sustained invasiveness on their descendants. This requires three distinct unverified links: removal increases local exposure, exposure creates surviving new lesions, and those lesions contribute causally to later invasion. The resident's protection here is functional exclusion of genotoxic exposure, not necessarily superior clonal fitness. Apparent coverage alone does not establish mucus, junction, polarity or secretory protection; even viability-preserving suppression may increase exposure, whereas extraction with rapid functional replacement may not. Toxin-dependent selection of an already invasive or resistant lineage, or transient signaling, is a separate compatible explanation. Removing a dysfunctional resident could improve later mature output while transiently increasing exposure. Preventing this channel could reduce the birth of new dangerous descendants but need not change the SPV_9 of existing dangerous clones; mutation acquisition, lineage growth and invasion remain distinct. No general claim that every aging epithelium carries the required producer is made.

Механизм. All causal claims are hypotheses about older human epithelial renewal, not demonstrated human-aging effects. The complete archived source corpus is empty; CHECKED FOUNDATIONS rates all supplied premises unknown. Candidate S-node IDs below identify motivating assertions, not primary evidence. No published novelty, effect size, safe clone size, clinical regimen, or whole-human aging benefit is claimed. Role: SCOUT 1, from microbial chemical toxicology, mechanistically distinct from lineage birth-death competition and corpse nutrient salvage. Candidate grounding is S_M_G4_DOM01_004, which asserts colibactin-derived heritable epithelial damage; it is not an archived study and no model conditions or effect sizes are supplied. Application and novelty in this exact aged mosaic-removal setting remain unverified. The hypothesis applies only where a producer and biologically meaningful exposure are demonstrated; it is not an assertion that all aging epithelia contain such microbes. Conditional practical implication: if removal is needed, preserving functional coverage and resolving a demonstrated genotoxic exposure would precede or accompany it in a future tested strategy. No antibiotic, microbiome product or human intervention is recommended. All predictions are proposed tests, not observations. Within each contrast use one prespecified older-human donor-derived epithelial site, recorded resident/invader genotypes and baseline lineages, comparable initial coverage, local contacts, nutrients, non-toxin injury, basement membrane and matrix. Site, donor age range and sex, perturbation intensity, repair timing and effect sizes remain unspecified. Measure absolute viable renewing and differentiated lineage counts, mutation acquisition, anatomically verified invasion and functional barrier recovery separately. SPV_9 is change in log cell fraction per year with a defined denominator and ancestry rule, not absolute growth or malignancy. Preserving mature output, progenitor reserve and growth control through repeated repair is an independent requirement. Experiments that change an intended control remain informative about a coupled mechanism but cannot isolate the proposed route. All four mechanisms can coexist with matrix effects; a selective effect identifies a contribution, and a null result bounds only the tested tissue, exposure and detectable effect. No whole-human antiaging efficacy follows. Operative repair qualifications (all proposed and unverified): The colibactin-style DNA-reactive exposure-to-surviving-new-lesion transfer remains unverified. Dose, accessible renewing compartment, producer identity, survival and latency are unspecified; damage may produce death/arrest instead of heritable lesions. Assume conditionally that the same NOTCH1 lesion changes daughter fates differently in normal esophageal progenitors and tumor cells; the supplied metadata do not establish any species, age, genotype combination or follow-up. Intrinsic tumor impairment is distinct from resident–neoplasm competition. Assume conditionally that competent mutant residents can exclude early neoplasms without immune removal being the operative cause. The mouse-style premise is unverified and transfers neither thresholds nor long-term human safety. Assume conditionally that chronic-colitis injury gives some IL-17-response mutant lineages, including NFKBIZ, relative resistance. Enrichment, resistance, barrier competence and prospective cancer prevention are different claims, all unverified here; the inflammatory-bowel-disease restriction remains. Assume conditionally that specified LOX-associated collagen crosslinking alters integrin/focal-adhesion signaling and cooperates with an oncogenic epithelial state to affect invasion. LOX crosslinking, LOXL2 inhibition, bulk stiffness and glycation chemistry are not interchangeable; no direct archived invasion or mutation-number result exists. Removal-to-exposure is a conditional first gate requiring an active producer in the relevant exposure compartment and an actual rise in biologically effective dose to renewing cells. Nominal intact area and the colibactin summary do not establish it; rapid functional replacement may prevent exposure and viable suppression may alter it. Surviving new lesions and lesion-mediated invasion are separate unsupported links. Deep ancestral sampling leaves a quantified possibility of rare pre-existing invasive ancestry; a signature or passenger lesion can accompany selection without causing invasion. Toxin interruption/restoration predicts an exposure-linked population contribution under a viable exposure regime, not recurrence of the identical rare lesion or clone in each replicate. Dose can shift death, arrest, selection and lesion acquisition in opposing directions; survival is measured, not assumed. Match initial deletion, initial non-toxin injury and initial corpse availability. For the total toxin effect, later toxin-induced death/injury and consequent feeding are mediators, so do not force them equal. A separately specified pulse-clamped arm estimates a controlled direct effect under its own feasibility assumptions. Conditioning only on post-exposure survival does not randomize pre-existing susceptibility. A nominated single lesion may be insufficient if new lesions cooperate or a stable exposure-induced state is also required. A null single-lesion intervention bounds that lesion in that background; it does not reject all genotoxic mechanisms. A stable state alone is an alternative unless causal acquired heritable lesions are also established; it is not silently substituted for the frozen mechanism.

Предсказание. Proposed common-condition test: use a defined older-donor intestinal epithelial mosaic supporting documented luminal microbial contact and repair, with banked, deeply characterized ancestral lineages split across conditions. Cross retention, viability-preserving suppression and controlled small-area removal with verified toxin-competent, toxin-deficient and complemented producer conditions plus sterile controls. The matched reagent pair is an experimental target: verify microbial growth, metabolism, adhesion, community composition and proximity; equal bacterial counts are not equal delivered dose. Match initial deletion, non-toxin injury, starting producer burden, baseline nutrients, initial corpse material and matrix; downstream toxin-induced corpse release is not matched away in the total-effect arm. Measure functional permeability and local toxin activity/contact over time and do not force downstream toxin-mediated injury equal, because it lies on the proposed causal path. First establish whether removal actually increases delivered exposure and DNA adducts/damage in surviving renewal cells. If it does, follow barcodes, repeated samples and descendant phylogenies to nominate sequence changes acquired after exposure and before phenotype, reporting deep-baseline detection limits rather than claiming every rare pre-existing subclone was absent. A new mutational signature or passenger plus expansion is insufficient. After toxin withdrawal, compare descendants in a shared uninjured niche and matrix; reconstruct a nominated acquired lesion in the appropriate ancestral background or correct it in the descendant, with matched genetic controls, to test causal invasive behavior and possible cooperation with pre-existing drivers. Under the hypothesis, specific toxin interruption reduces the acquired-lesion-mediated component, and restoration of verified delivered exposure is predicted to restore its population-level contribution under a viable exposure regime, not the identical lesion or descendant in every replicate. Toxin dependence alone can also reflect selective killing or growth of pre-existing invasive lineages; ancestry and lesion causality distinguish these routes. Sterile or toxin-negative arms should lack this toxin-mediated new-lesion component, while other release mechanisms can persist. A finite negative result bounds the tested dose/time and detectable lineage frequency, not all late events. Measure absolute descendant production, clone fractions with denominator, mature barrier recovery and basement-membrane crossing separately. Matrix-dependent invasion without required new causal lesions supports a matrix contribution and can coexist with genotoxicity. Additional required discriminators and bounded interpretations: Measure local delivered dose, activity/contact, adducts/damage, cell death/arrest and surviving descendant lesions in banked ancestral lines under matched toxin-deficient and complemented conditions. Bound pre-existing ancestry and require separate lesion-function evidence before predicting invasive descendants; current microbiome composition cannot establish past exposure. Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. Compare retention, suppression and the specified removal procedure using delivered toxin activity/contact, functional barrier measures and surviving-renewal-cell damage. Proceed to the lesion-mediated prediction only if that first link is supported in the proposed model; absence under rapid functional replacement bounds that procedure, not all epithelial removal. Preserve banked ancestral lines, baseline detection bounds, time-resolved ancestry and post-exposure lesion timing. Test nominated new changes in the relevant ancestral/descendant genetic background, with existing drivers characterized, and require a causal contribution to sustained anatomical invasion after washout in a justified common niche rather than signature enrichment or toxin dependence alone. Across independent ancestral replicates compare exposure-linked rates and distributions of surviving causal-lesion descendants, with uncertainty, delivered dose, cell loss/arrest and adequate follow-up recorded. Restoration means recovery of the conditional distributional contribution within a justified exposure regime; a finite unmatched stochastic realization is not falsification, and no universal monotonic dose response is asserted. Report both total-effect and pulse-clamped estimates with their distinct intervention conditions; track all initial lineages, death and surviving descendants, then report survivor-conditional quantities as such. Preserve the toxin-to-death-to-feeding chain in total-effect comparisons and use ancestral matching rather than treating survivor selection as randomization. Where indicated, test justified lesion sets and characterized cooperating state/background with matched genetic controls. Retain the exposure-to-ancestry chain and test sustained basement-membrane crossing in a shared niche justified for the original tissue. Invasion enabled only by an artificial permissive matrix does not establish consequential invasion caused by removal in aging tissue. Current finding-specific qualification: Toxin restoration remains a conditional distributional prediction, with distinct estimands per initial lineage, per exposure and conditional on survival. A pulse-clamped contrast is a separate controlled effect only if the clamp is feasible and does not independently alter delivered toxin, susceptibility or relevant repair functions; feasibility is not established. Prespecify follow-up and report the probability of at least one causal-lesion descendant per starting lineage, absolute causal-lesion descendant counts per initial lineage, and any exposure-normalized rate with its exposure denominator and uncertainty; separately label survivor-conditional quantities and follow all initial lineages including deaths/arrests. Validate any pulse clamp for exposure and susceptibility; if validation fails, omit its isolated causal interpretation while retaining the total-effect arm with toxin-induced injury, death and feeding intact. Validate producer deletion/complementation ecology and delivery; toxin dependence alone still does not distinguish new-lesion causality from selection.

HERETICAL: If a specific damaged contractile component in older human muscle retains a positional record that new material cannot reconstruct from surviving ordinary cues, clearing that component before its pattern is copied could create cumulative assembly error during repeated mild recovery. The proposed record is the local position and orientation of replacement sites relative to stable surrounding landmarks; copying means that an independently distinguishable old pattern prospectively predicts and causally redirects the nascent pattern when other assembly conditions are held equivalent. The central exception is useful information carried by damaged, actively force-inactive material: registered retention or transfer of its pattern could reduce later residual force loss despite more retained damage and no extra synthesis. Active force inactivity does not exclude passive stiffness, adhesion, force transmission, strain guidance or earlier unloading; the claim requires an incremental registration effect independent of those functions and ordinary surviving scaffold cues. Conditional loss of this information could leave restored mass and adequate fusion without ordered contractile work. Preserving or transferring registration before the carrier is lost could therefore matter more than globally maximizing clearance, but biochemical harm from retained material may offset or coexist with the benefit. Neither the carrier, copying operation, irrecoverability nor its importance in ordinary human aging is established.

Механизм. Evidence status: the archived source corpus is empty. The supplied S-nodes and CHECKED FOUNDATIONS are candidate assertions; all audited verdicts are unknown. Source dates, readiness labels and apparent specificity do not verify them. No published experiment, historical novelty or older-human causal benefit is certified here. These are competing hypotheses for a dominant bottleneck under matched conditions, not mutually exclusive biological laws. The specific candidate puzzle is the separation of precursor expansion, differentiation, fusion and force integration in S_M_G2_DOM05_010 (audit G2_1_006–008), together with machinery reformation after clearance in S_M_G2_DOM05_001. Neither supplied candidate assertion demonstrates informational templates; the proposed causal step is new and unverified. This is not prion-like conformer multiplication or a learned neural state: the stored quantity is spatial registration of replacement sites, tested independently of old material quantity and mechanical spanning. No SHAPES ALREADY CLAIMED block was supplied. The common self-templating-assembly family was considered; this hypothesis is retained only for its explicit spatial-registration versus force-path discriminator. Stop pursuing it if that distinction cannot be physically separated. Practical implication is a conditional research direction, not a drug, nutrition or exercise prescription. A reduction in tissue-level cumulative force loss would motivate human recovery studies, but would not establish radical slowing of whole-human aging. That further claim requires persistent multisystem damage and vulnerability trajectories without offsetting harm. Continued maintenance and benefit after withdrawal must be evaluated separately. If SPV_6 is subsequently used, preservation of a declining reserve means its signed annual slope increases toward zero, not decreases. All scientific support is unknown because the supplied sources archive is empty; S-node IDs, foundation IDs, RL labels, dates and embedded URLs are candidate metadata, not source evidence. No experiment or result described here has been performed in this task. These are conditional explanations of possible residual recovery loss in aging human muscle, with no certified historical novelty or living-human causal benefit. mTOR inhibition, autophagic initiation, completed cargo degradation, lysosome reformation, contractile-protein turnover, precursor fusion and whole-cell senolysis require separate causal accounts and readouts. Nutrient supply, absorption, utilization, synthesis, net accretion and mature integration are distinct. The post-disuse candidate concerns impaired rather than necessarily absent nutritional response; its related population is overweight, prediabetic older adults, and transfer to ordinary infection convalescence is unverified. Clearance can also remove toxicity, preserve precursor competence or supply repair substrates; direct repair can reduce replacement demand. No universal clearance-first or replenishment-first rule follows. The four mechanisms may coexist, oppose or enable each other within one tissue and across cycles. A failed selective manipulation is inconclusive; weakening one candidate does not establish another. Local force preservation tests a muscle recovery mechanism and cannot establish radical slowing of whole-human aging. Use SPV_5 only as a function-specific residual-loss measure: 100×(expected function−observed function)/expected function after the acute phase, where greater function is better and the expected denominator is meaningful. The counterfactual is uncertain, values may be negative, and episode changes are percentage points. The construct analogue needs an explicit reference trajectory. Avoid a progressively deeper residual deficit; stabilizing an already large deficit does not restore reserve. SPV_6, if later used, is a signed annual reserve slope; preservation raises a negative slope toward zero. Whole-human transfer requires persistent multisystem damage and vulnerability trajectories relative to expected untreated aging from the person's actual starting chronological age and state under comparable ordinary physical, infectious, psychosocial and environmental demands, without comparable harm or accelerated decline elsewhere. Maintenance during exposure and persistence after withdrawal are separate claims. Neither a radical effect magnitude nor a drug, nutrition or exercise protocol, dose, frequency, duration, adaptation or stopping rule is established. Latest repair preserves the frozen mechanism and unexpected consequence, all original fields and every current limitation. Criticisms retained in limitations are historical problem statements; the current tests below supersede the specific defective inference, not the candidate identity. Unknown evidence alone is not rejection. No alternative mechanism replaces a parent, so no branch is needed. The archive remains empty and no reported abstract is upgraded beyond abstract_only; here no abstract or source text is supplied.

Предсказание. Under the common conditions, first identify a damaged old component, establish its active and passive mechanical properties, and show that a measurable position/orientation pattern precedes nascent assembly beyond surrounding geometry. Only after validating selective manipulation, cross registered versus scrambled versions of the same material with pre- versus post-clearance introduction and with independently characterized mechanical support. Compare registration at each matched introduction time, delivery, persistence, actual removal, synthesis, viability, coassembly chemistry and locally measured fusion competence. IH_01 conditionally predicts direct transfer of imposed registration to new positions/orientations. Only a functionally competent registered pattern additionally predicts improved unassisted repeated-load force with no old-carrier coassembly or relevant mechanical assistance; an arbitrary imposed or scrambled pattern need not improve force. Equivalent scrambled material at the same stage should not reproduce that pattern-specific benefit. Compare mechanically equivalent ordinary scaffolds and intact surviving cues. Follow passive stiffness, adhesion, local strain, load paths and maturation throughout exposure, not just after removing the template: late persistence alone cannot exclude earlier unloading or maturation assistance. Erasure must remove the specified information while preserving viable architecture and alternative prerequisites; equal rescue after selective scrambling, or normal organized recovery after verified erasure, weakens necessity in that preparation without identifying a rival. If geometry, chemistry and mechanics cannot be separated, report a composite scaffold effect rather than informational causality; multiple successful crossed rescues allow coexistence. For a prespecified identified carrier, predict the nascent pattern from surviving cues alone versus cues plus the old pattern, then require selective imposed-pattern redirection relative to independently fixed landmarks. Separately follow actual ordinary renewal to test whether this carrier is removed before copying and whether the missing information is reconstructed from other cues. Association alone, or artificial sufficiency without endogenous occurrence, does not establish irrecoverable information loss or aging prevalence. Before outcomes, enumerate measured surviving landmarks, attachment geometry, ligand/contact distribution, adhesion, stiffness, strain and signaling; specify the moved old-carrier position/orientation variable and the ordinary-cue model's predicted new pattern. Claim an incremental record only for residual transfer prospectively predicted by carrier registration under demonstrated equivalence of those cues. If moving registration necessarily moves an explanatory ordinary cue, report scaffold-guided assembly with unresolved stronger information claim; do not relabel it memory. First define an experimentally admissible range of imposed positions/orientations using independent viability, ordinary architecture and mechanical compatibility criteria; no numeric range is supplied. Direct transfer is a prespecified old-to-new spatial mapping relative to stable landmarks. Functional quality is a separate mature alignment and unassisted repeated-load-force criterion. A displaced or scrambled pattern may redirect assembly and reduce force: redirection alone supports transfer, not beneficial guidance. The frozen surprise requires a functionally competent registered pattern to preserve later force despite higher retained damage and without extra synthesis or mechanical support over the entire repair history. Helpful guidance alone does not prove irrecoverability; verified selective erasure with intact alternative cues tests that separately. The common mature older-donor muscle platform is an eligibility requirement, not an existing validated preparation. Before any pairwise contest, demonstrate that both mechanisms can operate in the SAME preparation and SAME mild lesion with the necessary aged architecture retained. Separate favorable cultures, reconstituted assemblies or injury-rich fusion models provide staged component pilots only, not a common-condition ranking. Not every mechanism must be active in every preparation. Match initial lesion and direct procedural injury, baseline reserve, measured exposure and external loading boundary regime; do not force equal the downstream new pattern, occupancy, actual fusion, local redistribution, strain-dependent injury or rebuilt routes when one is the hypothesized mediator. Record them in temporal order. For comparisons that need a mediator already adequate as a prerequisite, validate that adequacy independently before the focal contrast. Effective local load is measured, not matched away when route loss changes it. All definitions below specify proposed operational tests; no identified carrier, molecular species, phase-selective tool, endogenous removal event or physiological incidence is invented.

SCOUT 2 — import from developmental timing of cell fusion: If older human muscle recovery from a specified mild lesion requires new precursor-to-fiber fusion, two independently closing competence windows could become misaligned and leave cumulative residual loss despite adequate precursor numbers and synthesis. The distinctive candidate is a recipient window separate from precursor maturation and a shared postinjury recovery gate: at otherwise competent local contact, the recipient and precursor must be ready together. A defined clearance event might shift recipient phase, so either early or late precursor readiness could miss it; this causal shift is an additional unverified premise, not inferred from a common injury signal. Synchronizing the two programs could improve fusion, mature integration and subsequent force without a universal clearance-first or replenishment-first rule. Competence must be defined independently using reference partners, not retrospectively from the failed test pairing or marker overlap. The mechanism assumes intact membranes and phase-appropriate machinery, and is distinct from changed cell identity, clonal composition or transport. Fusion may be important in an injury-rich culture yet nonlimiting in ordinary adult protein turnover; age-related prevalence and whole-human significance are unknown. The surprising benefit concerns aligning the two local programs rather than choosing a universal phase order. The predicted loss occurs when precursor readiness is too early OR too late relative to recipient readiness. Coincident windows are not predicted to fail merely because their coincidence is early or late in absolute recovery time; a separate absolute-time limitation would require evidence and would not be the defining mismatch mechanism.

Механизм. Evidence status: the archived source corpus is empty. The supplied S-nodes and CHECKED FOUNDATIONS are candidate assertions; all audited verdicts are unknown. Source dates, readiness labels and apparent specificity do not verify them. No published experiment, historical novelty or older-human causal benefit is certified here. These are competing hypotheses for a dominant bottleneck under matched conditions, not mutually exclusive biological laws. Scout field: developmental heterochrony and timed cell-fusion competence. Candidate anchor S_M_G2_DOM05_010 specifically separates differentiation from fusion and leaves innervation/force transmission unresolved; audit G2_1_006–008 marks the underlying reports unknown. The particular two-sided timing mechanism is a hypothesis beyond that anchor; there is no verified empirical demonstration or novelty search in this corpus. Mechanistic distinction from IH_03 is a relative temporal program restored without changing old–new molecular-complex chemistry. Unlike a forbidden interface-integrity mechanism, the claim assumes intact membranes and unchanged fusion machinery competence when sampled in the correct phase; it predicts a timing rescue, not repair of a leaky or transport-defective boundary. No additional hypotheses are added because variants involving another fusogen, nutrient, tissue or clock would restate these mechanistic distinctions rather than supply a new discriminable explanation. Practical implication is a conditional research direction, not a drug, nutrition or exercise prescription. A reduction in tissue-level cumulative force loss would motivate human recovery studies, but would not establish radical slowing of whole-human aging. That further claim requires persistent multisystem damage and vulnerability trajectories without offsetting harm. Continued maintenance and benefit after withdrawal must be evaluated separately. If SPV_6 is subsequently used, preservation of a declining reserve means its signed annual slope increases toward zero, not decreases. All scientific support is unknown because the supplied sources archive is empty; S-node IDs, foundation IDs, RL labels, dates and embedded URLs are candidate metadata, not source evidence. No experiment or result described here has been performed in this task. These are conditional explanations of possible residual recovery loss in aging human muscle, with no certified historical novelty or living-human causal benefit. mTOR inhibition, autophagic initiation, completed cargo degradation, lysosome reformation, contractile-protein turnover, precursor fusion and whole-cell senolysis require separate causal accounts and readouts. Nutrient supply, absorption, utilization, synthesis, net accretion and mature integration are distinct. The post-disuse candidate concerns impaired rather than necessarily absent nutritional response; its related population is overweight, prediabetic older adults, and transfer to ordinary infection convalescence is unverified. Clearance can also remove toxicity, preserve precursor competence or supply repair substrates; direct repair can reduce replacement demand. No universal clearance-first or replenishment-first rule follows. The four mechanisms may coexist, oppose or enable each other within one tissue and across cycles. A failed selective manipulation is inconclusive; weakening one candidate does not establish another. Local force preservation tests a muscle recovery mechanism and cannot establish radical slowing of whole-human aging. Use SPV_5 only as a function-specific residual-loss measure: 100×(expected function−observed function)/expected function after the acute phase, where greater function is better and the expected denominator is meaningful. The counterfactual is uncertain, values may be negative, and episode changes are percentage points. The construct analogue needs an explicit reference trajectory. Avoid a progressively deeper residual deficit; stabilizing an already large deficit does not restore reserve. SPV_6, if later used, is a signed annual reserve slope; preservation raises a negative slope toward zero. Whole-human transfer requires persistent multisystem damage and vulnerability trajectories relative to expected untreated aging from the person's actual starting chronological age and state under comparable ordinary physical, infectious, psychosocial and environmental demands, without comparable harm or accelerated decline elsewhere. Maintenance during exposure and persistence after withdrawal are separate claims. Neither a radical effect magnitude nor a drug, nutrition or exercise protocol, dose, frequency, duration, adaptation or stopping rule is established. Latest repair preserves the frozen mechanism and unexpected consequence, all original fields and every current limitation. Criticisms retained in limitations are historical problem statements; the current tests below supersede the specific defective inference, not the candidate identity. Unknown evidence alone is not rejection. No alternative mechanism replaces a parent, so no branch is needed. The archive remains empty and no reported abstract is upgraded beyond abstract_only; here no abstract or source text is supplied.

Предсказание. Under the common conditions, first demonstrate that actual fusion contributes to the chosen mild-load recovery. Define each partner's functional readiness separately by pairing it across time with a standardized competent reference partner, controlling handling/contact, then validate in situ that readiness is transient and closes rather than simply increasing with maturation. Do not use the same failed pairing to define and test competence. Only after selective reversible phase manipulation is validated, cross precursor phase, recipient phase and absolute time since the defined clearance/injury event at multiple recovery times. Monitor viable cell number, local contact duration, adhesion, differentiation, nutrient use, localization and active exposure of relevant proteins, coassembly chemistry, registration and mechanical paths; equal integrated marker totals do not isolate phase. IH_04 predicts that independently moving either functional window shifts the favorable phase of its partner, with a prospective relative-phase interaction and losses on either side of overlap. Selectively correcting an actual mismatch should restore observed fusion followed by mature integration and repeated-load force without a mechanical bypass or altered mixed-complex chemistry. A common maturation gate can also yield a peaked arrival-time curve, so a bell shape alone is insufficient: test whether optimum timing follows relative functional phase beyond absolute postinjury time, nutrient readiness and competent contact. Validated normal competence/fusion plus a selective ineffective timing correction can weaken dominance in that setting; rescue of a downstream bottleneck alone cannot eliminate an earlier timing contribution. Lack of separable phase manipulation leaves the mechanism unresolved. For the SAME specified mild lesion, use a validated fusion-specific perturbation/rescue with other precursor functions tracked to test whether actual fusion causally contributes to mature force recovery. If it is nonlimiting, state that scope limit; do not increase injury and call that ordinary renewal. Only eligible lesions proceed to separate precursor and recipient opening/closing trajectories and their prevalence. An injury-rich culture demonstrates at most its own regenerative setting. Calibrate each reference partner's competence repeatedly through the assay interval, including donor/batch drift. Compare matched handling, adhesion, contact and reference-derived signals; test whether reference contact induces or prolongs the queried window. Confirm the predicted opening and closing in situ with independently validated nonresetting readouts before predicting untouched test-pair outcomes. If reference-induced state changes cannot be excluded, the inferred windows remain assay-dependent and unresolved. Prespecify each calibrated functional window's onset, closure, amplitude and duration at the available temporal resolution. At matched absolute recovery time, translating only precursor phase should move the favorable recipient phase and vice versa; translate both together at several otherwise eligible absolute times to test whether relative alignment retains its predicted advantage. Preserve/measure window amplitude, duration, competent contact, differentiation and nutrient readiness. Predict lower fusion for precursor readiness either earlier OR later than recipient readiness, not for an aligned pair merely early or late in absolute time. If amplitude, duration or common maturation changes, assess those ordinary alternatives; without separable shifts, the phase mechanism remains unresolved. Identify a particular substrate-removal event and compare its timing or selective occurrence while matching initial/procedural injury and observing nutrient readiness and precursor state. Require the event to shift the independently calibrated recipient trajectory before changed overlap, actual fusion, mature integration and later force. A timing rescue without that link supports timed fusion only, not why accelerated clearance harms recovery. Broad mTOR manipulation is not a selective substitute; no substrate or effective perturbation is supplied. При достаточности остальных условий синхронизация местных окон готовности предшественника и принимающего волокна могла бы уменьшать остаточную потерю без универсального правила «сначала удалить» или «сначала восполнить». Потеря предсказывается при расхождении окон в любую сторону: готовность предшественника слишком рано или слишком поздно ОТНОСИТЕЛЬНО готовности волокна. Само совпадение окон не становится неудачным только из-за раннего или позднего абсолютного срока; абсолютное созревание проверяется отдельно.

HERETICAL, conditional: In a subset of aging human epithelial mosaics, rare somatic fusion between a nonmalignant resident and an emerging invasive lineage may create viable hybrid descendants whose retained resident-derived growth-restraining allele or alleles restore invader growth control. The central mechanism is functional genome complementation within an invader-derived descendant; hybrid ancestry alone, generic polyploid stress or checkpoint activation would not establish it. If quantitatively consequential, removing fusion-competent residents could remove this component of protection even when fusion-incompetent replacement preserves successful daughter replacement, mature output and occupation. Nonlethal suppression of resident division could preserve the complementation component during a measured interval in which encounter rates, actual fusion incidence, functional allele expression and barrier competence remain adequate. Existing arrested hybrids need not resume growth when formation of new hybrids is blocked. Hybrids may instead remain invasive or later escape through chromosome loss; fusion alone never classifies a resident as beneficial. A contribution to limiting dangerous lineage expansion is possible, while SPV_9, anatomical invasion and whole-tissue function remain separate outcomes. Ordinary turnover competition can operate alongside this route.

Механизм. All causal claims are hypotheses about older human epithelial renewal, not demonstrated human-aging effects. The complete archived source corpus is empty; CHECKED FOUNDATIONS rates all supplied premises unknown. Candidate S-node IDs below identify motivating assertions, not primary evidence. No published novelty, effect size, safe clone size, clinical regimen, or whole-human aging benefit is claimed. Role: HERETICAL, provisionally nominated rather than certified. This is deliberately distant from clonal-composition-as-memory: the causal substrate would be a complemented genome within one descendant, and protection would survive without an expanding resident population. The practical implication, conditional on confirmation, is to preserve the relevant resident function when considering lineage suppression; it is not to induce fusion in people. Hybrids can instead be dangerous, so arrest, specialization and later escape must be followed through successive repairs. The proposed benefit cannot be inferred from hybrid counts or reduced tumor size alone. All predictions are proposed tests, not observations. Within each contrast use one prespecified older-human donor-derived epithelial site, recorded resident/invader genotypes and baseline lineages, comparable initial coverage, local contacts, nutrients, non-toxin injury, basement membrane and matrix. Site, donor age range and sex, perturbation intensity, repair timing and effect sizes remain unspecified. Measure absolute viable renewing and differentiated lineage counts, mutation acquisition, anatomically verified invasion and functional barrier recovery separately. SPV_9 is change in log cell fraction per year with a defined denominator and ancestry rule, not absolute growth or malignancy. Preserving mature output, progenitor reserve and growth control through repeated repair is an independent requirement. Experiments that change an intended control remain informative about a coupled mechanism but cannot isolate the proposed route. All four mechanisms can coexist with matrix effects; a selective effect identifies a contribution, and a null result bounds only the tested tissue, exposure and detectable effect. No whole-human antiaging efficacy follows. Operative repair qualifications (all proposed and unverified): Assume conditionally that the same NOTCH1 lesion changes daughter fates differently in normal esophageal progenitors and tumor cells; the supplied metadata do not establish any species, age, genotype combination or follow-up. Intrinsic tumor impairment is distinct from resident–neoplasm competition. Assume conditionally that competent mutant residents can exclude early neoplasms without immune removal being the operative cause. The mouse-style premise is unverified and transfers neither thresholds nor long-term human safety. Assume conditionally that chronic-colitis injury gives some IL-17-response mutant lineages, including NFKBIZ, relative resistance. Enrichment, resistance, barrier competence and prospective cancer prevention are different claims, all unverified here; the inflammatory-bowel-disease restriction remains. Assume conditionally that specified LOX-associated collagen crosslinking alters integrin/focal-adhesion signaling and cooperates with an oncogenic epithelial state to affect invasion. LOX crosslinking, LOXL2 inhibition, bulk stiffness and glycation chemistry are not interchangeable; no direct archived invasion or mutation-number result exists. The fusion premise remains unverified: naturally occurring viable resident–invader hybrids must first occur in the nominated older-human tissue, retain a functional resident allele and arrest. Neither competition metadata nor a pillar identifier supplies this observation; no forced fusion experiment alone establishes natural event frequency. Allele dependence is not uniquely defect complementation. Nominate and characterize the invader growth-control defect, parental allele activity and physiological copy dosage; use independent selective edits and allele-specific restoration within the same ancestral hybrid background. Control ploidy, fusion history, editing selection and generic fusion stress. A checkpoint restored downstream of the resident allele is a possible mechanism of complementation and must not be forced identical between allele states. Hybrid prevalence is not hybrid formation rate: it reflects incident formation, survival, arrest duration, persistence/loss and sampling recovery. A detectable rare event is neither automatically sufficient nor automatically negligible. The nondividing-resident surprise applies only to a directly established function-preserving dose/window. Division arrest can change encounters, allele expression, actual fusion, secretion and differentiation before coverage declines; no supplied dose or duration establishes such a window. Early arrest may leave a persistent hybrid reservoir whose later chromosome loss or escape reverses net benefit. Immediate expansion restraint and durable net protection are separate hypotheses; an adequate escape horizon is not supplied.

Предсказание. Proposed common-condition test: begin in sterile immune-free older-donor organotypic mosaics of one specified epithelial site, with traceable resident/invader nuclear genomes, measured local contacts, successful heterotypic replacement, baseline nutrient delivery, functional permeability and matrix. First live-track two viable parental cells becoming one viable hybrid, then establish nuclear organization, phased parental genomes, copy number/ploidy and subsequent fate; exclude doublets, engulfed nuclei, undegraded phagocytosed material, label or DNA transfer and transient colocalization. Quantify assay recovery and whether hybrid incidence and the descendants restrained could account for the field-level effect; an undetected rare event gives a sensitivity-dependent bound. Authentic fusion must precede durable arrest, but a necessary but not uniquely sufficient allele-dependence test is loss of a nominated functional resident allele within an established hybrid followed by release of arrest, and allele-specific restoration followed by restored restraint, with matched ploidy, fusion history and generic fusion-stress controls, measuring allele-dependent checkpoint changes without matching them away. Compare appropriate same-ploidy fusion controls to separate functional allele rescue from generic extra-DNA or fusion stress. If allele identity remains unknown, report fusion-associated arrest only. After that, a validated resident-specific fusion block should reduce new protective hybrid formation and increase viable invader-derived output relative to rescue, provided adhesion, polarity, secretome, local encounter geometry, replacement hazard, nutrient access and barrier function remain comparable. Test a new invader challenge separately from already formed hybrids. Division-arrested viable residents should retain only the fusion-attributable protection within the window where actual encounters, fusion and mature function persist. Track late chromosome loss, escape, mature contribution and basement-membrane crossing independently of arrest and cell number. A selective fusion/allele null with adequate event detection limits the proposed contribution in this setting; generic ploidy-dependent arrest favors a hybrid-stress alternative. Factorial matrix swaps can reveal an additional matrix contribution, including retained soluble factors, ligands and geometry; they do not eliminate complementation unless validated fusion/allele contrasts add no effect within those matrix strata. Additional required discriminators and bounded interpretations: Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. First calibrate recovery and live-track spontaneous two-parent-to-one viable hybrid events, phase parental nuclear genomes and copy number, and follow viability and arrest before attempting allele tests. If none are detected, give a tissue/window/recovery-dependent upper bound; missing or insufficiently detectable events leave wider-subset support unknown. Conditional on viable selective edits, physiological restoration of the nominated deficient function should reinstate allele-mediated restraint, whereas matched controls and independent edits test dosage or linked-state alternatives. Measure checkpoint changes as possible mediators, distinguishing them from generic fusion stress. If selectivity, viability or defect identity cannot be established, report allele-associated arrest or unresolved identification rather than rejection or proven complementation. Estimate incident hybrid events per time and their counterfactual viable descendant output avoided per event with uncertainty, including unfused invaders and hybrid persistence/loss. Integrate these contributions through repairs and compare with the observed field effect; sustained arrested-hybrid accumulation alone cannot account for a formation-mediated protective flux. Before the contrast, pilot and prespecify a window based on actual local contacts, fusion incidence, resident allele expression and mature/barrier function, then independently validate those conditions during the comparison. Retained fusion-attributable protection in that window does not predict months–years of adequate replenishment; follow repeated repair separately and call the isolated comparison inconclusive if its controls fail. Compare cumulative viable invasive descendants, hybrid persistence/escape and mature tissue contribution across successive repairs, with late chromosome and phenotype tracking. Report the observed horizon and remaining tail uncertainty explicitly; no early arrest or arbitrary finite horizon certifies long-term safety. Current finding-specific qualification: The avoided output of a fused invader is an unobserved counterfactual: an arbitrary unfused invader need not be exchangeable because fusion may select contact histories and cell states. A formation-mediated field contribution remains conditional on a justified comparable-ancestry/history contrast, not on hybrid prevalence. Constrain avoided descendant output using comparable ancestral lineages and pre-event contact/state histories together with selective formation loss/rescue; report residual selection uncertainty and sensitivity bounds if comparability fails. Integrate incident events, counterfactual output, hybrid persistence/loss, late escape and unfused descendants over the same horizon. No event frequency or quantitative protective effect is supplied.

SCOUT 1 — import from dominant-negative complex assembly and reaction kinetics: If a defined damaged old contractile species remains intact and incorporation-competent in aging human muscle, replenishment before its clearance could capture newly made functional material in defective mixed complexes. The strong candidate is incorporation-dependent impairment of nascent material beyond the expected loss from the measured mixture under an adequate ordinary native assembly model, including nonlinear cooperative and serial-link effects, with sufficient abundance, incorporation rate and residence time to affect force across repeated mild recovery. Bulk synthesis, adequate fusion and intact paths could then coexist with excess intrinsic complex dysfunction. Selective prior removal or temporary exclusion might improve later residual force despite a larger acute dip, but only if that dip does not create greater subsequent injury and exclusion does not merely lower toxic exposure. The stored lesion is species-specific biochemical identity and incorporation competence, not total damage, conformer propagation or position alone. The same retained component may supply registration or mechanical support while interfering chemically, so net sequence benefit is conditional. No molecular target, selective tool, physiological prevalence or older-human benefit is established; the implication does not prescribe withholding nutrition.

Механизм. Evidence status: the archived source corpus is empty. The supplied S-nodes and CHECKED FOUNDATIONS are candidate assertions; all audited verdicts are unknown. Source dates, readiness labels and apparent specificity do not verify them. No published experiment, historical novelty or older-human causal benefit is certified here. These are competing hypotheses for a dominant bottleneck under matched conditions, not mutually exclusive biological laws. Scout field: physical chemistry of mixed-subunit assembly, distinct from network connectivity and developmental timing. The supplied candidate puzzles are that clearance machinery must complete a cycle (S_M_G2_DOM05_001), precursor expansion does not ensure functional integration (S_M_G2_DOM05_010), and an anabolic signal is not completed replacement (audit G2_1_042). They do not report the proposed mixed-complex poisoning. Empirical grounding in this particular older-human mechanism, and whether this import has previously been applied, cannot be verified from the empty corpus; both remain explicit outstanding requirements. No particular oxidized protein, binding constant or human effect size is invented. This is a genuine competing biological explanation, not a claim that the functional gap is an artifact. Practical implication is a conditional research direction, not a drug, nutrition or exercise prescription. A reduction in tissue-level cumulative force loss would motivate human recovery studies, but would not establish radical slowing of whole-human aging. That further claim requires persistent multisystem damage and vulnerability trajectories without offsetting harm. Continued maintenance and benefit after withdrawal must be evaluated separately. If SPV_6 is subsequently used, preservation of a declining reserve means its signed annual slope increases toward zero, not decreases. All scientific support is unknown because the supplied sources archive is empty; S-node IDs, foundation IDs, RL labels, dates and embedded URLs are candidate metadata, not source evidence. No experiment or result described here has been performed in this task. These are conditional explanations of possible residual recovery loss in aging human muscle, with no certified historical novelty or living-human causal benefit. mTOR inhibition, autophagic initiation, completed cargo degradation, lysosome reformation, contractile-protein turnover, precursor fusion and whole-cell senolysis require separate causal accounts and readouts. Nutrient supply, absorption, utilization, synthesis, net accretion and mature integration are distinct. The post-disuse candidate concerns impaired rather than necessarily absent nutritional response; its related population is overweight, prediabetic older adults, and transfer to ordinary infection convalescence is unverified. Clearance can also remove toxicity, preserve precursor competence or supply repair substrates; direct repair can reduce replacement demand. No universal clearance-first or replenishment-first rule follows. The four mechanisms may coexist, oppose or enable each other within one tissue and across cycles. A failed selective manipulation is inconclusive; weakening one candidate does not establish another. Local force preservation tests a muscle recovery mechanism and cannot establish radical slowing of whole-human aging. Use SPV_5 only as a function-specific residual-loss measure: 100×(expected function−observed function)/expected function after the acute phase, where greater function is better and the expected denominator is meaningful. The counterfactual is uncertain, values may be negative, and episode changes are percentage points. The construct analogue needs an explicit reference trajectory. Avoid a progressively deeper residual deficit; stabilizing an already large deficit does not restore reserve. SPV_6, if later used, is a signed annual reserve slope; preservation raises a negative slope toward zero. Whole-human transfer requires persistent multisystem damage and vulnerability trajectories relative to expected untreated aging from the person's actual starting chronological age and state under comparable ordinary physical, infectious, psychosocial and environmental demands, without comparable harm or accelerated decline elsewhere. Maintenance during exposure and persistence after withdrawal are separate claims. Neither a radical effect magnitude nor a drug, nutrition or exercise protocol, dose, frequency, duration, adaptation or stopping rule is established. Latest repair preserves the frozen mechanism and unexpected consequence, all original fields and every current limitation. Criticisms retained in limitations are historical problem statements; the current tests below supersede the specific defective inference, not the candidate identity. Unknown evidence alone is not rejection. No alternative mechanism replaces a parent, so no branch is needed. The archive remains empty and no reported abstract is upgraded beyond abstract_only; here no abstract or source text is supplied.

Предсказание. Under the common conditions, identify the damaging modification and intact old molecular lineage inside native nascent functional complexes with orthogonal structural/biochemical association measurements. Include isotope-recycling, juxtaposition, aggregation, contamination, extraction and post-lysis exchange controls; tracer incorporation alone is not intact coassembly. Test isolated or minimally reconstituted assemblies across measured occupancy, comparing undamaged and damaged incorporation-competent versus suitably matched nonincorporating material. IH_03 predicts occupancy-dependent dysfunction exceeding a prospectively specified ordinary native composition-and-assembly null incorporating stoichiometry, cooperativity, serial weak links, occupancy distributions and spatial heterogeneity, then replacement-first increases this occupancy before persistent force loss in tissue with adequate registration, connectivity and actual fusion. Only after a selective tool is validated, cross sequence with permission/exclusion of coassembly while validating comparable total amount, time-resolved local free/bioactive exposure and encounter history, and normal assembly composition and competence, accessibility to degradation, signaling and effective synthesis. Selective exclusion should restore complex function and later force and reduce the portion of sequence effect mediated by poisoning; no complete abolition is expected if other bottlenecks remain. Incorporation-competent add-back should reverse the rescue, while an otherwise validated equal-damage nonincorporating comparator should not. If exclusion sequesters toxin or alters ordinary assembly, rescue is ambiguous. Clearance benefit alone, oxidation correlations or ordinary old/new mixtures do not discriminate. A selective null weakens this species-specific mechanism; benefits from registration, routes or timing may coexist and do not confer a unique winner. Before sequence inference, identify intact damaged old molecules in native nascent complexes with orthogonal lineage/association and artifact controls, and measure abundance, encounter/incorporation kinetics, occupancy distribution and residence time during the same mild recovery. Establish whether enough intact material persists at physiological occupancy to impair intrinsic function across ordinary cycles. No invented protein identity, affinity, modification or effective dose is substituted for this gate. Specify the native assembly unit and expected intrinsic function prospectively using measured stoichiometry, occupancy distribution and spatial heterogeneity, cooperativity, serial weak links and ordinary mechanical coupling. Include independently measured undamaged and damaged component behavior and uncertainty; do not assume proportional dilution. Only a reproducible residual beyond this adequate null, together with intact incorporation and selective causal evidence, supports the stronger impairment-of-new-material claim. Raw nonlinearity or residuals against an inadequate linear model are non-diagnostic. Validate time-resolved local free/bioactive concentration, encounter/contact history over the assembly interval, normal composition and stoichiometry, degradation accessibility, signaling and synthesis in permission/exclusion arms. Show that exclusion/add-back itself does not change damage or ordinary assembly competence. Equal steady-state concentration alone fails this test. If that counterfactual cannot be realized, rescue remains ambiguous and a null is not a falsification; species-specific inference requires demonstrated selectivity and adequate sensitivity. After validating the complex lesion, test whether actual clearance reaches the species selectively and whether sequence changes occupancy before force loss. Account separately for acute force dip, subsequent injury, registration loss, route loss, rebuilding, precursor integration and retained toxicity across cycles. Predict later unassisted benefit only when avoided incorporation harm exceeds these costs. An isolated-assembly result does not determine net sequence benefit, dose, interval, prevalence or persistence. No nutrition withholding or living-human clearance protocol follows.

SCOUT from cutaneous pharmacology and lipid receptor biology, conditional: In a prospectively defined subset of aging humans, a topical lipid L may activate a receptor R in a defined viable skin-cell population, alter a receptor-regulated endogenous mediator K and thereby reduce formation of a specified remote damage class independently of equivalent physical barrier restoration. L, R, K, the responding cells and the remote damage class remain unresolved identities. The frozen unexpected consequence is retained as a separate strict comparative hypothesis: under a specified population, exposure, maintenance regime and post-transient interval, receptor-active formulation A has a lower deterioration slope than a defined metabolic-demand-reduction comparator M, while barrier-equivalent receptor-inactive formulation B does not: b_A<b_M and b_B≥b_M. Practical effect-margin hypotheses are distinct and cannot substitute for this ordering. Receptor dependence alone entails neither version. Physical barrier repair, lysosomal repair, efferocytosis restoration and metabolic-demand reduction may provide compatible or interacting benefits. The proposed endogenous-mediator pathway must be distinguished from direct remote action of formulation constituents and metabolites, including receptor-regulated production or transport of active metabolites in skin. If sustained endogenous signaling reduces remote damage formation while preserving function, it could improve corresponding SPV_1 components. Neither the pathway, strict ordering, practical magnitude nor whole-human benefit is established.

Механизм. The SCOUT role and lipid-receptor-pharmacodynamics mechanism are retained. The frozen active-only strict ranking is preserved separately from receptor mediation and separately from practical margins. A and B may both improve upon vehicle while only A exceeds M. Evidence excluding a meaningful benefit for B may still permit a small benefit for B and cannot confirm b_B≥b_M. Evidence for b_A<b_M may still be too small to be practically important. No observed ordering or margin result is supplied. This comparison concerns A and B relative to the defined M in the specified regime, not universal superiority over all interventions or all people. Downstream lysosomal or corpse-clearance benefits remain possible even when they leave the skin source intact. Skin is not assumed to be the exclusive inflammatory source. Foundations C05–C07 are contextual provenance labels, not archived evidence. Circulating cytokines establish neither skin origin nor remote damage formation nor aging-rate control. All shared source, SPV_1, accounting, measured-demand, function, clinical-vulnerability, harm, maintenance and feasibility conditions in IH_Q_L3_M_G1_1_01 apply. Physical barrier permeability, constituent penetration, receptor activity and remote exposure are distinct measurements. Unresolved direct pharmacology and endogenous mediation can coexist. Actual exposure, baseline barrier impairment, remote vulnerability and adherence bound the comparison. Skin irritation, infection defense, wound repair and hidden systemic costs require separate assessment. The hypothesis remains distinct from microbial toxicology, latent microbial reservoirs and marker-artifact explanations. No replacement mechanism is introduced.

Предсказание. Use paired older-human skin explants with recorded age, sex, anatomical site, baseline barrier condition, disease and treatment, coupled initially to a specified human endothelial model. The proposed initial scope is viable older-donor skin with reproducible receptor engagement and measurable baseline secretory activity, connected to remote cells with a prospectively defined damage-formation endpoint. Identify L, R, responding skin-cell type, endogenous K and the remote damage class before confirmatory mechanism testing. Define eligibility independently of a favorable confirmatory outcome. Confirm the identified chain in separate material. Compare chemically defined active A and inactive B with matched vehicle, coverage and hydration. Repeatedly establish equivalence of relevant physical permeability, water loss, irritant flux, lipid organization, viability and local injury throughout exposure and receptor manipulation, using justified model-specific bounds and intervals. Define each permeability probe and compartment. Measure penetration and concentration-time profiles of each formulation constituent separately; equivalent physical permeability does not imply equal biologically active ligand exposure or receptor engagement in A and B. If the needed physical separation cannot be maintained, the independent receptor contribution remains unresolved rather than disproved. Cross skin-restricted receptor interruption with rescue. Deplete or block K and restore it at its measured physiological exposure. Include sham depletion, recovery measurements and an orthogonal mediator-blocking approach where feasible; quantify whether depletion also removes bound lipid, metabolites, carrier proteins or other active medium components. Receptor interruption can change uptake or metabolism of the formulation, so quantify those changes rather than interpreting receptor dependence alone as endogenous mediation. Trace applied L, other constituents, metabolites, tissue binding, reservoirs and delayed release; reproduce measured remote concentration-time profiles in direct-exposure controls. Establish endogenous K identity and origin separately from formulation-derived active metabolites. The focal mechanistic prediction is R-dependent endogenous K output reaching the remote compartment at sufficient exposure, with reduced formation of the specified damage and preserved function. Selective K interruption removes its attributable protection, and physiological add-back restores that component after physical and direct-exposure explanations are accounted for. Add-back demonstrates sufficiency only in the tested background, not universal sufficiency. Incomplete exposure accounting or nonselective depletion retains a mixed or unresolved mechanism. For the stronger ranking, directly compare A, barrier-matched B, a defined measured-demand-reduction arm M, and vehicle or appropriate usual-care controls, adding rival handles where feasible. Here M names the comparator arm, whereas M in IH_02 denotes macrophage density. Fix population, baseline impairment, remote vulnerability, exposures, maintenance, damage class and post-transient interval prospectively. For the selected deterioration slope, positive means worsening. Define Δ_A=b_A−b_M and Δ_B=b_B−b_M in the same damage-per-time units. The frozen strict hypothesis H_strict is Δ_A<0 AND Δ_B≥0. Evaluate both zero-threshold contrasts jointly with prespecified uncertainty control: an upper confidence bound below zero for Δ_A supports A's strict superiority; a lower bound at or above zero for Δ_B supports B's non-superiority under the stated inferential assumptions. An interval crossing zero leaves the corresponding ordering unresolved. Exact equality cannot generally be established by finite noisy observations, and nonsignificance does not establish Δ_B≥0. Separately define positive practical margins δ_A and δ_B before testing. A practical hypothesis H_practical may be Δ_A<−δ_A AND Δ_B>−δ_B: A exceeds the chosen meaningful-benefit margin, while a benefit of at least δ_B for B is excluded. This allows a small negative Δ_B and therefore does not establish H_strict. Conversely, H_strict allows an arbitrarily small negative Δ_A and therefore does not establish meaningful superiority for A. Assess practical bounds against their own thresholds and report strict ordering, meaningful A benefit and exclusion of meaningful B benefit separately. Symmetric equivalence, if tested, is another claim and does not prove Δ_B≥0. Call a margin clinically meaningful only if its clinical interpretation is justified; a culture-assay threshold alone supplies an experimental relevance margin. No margin value is established here. R interruption or K depletion should remove A's mediator-attributable protection or comparative component, and rescue should restore it; the direction of every residual A-versus-M contrast is not fixed if other pathways also act. Measure formation, removal, cell loss, composition and function separately. Observe signaling over hours and injury over days, repeating only within verified viability. Failure of strict or practical ranking limits that specific claim even if endogenous receptor-mediated protection exists. Human systemic delivery, maintenance and multisystem trajectories require subsequent evidence.

CROSS-DOMAIN TRANSFER, conditional: During aging human epithelial renewal, successful incorporation of resident progenitor daughters may displace viable invader cells from renewing positions and thereby restrain dangerous lineage growth. The proposed protective variable is an event-resolved heterotypic replacement hazard. Gross daughter production, resident fraction and mutation count do not by themselves measure that hazard: daughters can replace their own parent or remain within a resident patch. Stable resident abundance with positive production is compatible with turnover but does not prove invader displacement. Nonlethal reduction of resident output could release pre-existing invaders before mean coverage changes if it actually reduces successful heterotypic replacement; competent fusion-incompetent replacement could restore this protection if it restores the relevant local replacement events. Spatial crowding, contact mechanics and neighbor fate may implement this mechanism and are not automatically rivals. The nontrivial transferable claim is prospective prediction of invader renewing-cell growth in held-out repairs from previously estimated time/geometry-conditioned fate and replacement relationships, not reconstruction from the same repair after observing its outcome. Higher progenitor retention must not divert output from mature specialization or deplete future reserve; a strong competitor can still be harmful. SPV_9 and anatomical invasion require independent outcomes beyond absolute renewing-cell growth.

Механизм. All causal claims are hypotheses about older human epithelial renewal, not demonstrated human-aging effects. The complete archived source corpus is empty; CHECKED FOUNDATIONS rates all supplied premises unknown. Candidate S-node IDs below identify motivating assertions, not primary evidence. No published novelty, effect size, safe clone size, clinical regimen, or whole-human aging benefit is claimed. Role: CROSS-DOMAIN TRANSFER from developmental morphogenesis and pattern formation, specifically a branching differentiation/population-asymmetry model of tissue renewal. It imports cell-production and cell-fate accounting, not bioelectric sensing, reaction-diffusion signaling or tissue topology. S_M_G4_DOM01_008 and G4_1_C01-C03 are the unverified candidate motivation. Clonal dynamics is unavoidable in this focal question; the particular causal claim is measured daughter-replacement flux at fixed lineage composition, not clonal composition as a stored state. A candidate practical sequence would preserve competent replacement output while investigating selective restriction of functionally harmful output; no clinical schedule follows. Model mismatch is itself informative and does not make invasion an artifact. All predictions are proposed tests, not observations. Within each contrast use one prespecified older-human donor-derived epithelial site, recorded resident/invader genotypes and baseline lineages, comparable initial coverage, local contacts, nutrients, non-toxin injury, basement membrane and matrix. Site, donor age range and sex, perturbation intensity, repair timing and effect sizes remain unspecified. Measure absolute viable renewing and differentiated lineage counts, mutation acquisition, anatomically verified invasion and functional barrier recovery separately. SPV_9 is change in log cell fraction per year with a defined denominator and ancestry rule, not absolute growth or malignancy. Preserving mature output, progenitor reserve and growth control through repeated repair is an independent requirement. Experiments that change an intended control remain informative about a coupled mechanism but cannot isolate the proposed route. All four mechanisms can coexist with matrix effects; a selective effect identifies a contribution, and a null result bounds only the tested tissue, exposure and detectable effect. No whole-human antiaging efficacy follows. Operative repair qualifications (all proposed and unverified): Use hbar_RI[a,b]=H_RI[a,b]/integral_a^b I(t)dt only as an interval cell-time-weighted estimator. Define the proposed time-local conditional intensity h_RI(t,s) per viable renewing invader in prespecified spatial/contact stratum s, with E[dH_RI(t,s)|history]=h_RI(t,s) I_s(t)dt. This is a modeling convention requiring event-resolved validation, not a measured law. In a closed homogeneous stratum the rare-invader mean equation is dI_s/dt=[lambda_I(t,s)(2p_I(t,s)-1)-delta_I_other(t,s)-h_RI(t,s)]I_s; explicitly add measured net migration/other flows if present. For no omitted flows, predict I_s(b)=I_s(a)exp(integral_a^b g_I(t,s)dt), then sum strata, or integrate the coupled flow equations. Do not substitute hbar for h(t,s) without validating approximate stationarity. A pooled average can hide repair-stage or boundary changes. At fixed lambda_R AND fixed P_R, or at an instantaneous comparison with the same progenitor count, increasing p_R decreases gross mature daughter production 2lambda_R(1-p_R)P_R. Over time P_R(t), division rates and mature survival change, so the sign of cumulative mature output is not determined by p_R alone. No universal longitudinal monotonic reduction is claimed. These are conditional mean compartment-balance equations under binary division, measured marginal daughter fate probabilities and exhaustively represented compartment flows, not a validated aged-human developmental law. Correlated sisters do not invalidate mean counting; omitted immigration, dedifferentiation or heterogeneous rates can invalidate this reduction. J_R=2lambda_R p_R P_R/A is a proposed gross daughter-production measure under the stated accounting and area convention, not a measured displacement hazard. Stable P_R with positive J_R is compatible with turnover but does not prove invader loss. The complete fate balance is near an accounting identity. The nontrivial transfer claim is that relationships estimated before a new repair predict its trajectory without using that repair's final growth to choose kappa_R. h_RI(t,s)=kappa_R(t,s)J_R(t,s) remains an unverified restricted relation, not a universal constant-coefficient law. The log-fraction relation is an algebraic identity for positive consistently counted numerator and denominator, not empirical evidence or a validated causal transfer. Its tissue application remains conditional on ancestry, compartment and copy-number-corrected counting; zeros require reported detection bounds rather than undefined logarithms. Assume conditionally that the same NOTCH1 lesion changes daughter fates differently in normal esophageal progenitors and tumor cells; the supplied metadata do not establish any species, age, genotype combination or follow-up. Intrinsic tumor impairment is distinct from resident–neoplasm competition. Assume conditionally that competent mutant residents can exclude early neoplasms without immune removal being the operative cause. The mouse-style premise is unverified and transfers neither thresholds nor long-term human safety. Assume conditionally that chronic-colitis injury gives some IL-17-response mutant lineages, including NFKBIZ, relative resistance. Enrichment, resistance, barrier competence and prospective cancer prevention are different claims, all unverified here; the inflammatory-bowel-disease restriction remains. Assume conditionally that specified LOX-associated collagen crosslinking alters integrin/focal-adhesion signaling and cooperates with an oncogenic epithelial state to affect invasion. LOX crosslinking, LOXL2 inhibition, bulk stiffness and glycation chemistry are not interchangeable; no direct archived invasion or mutation-number result exists. Successful daughter incorporation is causal only if it contributes to loss of an otherwise viable invader renewing position, rather than filling an already empty position or following an independently determined fate. Ordinary mechanics may implement this displacement and is compatible with the mechanism. Use a prespecified event ledger: assign each division's initial daughter renewing/differentiated fate at a validated early post-division assessment before a later separately scored replacement; any ensuing renewing-position exit is recorded once as replacement-attributable or other loss. The timing and phenotype rules must be validated for the selected tissue, not invented as measured biology. Simultaneous or uncertain ordering remains a separate ambiguous category with alternative-allocation bounds. Replacement-caused extrusion/differentiation/death is not counted again in delta_I_other or p_I.

Предсказание. Proposed common-condition test: in a sterile immune-free older-donor epithelial mosaic of one site, track a complete resident–invader boundary fate ledger: division, daughter retention and differentiation, migration, extrusion direction, death, vacancies and actual replacement of viable invader renewing positions. Keep invader genotype, initial lineage composition, matrix, baseline nutrients and functional permeability comparable and measure local contact geometry, density, cell size, tension proxies and signaling. First test whether gross J_R predicts directly observed h_RI at all. Then reversibly alter resident output with a resident-autonomous perturbation and rescue during the measured window before mature function or coverage diverges, with direct invader-exposure controls. If the mechanism operates, a reduction in successful h_RI should reduce position-loss events and increase absolute renewing-invader growth by the event-accounted amount when other rates are unchanged; restoring h_RI with competent fusion-incompetent cells should restore that component of restraint. Equal J_R alone does not establish equivalent replacements, and no mutation-count-independent invasion claim is made without equivalent contacts, hazards and function. Estimate parameters from mutually exclusive observed fates, predict held-out episodes, and vary geometry explicitly rather than absorbing every result into kappa_R. Gross production changes with no h_RI change and no growth effect favor a contact/occupancy explanation over a transferable gross-flux law. Coupled mechanical and replacement effects support spatial turnover competition and limit an independent constant-coefficient model. Measure mature output and next-cycle reserve independently; a lower g_I cannot compensate for their deterioration. If toxin or feeding interruption removes an ablation-associated excess while h_RI stays low, this limits flux loss as a sufficient or dominant cause only when invader growth capacity is preserved. Nutrients can increase lambda_I or survival enough to overcome high h_RI without disproving displacement. Cross matrix strata that preserve both lineages and allow events; matrix effects may alter h_RI or other rates and can coexist, while a selective h_RI null bounds this contribution. Report SPV_9 with denominator growth and anatomical crossing separately. Additional required discriminators and bounded interpretations: Before observing held-out net growth, estimate time/geometry-conditioned rate relationships on other repairs, then integrate their predicted local trajectories and propagate event-recovery, parameter and ambiguous-fate uncertainty. Compare predicted absolute I and separate tissue clone fractions with observations. A failed stationary approximation limits that reduction, not the possibility of displacement; post hoc reconstruction from the same outcome episode is bookkeeping, not predictive transfer. Follow P_R(t), mature daughter production, D_R survival/lifespan, tissue-specific mature function, growth control and reserve available at the next repair jointly. Integrate mature inflow and loss over time; a lower renewing-invader growth rate or higher J_R does not establish beneficial aging renewal or adequate specialization. Track divisions, daughter states, nondivision loss and mature survival separately; audit migration/dedifferentiation and include their net flows or restrict the model to a justified closed interval. Estimate time/geometry-conditioned rates and prospectively integrate held-out repair trajectories with uncertainty, preserving specialized function as an independent outcome. Directly count gross progenitor daughters per measured area/time and separately follow which reach and causally replace viable invader positions. Record changing area and boundaries; compare J_R with the event-resolved hazard in held-out geometry/time strata, allowing no relation or changing kappa_R. Freeze training-derived time/geometry relationships and predictive uncertainty before held-out episodes, including reciprocal replacement and repair-stage changes; use observable starting state and prespecified inputs. Recounting all held-out fates afterward checks accounting only. If no useful stable relation survives, retain event-caused displacement conditionally and reject or bound that transportable reduction, not replace its mechanism. Prespecify invader-derived hybrid membership and count each viable descendant once in a lineage numerator, track renewing and differentiated compartments and denominator dynamics, and report SPV_9 per year separately from absolute growth and crossing. Check observed count consistency and uncertainty; changing fractions or mutation counts alone cannot establish malignancy or whole-human aging benefit. Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. Use time-resolved boundary imaging plus selective resident output/incorporation perturbation and rescue, comparing the ordering of viable position occupancy, incorporation and invader exit. Prespecify uncertain-order cases and bound their influence; preserved area or gross J_R alone cannot identify replacement causation. Calibrate fate observation and missed events; report growth bounds under plausible assignments of ambiguous events without allocating them to fit the equation. Track displaced descendants as viable differentiated, basally displaced, dead or unresolved separately: loss from the renewing compartment is not automatically loss of the clone or anatomical safety. Current finding-specific qualification: The exponential compartment trajectory applies to a deterministic or justified conditional-mean reduction with homogeneous prescribed rates and represented flows; it is not a realized rare-clone trajectory or an extinction law. For random history-dependent rates, dE[I_s]/dt=E[g_s I_s]+E[net flows], and E[g_s I_s] generally differs from E[g_s]E[I_s]. A product-of-means closure requires independent justification. Prespecify and validate the closure on training repairs or integrate an explicit history-dependent stochastic model; propagate event, rate and demographic variability into held-out expected counts and outcome distributions. Report realized counts and extinction separately, without replacing the already defined time-local hazard by the pooled interval estimator. Compare equally prespecified contact/occupancy models. Match baseline mechanics; measure mechanics caused by daughter incorporation as part of its total displacement effect instead of clamping that mediator. A failed closure or proportional hazard reduction limits that reduction, not event-caused displacement.